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MLBG Melki lysis buffer denaturing buffer 
MLBGE Melki lysis buffer elution 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NHS N-Hydroxysuccinimide 
mAu Milli absorbance unit 
PBS Phosphate buffered saline 
PMSF Phenylmethanesulphonyl fluoride 
ssNMR Solid-state nuclear magnetic resonance 
SEB ɲ-Synuclein ion exchange entry buffer 
SEM Standard Error Mean 
SEIB ɲ-Synuclein ion exchange elution buffer 
SFFB Sup35 fibril forming buffer 
 xiii 
SPAAC Strain promoted azide alkyne cycloaddition 
SyFFB ɲ-Synuclein fibril forming buffer 
SIA Succinimidyl iodoacetate 





PCR Polymerase chain reaction 
PTM Post-translational modification 
PPI Protein-protein interaction 
Rpm Revolutions per minute 
rDNA Recombinant deoxyribonucleic acid technology 
SDD-AGE Semi-denaturing detergent agarose gel electrophoresis 
SDS Sodium dodecylsulphate 
SDS-PAGE Sodium dodecylsulphate polyacrylamide gel electrophoresis 
TAE Tris base, acetic acid and EDTA buffer 
TEMED Tetramethylethylenediamine 
Tris-HCl Tris(hydroxymethyl)aminomethane hydrochloride salt 
Tris base Tris(hydroxymethyl)aminomethane 
TEM Transmission electron microscopy 
ThT Thioflavin T 
TMS Tetramethylsilane 






Amyloid structures have been identified as a key pathological marker in a range of 
ĐŽŶĚŝƚŝŽŶƐ ƐƵĐŚ ĂƐ ůǌŚĞŝŵĞƌ ?Ɛ ĂŶĚ WĂƌŬŝŶƐŽŶ ?Ɛ ĚŝƐĞĂƐĞ ?  ĐŽŵďŝŶĂƚŝŽŶ ŽĨ ƚŚĞŝƌ ĚŝƐĞĂƐĞ
relevance and potential nanomaterial applications has made understanding amyloid 
formation and the source of its toxicity of great interest. The fragmentation of amyloid 
fibrils into smaller particles is important for the kinetics of their formation and how they 
elicit toxicity.  This thesis sheds light on how fibrils formed from different proteins 
fragment, and compares their resistance to mechanical stress, in order to decipher if fibril 
fragmentation mechanism is fibril dependent or a property shared by amyloid fibrils in 
general.  To accomplish these goals, this thesis is divided into three sections. 
The first part of this thesis develops methods for recombinant production and purification 
ŽĨ^ƵƉ ? ?ED ?^ƵƉ ? ?EDĂŶĚɲ-synuclein proteins.  In vitro polymerisation conditions for 
these proteins and the commĞƌĐŝĂůƉƌŽƚĞŝŶƐ ůǇƐŽǌǇŵĞ ?ɴ-lactoglobulin and insulin B chain 
has enabled, via AFM imaging methods and MatLab tracing, the calculation of persistence 
length from far larger populations than has previously been observed. 
The second part investigates the resŝƐƚĂŶĐĞ ƚŽ ŵĞĐŚĂŶŝĐĂů ƐƚƌĞƐƐ ŽĨ ɲ-ƐǇŶƵĐůĞŝŶ ? ɴ-
lactoglobulin and lysozyme fibrils using a fragmentation assay, which enables the 
ĚĞƚĞƌŵŝŶĂƚŝŽŶĂŶĚĐŽŵƉĂƌŝƐŽŶŽĨƚŚĞĨŝďƌŝůƐ ?ƌĞƐŝƐƚĂŶĐĞƚŽŵĞĐŚĂŶŝĐĂůƐƚƌĞƐƐ ?dŚŝƐǁŽƌŬŚĂƐ
demonstrated that polymer rigidity (Lp) is inherently linked to the resistance of the tested 
amyloid fibrils to mechanical stress.  
 The third part of the thesis successfully implements a chemical labelling strategy using 
 ‘ĐůŝĐŬ ? ĐŚĞŵŝƐƚƌǇto allow a modification of fibril functionality.  This has been applied to 
fluorescence labelling strategies and 19F-labelling for novel methods of determining the 
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1.1   History and Origins of Amyloid 
In 1854 the pioneer pathologist Rudolph Virchow showed evidence of starch like 
accumulations in abnormal brain tissue using iodine/sulphuric acid staining, and termed 
them amyloid through this association with starch and its Latin/Greek root 
Amylum/Amylon (Sipe and Cohen, 2000).  ^ƵďƐĞƋƵĞŶƚƌĞƐĞĂƌĐŚ ŝĚĞŶƚŝĨŝĞĚƚŚĞƐĞ  ‘ƉůĂƋƵĞƐ ?
as proteinaceous in nature and, in fact, the product of the aggregation of misfolded 
proteins.  In the majority of cases protein misfolding and aggregation leads to unstructured, 
amorphous deposits but the formation of amyloid is far more ordered, developing into long 
needles or fibrils, with dimensions ranging from 2-10nm in width and a heterogeneous 
mixture of lengths from nanometres to many micrometres (Fitzpatrick et al., 2013).  The 
core, structured region of amyloid fibres, contains a cross-beta sheet architecture, the 
presence of which is now the structural definition of amyloid.  The confirmation of the 
cross-beta sheet is usually by biophysical methods like X-ray diffraction (Bonar et al., 1969) 
and the binding of cross-beta sheet specific dyes such as Thioflavin T (Biancalana and 
Koide, 2010; Khurana et al., 2005; Krebs et al., 2005) and Congo Red.  
 
Table 1.1 Observed Amyloidogenic Proteins.* 
Protein Type Disease/Role 
Amyloid-ɴƉĞƉƚŝĚĞ Disease ůǌŚĞŝŵĞƌ ?ƐĚŝƐĞĂƐĞ 
ɲ-Synuclein Disease WĂƌŬŝŶƐŽŶ ?ƐĚŝƐĞĂƐĞ 
Huntingtin Disease ,ƵŶƚŝŶŐƚŽŶ ?ƐĚŝƐĞĂƐĞ 
ɴ ?-microglobulin Disease Haemodialysis-related amyloidosis 
Lysozyme Disease Lysozyme amyloidosis 
Insulin Disease Injection localized amyloidosis 
Curli Functional Role in colonisation of inert surfaces and 
aids in Biofilm formation 
Sup35 Functional Acts as an epigenetic switch generating 
new phenotypes 
Chaplins Functional Lowers water tension allowing formation 
of aerial hyphae 
*Examples of the peptides/proteins associated with Amyloid formation and their biological 
significance whether a relationship to a disease or a biological function of the material.  
Adapted from (Chiti and Dobson, 2006; Knowles et al., 2014). 
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The phenomenon of amyloid formation is not limited to a single protein/peptide sequence 
but a trait of many different and unrelated protein sequences.  Examples include amyloid 
associated with disease and functional biological amyloid materials (Table 1.1).  Whilst the 
identified human proteome currently consists of 17294 proteins (Kim et al., 2014) the 
number of proteins shown to form amyloid fibrils, across all species, is currently only 40 
(Chiti and Dobson, 2006).  Whilst this list of proteins, to date, is relatively small it has been 
postulated, due to the presence of smaller amyloiogenic sequences in far more proteins, 
that if subjected to the appropriate conditions all proteins could form amyloid structures 
(Dobson, 1999). 
The physical properties such as strength that make amyloid a useful material for organisms 
also makes them potentially useful as a nanomaterial (Maji, 2011).  When considering their 
potential as a nanomaterial, their involvement in numerous debilitating illnesses, and the 
difficulty in obtaining information about even the earliest points in the assembly, it is of no 
surprise that there is a vast amount of research carried out in the area of amyloid.  
Understanding the underlying processes of amyloid formation is therefore imperative to 
curing amyloid associated disease and developing the next generation of nanomaterials. 
1.2   The Mechanism of Fibril Formation 
Proteins are the workhorses in all cells and organisms.  Many processes in the cell are 
under the strict control/regulation of numerous pathways, which are built up of numerous 
highly selective protein-protein interactions (PPI) including the formation of multimeric 
complexes and catalysing post-translational modifications (PTM) such as phosphorylation 
and acetylation. 
The process of Translation, the ribosome-mediated synthesis of polypeptides from mRNA, 
is a core biological process in which genetic information is converted into proteins.  The 
folding of the synthesised polypeptide (primary structure) into the secondary and tertiary 
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structures are what gives the protein the appropriate three dimensional shape to function 
(Dobson, 2003) (Fig. 1.1).   
 
The shape and activation state of a protein can also be altered by the modification of 
amino acid sidechains in a process called Post-Translational Modification e.g. 
phosphorylation and acetylation (Seo and Lee, 2004).  A single three dimensional image of 
a protein only represents one conformation, usually the lowest energy, but this is not an 
accurate representation of a protein molecule in solution.  A protein molecule is dynamic in 
its shape, constantly changing due to its bonds stretching and bending, and moving 
between multiple low energy conformations (Frauenfelder et al., 1991).  By considering 
each different species and their energy it is possible to create an energy landscape showing 
folding intermediates and aggregates (Fig. 1.2). 
 
Figure 1.1 Abberrant Protein Folding Can Lead to Aggregation. 
The ribosomal synthesis of proteins generates a nascent peptide chain which is folded by 
molecular chaperones (see blue cylinders) into native folded proteins.  The misfolding of 
proteins can give rise to amorphous aggregates as well as the generation of amyloid fibrils.  
With Lysozyme as a folded protein example. 
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The  ‘ƉƌŽƚĞŝŶ ŵŝƐĨŽůĚŝŶŐ ŚǇƉŽƚŚĞƐŝƐ ? ĚĞƐĐƌŝďĞs the formation of amyloid whereby the 
aberrant folding of a normally soluble protein to give an unfolded or partially folded species 
interacts with another similarly misshapen protein, the addition of further misfolded 
monomers to this dimer and subsequent species forms the fibril (Soto, 2001), see the right-
hand side of figure 1.2. 
 
When the appropriate conditions are encountered the misfolding of proteins can occur 
spontaneously but the propensity of this process can be modified by two main factors: 
primary sequence alteration and post-translational modifications. 
1.2.1   Primary Sequence Alterations 
A single change to the nucleotide sequence which codes for a protein can result in a change 
in the amino acid sequence of the protein.  These mutations could have a negligible effect 
on the protein but conversely could also seriously affect the function of the protein by 
removing catalytic residues or changing the overall shape of the protein.  A single change to 
the amino acid sequence has the potential to alter the energy barriers for the 
interconversion between protein conformations and therefore inhibiting or promoting 
amyloid formation.  This is seen for example with mutations to ɲ-synuclein, aggregates of 
 
Figure 1.2 Energy Landscape of Amyloid Formation. 
An energy level diagram showing the energy of species per monomer involved in the proper 
folding of a protein monomer (left) leading to the aggregation of monomeric proteins in to 
fibrillar aggregates (right).  Taken from (Hartl and Hayer-Hartl, 2009) 
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which have been shown to form the major component of Lewy bodies, the pathogenic 
marker ĂƐƐŽĐŝĂƚĞĚǁŝƚŚƚŚĞŽŶƐĞƚŽĨWĂƌŬŝŶƐŽŶ ?ƐĚŝƐĞĂƐĞ (Dauer and Przedborski, 2003).  
 
dŚĞƌĞĂƌĞƚǁŽŵĂŝŶƚǇƉĞƐŽĨWĂƌŬŝŶƐŽŶ ?ƐĚŝƐĞĂƐĞ PƐƉŽƌĂĚŝĐ ?ǁŚŝĐŚŝƐŵŽƌĞĐŽŵŵŽŶŝŶŽůĚĞƌ
ƉĂƚŝĞŶƚƐĂŶĚŝŶǀŽůǀĞƐƚŚĞĂŐŐƌĞŐĂƚŝŽŶŽĨtdɲ-synuclein, and inherited, where symptoms 
ƚǇƉŝĐĂůůǇ ŽĐĐƵƌ Ăƚ ĂŵƵĐŚ ǇŽƵŶŐĞƌ ĂŐĞ ĂŶĚ ŝŶǀŽůǀĞŵƵƚĂƚŝŽŶƐ ŝŶ ƚŚĞ ɲ-synuclein protein 
such as A30P and A53T.  dŚĞɲ-synuclein mutant A53T has been shown in vitro to have 
much faster fibril formation kinetics than the wild-type monomer, which potentially 
explains the early onset of disease observed with this mutation (Fig. 1.3, triangles).  
Although the A30P mutant is also associated with the early onset inherited form of the 
disease, in vitro assessment of the fibril formation kinetics shows that it is actually slower 
than the wild-type monomer (Fig. 1.3, A30P - squares, WT - circles).  The earlier onset of 
 
Figure 1.3 Protein Sequence Affects Fibril Formation/Kinetics. 
 Amyloid growth curve monitored by Thioflavin T fluorescence showing the kinetics of fibril 
ĨŽƌŵĂƚŝŽŶ ĨŽƌ ƚŚĞ ĨŽƌŵĂƚŝŽŶŽĨĂŵǇůŽŝĚ ĨŝďƌŝůƐŽĨtdɲ-^ǇŶƵĐůĞŝŶ  ?ĐŝƌĐůĞƐ ) ? ? ?Wɲ-Synuclein 
 ?ƐƋƵĂƌĞƐ )ĂŶĚ ? ?dɲ-Synuclein (inverted triangles).  Adapted from Li et al. (2001)  (Li et al., 
2001) 
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disease associated with this slower polymerising mutant can be rationalised as it is 
proposed to stabilise toxic prefibrillar oligomers (Conway et al., 1998; Li et al., 2001). 
 
The propensity to form amyloid aggregates can also be influenced by the expansion of 
regions of repeating amino acids in a protein sequence via the incorporation of 
trinucleotide repeats into the gene encoding the protein of interest  The expansion of 
trinucleotide repeat regions has been associated with several disease states, trinucleotide 
repeat disorders, although the disease phenotype is not necessarily due to the translation 
of the expanded gene into a protein, e.g. fragile X syndrome (Bagni and Tassone, 2012).  In 
,ƵŶƚŝŶŐƚŽŶ ?ƐĚŝƐĞĂƐĞƚŚĞƌĞƉĞĂƚƌĞŐŝŽŶĨĂůůƐŝŶĂƉƌŽtein coding region, where a repeating 
CAG is translated into a polyglutamine sequence (polyQ).  The expansion of the Huntingtin 
protein with a polyQ sequence is thought to be a causative process in progression of the 
neurological disorder ,ƵŶƚŝŶŐƚŽŶ ?Ɛ ĚŝƐĞase (Scherzinger et al., 1997).  The disease 
ƉŚĞŶŽƚǇƉĞĂƐƐŽĐŝĂƚĞĚǁŝƚŚ,ƵŶƚŝŶŐƚŽŶ ?Ɛ ŝƐĐůŽƐĞůǇ ůŝŶŬĞĚƚŽƚŚĞƐŝǌĞŽĨƚŚĞƌĞƉĞĂƚƌĞŐŝŽŶ ?
 
Figure 1.4 Genetic Expansion Can Increase Amyloidogenicity. 
Graph showing a comparison of the number of repeating units in non-,ƵŶƚŝŶŐƚŽŶ ?ƐĚŝƐĞĂƐĞ
patients.  Progression from the bottom of the graph, healthy individuals to the highest part of 
ƚŚĞŐƌĂƉŚǁŝƚŚũƵǀĞŶŝůĞŽŶƐĞƚ,ƵŶƚŝŶŐƚŽŶ ?ƐĚŝƐĞĂƐĞŝƐĨŽůůŽǁĞĚďǇĂŶŝŶĐƌĞĂƐĞŝŶƚŚĞŶƵŵďĞƌ
CAG repeats.  TŚĞ ŶƵŵďĞƌ ŽĨ ƌĞƉĞĂƚƐ ƌĞƋƵŝƌĞĚ ƚŽ ƐŚŽǁ ,ƵŶƚŝŶŐƚŽŶ ?Ɛ ƐǇŵƉƚŽŵƐ ŝƐ  ? ?.  
Adapted from http://medicaliaorg.ning.com/group/neurosciences/forum/topics/parkinson-s-
disease-and-other-movement-disorders and  (Fahn and Cohen, 2007). 
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with thirty seven repeats being the lower limit to disease onset and the aggregation of 
monomers into amyloid fibrils (Duyao et al., 1993) (Fig. 1.4).  
1.2.2   Post Translational Modification 
The process of translation and folding gives native protein conformations but their ability 
to undertake cellular processes is modulated by post-translational modifications.  Common 
post-translational modifications utilised in the cell are phosphoryation, acetylation and 
glycosylation.  It is the addition or removal of these groups which can activate or deactivate 
proteins, allowing the control of cellular processes.   
 
The addition of these groups to the protein also has the potential to alter the energy 
barriers to conformational change and therefore, potentially, amyloid formation as 
ŽďƐĞƌǀĞĚǁŝƚŚƚŚĞƉŚŽƐƉŚŽƌǇůĂƚŝŽŶŽĨ^ ? ?ŽĨɲ-synuclein (Paleologou et al., 2010). 
Post-translational modifications do not only involve the addition of groups to proteins, but 
also the hydrolysis of the peptide chain into smaller fragments by hydrolases.  The specific, 
enzyme mediated, cleavage of a peptide has the potential to liberate a smaller fragment 
with higher propensity to adopt an amyloidogenic conformation.  One of the key 
 
Figure 1.5 APP Processing Generates Amyloidogenic Peptides. 
Top  W A diagram showing full length amyloid precursor protein (APP) and the intermembrane 
domain where secretase activity is observed.  Bottom  W A zoom in on the intermembrane 
ĚŽŵĂŝŶǁŚŝĐŚ ĐŽŶƚĂŝŶƐ ƚŚĞ ƐĞƋƵĞŶĐĞ ĨŽƌ ƚŚĞƉĞƉƚŝĚĞɴǁŚŝĐŚ ŝƐ ůŝďĞƌĂƚĞĚďǇĂĐƚŝon o f y-
Secretase on residue 671 of the protein sequence and the non selective proteolysis by beta-
secretase which gives a range of peptides from 40-42 residues long.  
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ďŝŽŵĂƌŬĞƌƐ ŽĨ ůǌŚĞŝŵĞƌ ?Ɛ ĚŝƐĞĂƐĞ ŝƐ ƚŚĞ ƉƌĞƐĞŶĐĞ ŽĨ ĂŵǇůŽŝĚ ĚĞƉŽƐŝƚƐ ĚĞƌŝǀĞĚ ĨƌŽŵ
peptides originating from the protein Amyloid Precursor Protein (APP).  The processing of 
WWďǇɴĂŶĚɶƐĞĐƌĞƚĂƐĞƐ gives rise to peptides ranging from 40-42 residues in length.  It is 
these small peptides which aggregate to form amyloid fibrils and are associated with 
ůǌŚĞŝŵĞƌ ?ƐĚŝƐĞĂƐĞ ?ŐƵǌǌŝĂŶĚK ?ŽŶŶŽƌ ? ? ? ? ? ) (Fig. 1.5). 
1.3   Structure of Amyloid Fibrils 
Throughout history, the need to cure or relieve the symptoms of human diseases has 
driven many studies of biological systems.  The modern era of major advances in 
biology/molecular biology has been catalysed by the accurate characterisation of the 
structure and function of biomolecules.  The development of x-ray diffraction, where a 
crystalline material is placed in an x-ray beam and the scatter pattern of the beam is 
collected and converted into an atomic resolution 3D structure, has been key to this 
advance.  This is exemplified by work of Dorothy Hodgkin, from 1945 onwards, examining 
the structure of small biomolecules such as cholesterol and insulin to the work of Rosalind 
Franklin, from 1950 onwards, on the macromolecular structure of DNA (Jaskolski et al., 
2014). 
The field of x-ray crystallography relies on the deconvolution of the diffraction pattern 
obtained when a large crystal of the molecule is placed in an X-ray beam (Smyth and 
Martin, 2000).  Amyloid fibrils are large ordered but heterogeneous polymers, which limits 
their analysis by high resolution x-ray diffraction methods.  By placing non-crystalline 
materials into the x-ray beam and analysing the scattering spectrum obtained, it is still 
possible to gain structural insight into the material analysed.  In fact, cross-beta structures 
give a specific x-ray fibre diffraction pattern.  This cross-ɴ ƉĂƚƚĞƌŶ ŐŝǀĞƐ ƌŝƐĞ ƚŽ Ă  ? ? ?-8Å 
diffraction on the meridian due to the distance between of the strands of the cross-beta 
sheet and 10-12Å diffraction on the equator which is due to the distance between the 
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sheets.  Due to this consistent x-ray diffraction it is an important method for confirming the 
presence of the cross-beta sheet core of amyloid fibrils (Morris and Serpell, 2012) (Fig. 1.6). 
 
Nuclear Magnetic Resonance (NMR) spectroscopy has been a key technique for the 
identification and investigation of small molecules for many years.  Its versatility and ability 
to differentiate between atoms due to their different electronic environments as well as 
their connectivity and spatial orientation means it is highly suited to many biological 
applications including the structural characterisation of biomolecules (Marion, 2013).  NMR 
is typically a solution based technique that can detect molecules upto 30kDa in size.  The 
slower tumbling of larger materials means that in the time frame of the NMR experiment 
the visualisation of average peaks for each 1H species is impossible.  NMR requires the use 
of NMR active isotopes, having a spin quantum number of ±½, of which 1H, 13C, 15N and 31P 
are examples of isotopes commonly found in biomolecules.  When these nuclei are aligned 
with a magnetic field their chemical environment is probed by irradiation with radio 
frequency electromagnetic radiation causing the nuclei spin state to change.  The different 
 
Figure 1.6 Cross ɴ-sheet Architecture of Amyloid Fibrils. 
A model of the cross beta-ƐŚĞĞƚĂƌĐŚŝƚĞĐƚƵƌĞŽĨɴ ? ?-42) peptides from above (a) and through 
ƚŚĞĨŝďƌŝů  ?ď ) ? dŚĞɴ-strands are packed perpendicular to the fibre axis separated by 4.7-8Å.  
dŚĞ ɴ-sheets run parallel to the fibre axis with a distance of 10Å separating them.  These 
values can be accessed from the Meridian and Equator of the X-ray diffraction pattern (c).  
Adapted from (Morris and Serpell, 2012) 
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wavelengths of radiowaves absorbed gives information on the electronic environment of 
the nuclei.  As amyloid fibrils are very large polymeric materials the use of solution NMR to 
understand their structure and dynamics is limited.  Recent advances in the application of 
magic angle spinning (MAS) solid state NMR (ssNMR) techniques has however opened up 
(Bai et al., 2010).  In these instruments the sample, in the form of a dry powder containing 
an internal reference, 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS), is placed into a 
rotor and spun allowing for average NMR spectra of the solid to be captured (Schuetz et al., 
2010; Shi and Ladizhansky, 2012).  New ssNMR approaches allow for structural information 
to be gleamed from solid materials such as amyloid (Heise, 2008) (Fig. 1.7). 
 
 
Figure 1.7 Amyloid Structural Modelling by Combined ssNMR and cryoEM. 
This high resolution model was generated by combining data acquired through cryo-electron 
microscopy (a) and solid-state NMR (b) the fibril surfaces assigned by solid state NMR (c) of an 
11 amino acid peptide from the protein Transthyretin.  Adapted from (Fitzpatrick et al., 2013) 




Proteins are polypeptide chains that consist of multiple amide bonds, aromatic species and 
disulphide bonds, all of which absorb in the UV region, 180nm-240nm, of the 
electromagnetic spectrum.  Circular Dichroism (CD) uses left and right circularly polarised 
light to probe this spectral region, giving information on different types of secondary 
structure in a sample.  CD is therefore particularly useful for proteins (Greenfield, 2006) 
and is effective for monitoring amyloid formation, due to its ability to follow the structural 
changes associated with cross beta sheet formation when monomers convert to fibrils (Fig. 
1.8). 
Infrared spectroscopy is a vibrational spectroscopy which uses infrared light to excite bonds 
in molecules, causing them to stretch and bend.  Functional groups in proteins give rise to 
different absorbances and can be used to monitor changes in conformational states.  For 
example, the stretch of the carbon oxygen double bond in an amide, typically 1630-
1680cm-1, is commonly used (Barth, 2007). 
 
Figure 1.8 Circular Dichroism Shows Conformational Changes on Conversion 
from Monomer to Polymer. 
Circular Dichroism spectra showing the conversion of Myostatin Precursor Protein on 
conversion of monomer (green) to functional dimer (blue) to prefibrillar aggregates formed 
overnight (red) to a mixture of fibrils and prefibrillar species after a week of incubation 
(black).  Adapted from (Starck and Sutherland-Smith, 2010) 
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1.4   Imaging of Amyloid Fibrils 
The elongation of fibrils occurs by addition of monomers to the ends of fibrils (Pinotsi et al., 
2014; Scheibel et al., 2001) but lateral growth of a fibril is achieved by bundling of these 
individual strands into thicker fibres.  These fibrils start to display a further level of 
structural organisation as they entwine themselves together to give twisted structures.  For 
each fibril formed, it is possible for them to laterally associate in different ways giving rise 
to different morphologies of fibril, which is of potential interest when considering the 
biological interactions of amyloid fibrils. 
Amyloid fibrils are typically 2-10nm in width and have a heterogeneous mixture of lengths 
typically ranging from nanometres to many micrometres.  Their size has traditionally 
limited their visualisation by optical microscopy but recent advances in super resolution 
microscopy is making this more feasible (Pinotsi et al., 2014).  It is, however, possible to 
visualise these structures using microscopy techniques such as transmission electron 
microscopy (TEM) and atomic force microscopy (AFM).  These techniques allow for 
discrimination of particles in terms of their lateral assembly and provide information about 
the different fibril morphology populations contained in a sample.  Imaging using TEM 
requires negative staining of the fibrils with a heavy metal ion, typically uranium from 
uranyl acetate.  The stain coats the outside of the fibril and stops the electron beam from 
passing through the sample which gives rise to the observed contrast, enabling the 
measurement of length and investigation of morphological structure of the fibres (Fig. 1.9, 
Left).  TM-AFM is a scanning probe microscopy technique that differs from other 
microscopy techniques in that is does not use the absorption or emission of energy from 
the electromagnetic spectrum to visualise materials, instead images are constructed 
through the physical interaction of a probe with a sample.  The mechanism by which this 
microscope works allows not just imaging of a sample but investigation of the 
ŶĂŶŽŵĞĐŚĂŶŝĐĂů ƉƌŽƉĞƌƚŝĞƐ ĂƐƐŽĐŝĂƚĞĚǁŝƚŚ ƚŚĞŵĂƚĞƌŝĂů ƐƵĐŚĂƐ ƚŚĞzŽƵŶŐ ?ƐŵŽĚƵůƵƐ ĂƐ
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well as the forces which hold material together (Adamcik and Mezzenga, 2012; Sweers et 




Figure 1.10 The workings of Atomic Force Microscopy. 
A  W A scanning electron micrograph of the tip of a Bruker scan asyst probe with a height, 2.5-
8µm and nominal tip radius  W 2nm.  http://www.brukerafmprobes.com/p-3726-scanasyst-
air.aspx.  B  W An SEM of a bruker scanasyst cantilever made of silicon nitride 
http://www.brukerafmprobes.com/p-3726-scanasyst-air.aspx.  C  W The determination of 
amyloid particles height and length using Atomic Force Microscopy (Adamcik and Mezzenga, 
2012). 
 
Figure 1.9 Fibrillar Structure of Amyloid Imaged using Microscopy.  
ŵǇůŽŝĚ ĨŝďƌŝůƐ ĚĞƌŝǀĞĚ ĨƌŽŵ ɲ Wsynuclein.  Fibrils imaged using Transmission Electron 
Microscopy with Uranyl Acetate staining (left, 200nm scale bar) and Atomic Force Microscopy 
(right) with 20x20µm imaged at a resolution of 2048 x 2048 pixels (1000nm scale bar) and a 
height scale bar on the far right.  The AFM height colour scale is set between -10 and 10nm. 
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When a probe (Fig. 1.10, A) attached to a cantilever (Fig. 1.10, B) is oscillated by a piezo 
electric current and then lowered onto a surface a tapping motion is generated.  For 
imaging purposes, the probe is moved over the surface of interest and any change in height 
is identified by the deflection of a laser aligned onto a sensor via reflection off of the 
cantilever (Fig. 1.10, C).  The probe generates a height measurement per pixel, which when 
placed together produces a topographic map (Fig. 1.09, Right) that allows for the 
assessment of the lengths, heights and morphology of individual particles. 
1.5   Intermolecular Interactions 
The conversion of monomers to ordered amyloid aggregates via cross-beta sheet formation 
results in large polymers which are held together by intermolecular forces such as Van der 
Waals interactions and hydrogen bonding.  One of the major properties associated with 
amyloid is their resistance to disaggregation by sodium dodecyl sulfonate (SDS), conditions 
which would normally interrupt most non-covalent intermolecular interactions.  This effect 
is potentially due to the cumulative effect of numerous intermolecular interactions and the 
inability of SDS to penetrate the cross-beta sheet and interrupt the interaction.   
There is also potential for covalent bonds to form between two strands.  For example 
copper has been shown to catalyse formation of dityrosine crosslinks between ɴ 
monomers suggesting that the stability could be aided by covalent interactions (Al-Hilaly et 
al., 2013; Atwood et al., 2004; Kok et al., 2013) (Fig. 1.11).   




The SDS resistance of amyloid fibrils has led to the development of electrophoresis based 
methods for characterising aggregate size. Semi-Denaturing Detergent Agarose Gel 
Electrophoresis (SDD-AGE) has been used to show and compare the different sizes of 




Figure 1.12 An example of an Immunoblotted SDD AGE. 
An SDD AGE gel showing the different sizes of Sup35 protein in [PSI+] and [psi-] cells, larger 
aggregates do not move travel through the gel as far as the monomeric protein and form a 
diffuse band due to the range of sizes contained with a population of amyloid species.  Image 
supplied by Ricardo Marchante. 
 
 
Figure 1.11 Reaction Mechanism for Radical Mediated Formation of Dityrosine 
Crosslinks. 
The formation of a dityrosine moiety (right) from tyrosine monomers (left) follows a radical 
mechanism in which two carbon centred radicals (middle) combine in a termination reaction. 
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1.6   Dye Binding Properties 
In 1854, Rudolph Virchow used non specific staining to show the presence of deposits in 
tissue samples using iodine and sulphuric acid.  Thus one of the first and defining 
characteristic properties of amyloid is the ability of the cross-beta sheet structure to bind 
certain dye molecules.   
 
dŚĞŵĂŝŶĚǇĞŵŽůĞĐƵůĞƐƵƐĞĚŝŶƚŚŝƐĐŽŶƚĞǆƚĂƌĞƚŚĞŚŝŐŚůǇʋ-conjugated dyes Thioflavin T 
(ThT) and Congo Red (Fig. 1.13), which both give a change in the absorbance/emission 
profile when in the presence of amyloid fibrils.  Although the binding mode of these dyes to 
the amyloid is not resolved it is assumed that the dyes bind in the grooves of the cross beta 
sheet structure locking of the molecules into one conformation giving rise to the change in 
their absorption/emission characteristics (Biancalana and Koide, 2010; Khurana et al., 2005; 
Krebs et al., 2005). 
These amyloid binding dyes have been useful in the identification of amyloid plaques in 
histological samples.  The change in wavelength of the spectroscopic profile of these dyes, 
in particular ThT, which exhibits a stokes shift from 450nm to 480nm (Naiki et al., 1989), on 
binding to amyloid fibrils also offers great advantages for measuring the kinetics of fibril 























Figure 1.13 Chemical Structures of Amyloid Binding Dyes.  
The chemical structures of the dyes commonly used in the analysis and identification of amyloid 
fibrils. Left) Thioflavin T (ThT)  Right) Congo Red 
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1.7   Resistance to Proteolysis 
The control of protein levels in the cell is regulated by their synthesis and degradation into 
their constitutive amino acids by proteases which recognise specific regions of proteins and 
hydrolyse appropriate amide bonds.  When a ligand is bound to a protein (holo form), it has 
been shown to have increased stability to denaturation and proteolysis than its apo-form 
(Lomenick et al., 2011; Pace and McGrath, 1980).   
 
Similarly, when a protein adopts the amyloid state the cross-beta sheet of the structure is 
protected from proteolysis but regions that are exposed can still be accessed by proteases 
and therefore digested (Fig. 1.14).  Thus limited proteolysis, followed by mass 
spectrometric analysis is able to determine which regions are protected and therefore part 
of the amyloid core (Frare et al., 2006; Kheterpal et al., 2001). 
1.8   The Kinetics of Fibril Formation 
The process of amyloid fibril formation follows a nucleated growth mechanism and is 
described simplistically by the cartoon in Fig. 1.15.  The process initiates with a 
conformational change in the protein that exposes surfaces that are normally buried, which 
then interact with other similarly misfolded protein molecules to give a dimer in a 
reversible process (Knowles et al., 2014).  The requirement for conformational change prior 
to amyloid formation is sŚŽǁŶĨŽƌɴ2-microglobulin, where a shift in pH from pH7 to below 
 
Figure 1.14 Amyloid Core is Protected From Proteolysis. 
The amyloid core (repeating rectangles) is protected from proteolysis but the exposed 
polypeptide chains are still susceptible to proteolysis. 
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pH5 initiaties the conversion of ŵŽŶŽŵĞƌŝĐ ɴ2-microglobulin to its amyloid form, as 
determined by an increase in Thioflavin T fluorescence and the generation of long needle 
like structures.  The cause of this pH induced fibril formation was shown, by ANS binding, 
EDZĂŶĚ ?ƚŽďĞĐŽŶĨŽƌŵĂƚŝŽŶĂůĐŚĂŶŐĞƐƌĞƐƵůƚŝŶŐŝŶƉĂƌƚŝĂůůǇƵŶĨŽůĚĞĚɴ2-microglobulin 
which is then susceptible to polymerisation (McParland et al., 2000).  Further reversible 
and unfavourable interactions of the transient dimeric species with misfolded monomers 
give rise to small oligomeric species.  The reversibility of the process continues until a 
nucleus is formed where subsequent favourable addition of monomers to the ends of the 
species results in fibril elongation and generation of the fibrillar species observed in vivo 
and in vitro (Fig. 1.15).  
 
The key step of a nucleated growth mechanism is the generation of a nucleus onto which 
subsequent monomer addition follows to give fibrillar species.  The rate of nucleus 
formation can be affected by many different factors such as monomer concentration and 
temperature.  
 
Figure 1.15 Reaction Scheme Showing Amyloid Fibre Formation.   
This depiction represents the conversion of properly folded monomers (red pyramid) to 
misfolded monomer (blue cube) and then their subsequent oligomerisation to a critical 
nucleus and elongation to fibrils. This process is then followed by secondary effects such as 
fragmentation and surface nucleation.  




The change in 'ŝďď ?Ɛ ĨƌĞĞ ĞŶĞƌŐǇ(ȴGo) of a system takes into account enthalpic and 
entropic considerations giving a prediction of how likely a process is to occur.  A positive 
ȴGo is equivalent to an unfavourable process where as a negative ȴ'o is evidence of a 
favourable process.  
 
 
Figure 1.17 The Kinetics of Fibril Formation 
This is a depiction of the standard sigmoidal Thioflavin T fluorescence curve associated with 
the formation of amyloid fibrils.  A lag phase dominated by the formation of the critical 
nucleus is followed by exponential growth where fibrils growth is mainly observed. 
 
Figure 1.16 Energetic Considerations of Critical Nucleus Formation. 
Energy level diagram showing the increase in Gibbs free energy associated with the reversible 
generation of the critical nucleus followed by the decrease in Gibbs free energy as the process 
essentially becomes irreversible. 
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The process of nucleation in terms of Gibbs free energy change shows the initial reversible 
processes of dimerisation and oligomerisation gives rise ƚŽĂŶ ŝŶĐƌĞĂƐĞ ŝŶȴ'o to a point 
ǁŚĞƌĞďǇ ȴ'o then starts to decrease again, towards lower energy species.  The higher 
energy species formed in this process are transient and short lived when compared to the 
lower energy species and therefore of lower concentration.  It is this free energy maximum 
that describes the nucleus of the fibril formation under the conditions used (Fig. 1.16) 
(Knowles et al., 2014; Xue et al., 2008). 
The characterisation of fibril formation kinetics has been aided by the use of the 
profluorescent dye Thioflavin T.  Binding of ThT to the cross beta sheet architecture of the 
amyloid fibrils gives a change in the absorption/emission profile of the material, thereby 
allowing fibril formation processes to be followed (Biancalana and Koide, 2010; Khurana et 
al., 2005; Krebs et al., 2005).  By monitoring fluorescence periodically over the course of 
fibril formation, in the presence of ThT, a sigmoidal curve is observed as fibrils are formed. 
It is possible to assign the dominant reaction processes shown in Fig. 1.15 to each region of 
the sigmoidal curve (Fig. 1.17).  At the start of fibril formation the initial lag phase is 
associated mainly with monomer conformational interconversion and interaction up until 
the generation of the critical nuclei (Xue et al., 2008).  The subsequent exponential growth 
phase is dominated by fibril growth and an increase in the proportion of beta-sheet in the 
sample.  The lag phase is a stochastic process which is dependent on the probability of a 
first critical nucleus forming.  A side effect of the stochasticity of nucleation is that two fibril 
formations carried out using identical conditions may not have equal lag phase lengths.  
The exponential growth of the system following the lag phase is not only due to the 
elongation of nuclei into fibrils by monomer addition, but also a series of secondary 
processes which may occur once fibril elongation has started (Lorenzen et al., 2012).  It 
must be noted that nucleation still occurs but is no longer the primary mechanism of 
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increasing the proportion of cross beta sheet in the sample.  Currently there are two main 
secondary effects that are observed to occur: fibril fragmentation and aggregate surface 
nucleation.  Fibril fragmentation is the process where a fibril breaks into two smaller 
particles, and affects fibril formation by increasing the number of ends available for fibril 
extension (Fig. 1.15) (Xue and Radford, 2013).  Surface nucleation is the process where a 
fibril interacts laterally with a monomer, causing a conformational change in the monomer 
and essentially catalysing the generation of new nuclei (Fig. 1.15) (Foderà et al., 2008; 
Kashchiev et al., 2013).  The exponential phase of fibril growth occurs until the monomer is 
consumed to a level where no further increase in amyloid content of a sample and 
plateauing of the growth. 
1.9   Amyloid Toxicity 
Since its discovery in 1854 amyloid has been associated with the progression of numerous 
diseases, most notably neurodegenerative, and age related diseases such as Alzheimer ?Ɛ ?
WĂƌŬŝŶƐŽŶ ?ƐĂŶĚ,ƵŶƚŝŶŐƚŽŶ ?ƐĚŝƐĞĂƐĞ.  The common structural component, the cross-beta 
sheet is independent of amino acid sequence and leads to an assumption that the toxicity 
associated with diseases occurs via a common mechanism.  Consequently by developing an 
inhibitor of fibril formation a panacea for amyloid associated disease could be realised.  
Despite this assumption and a vast amount of research on the biological effect of amyloid 
and their disease association there are still questions relating to how and why toxicity is 
observed.  Identifying the toxic species that are associated with amyloid related diseases is 
currently one of the most important questions with respect to desigining therapeutic 
interventions of these diseases.  The current contenders for the toxic species are fibrils, 
prefibrillar oligomers and fibril fragments. 
There are several current hypotheses on the mechanism of amyloid toxicity including cell 
membrane pore formation, through interaction with fibrillar materials, or loss of function 
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of the aggregating species.  The debate surrounding the identity of the toxic amyloid 
species is highlighted by the disease synonymous with neurodegeneration due to amyloid 
formation, ůǌŚĞŝŵĞƌ ?Ɛ ĚŝƐĞĂƐĞ ? The generation of fibrils from amyloid beta had been 
thought to be the causative reason for cytotoxicity ŽďƐĞƌǀĞĚ ŝŶůǌŚĞŝŵĞƌ ?ƐĚŝƐĞĂƐĞ.  For 
some time the disagreement between observed fibril load and toxicity (Ferreira et al., 
2007) has led to the postulation that large fibrils are relatively innocuous.  In fact, the 
generation of small  “oligomeric ? species, on pathway to fibrils, and their internalisation or 
interaction with cell surface receptors are thought to cause cell death and the onset of 
neurodegeneration (Kayed and Lasagna-Reeves, 2013; Kayed et al., 2003).   
 
Small prefibrillar oligomers have also shown a propensity to form circular pore like 
structures on cell membranes. These structures, like ion channels, may allow the diffusion 
of small molecules and ions into and out of cells or cell compartments and thus negatively 
affecting cellular homeostasis (Fig. 1.18) (Quist et al., 2005).  However this still does not 
explain why the onset of toxicity is delayed as these prefibrillar structures would have been 
expected to exist all through life. 
Anti-ůǌŚĞŝŵĞƌ ?Ɛ ĚƌƵŐ ĚŝƐĐŽǀĞƌǇ ŚĂƐ ďĞĞŶ ĂƚƚĞŵƉƚĞĚthrough inhibition of secretases, 
inhibition of fibril formation, and removal of plaques/plaque intermediates with antibodies 
 ?ŐƵǌǌŝĂŶĚK ?ŽŶŶŽƌ ? ? ? ? ? ). These research have yet to lead to a viable treatment, adding 
 
Figure 1.18 Oligomer Particles on the Pathway to Amyloid can Cause 
Membrane Pore Formation.  
Atomic Force Microscope images of different amyloidogenic proteins forming pores on lipid 
bilayers of DOPC.  Aggregating proteins: A  W ɴ ? ?-40), B  W ɲ-synuclein, C  W amylin and D  W 
serum amyloid A (SAA).  Adapted from (Quist et al., 2005). 
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weight to the assumption that fibrils are not the sole cause of toxicity.  Thus the identity 
and mechanisms of amyloid-associated toxicity in disease is still an open question.   
Another potential mechanism of cytotoxicity revolves around the sequestering of necessary 
proteins to amyloid aggregates, which means that they are subsequently unable to take 
part in their usual cellular processes, leading to a disease phenotype.  The cellular response 
to misfolded/aggregated proteins is to resolubilise or degrade them.  As well as their role in 
the folding of proteins into their native state, chaperones also have disaggregation function 
(Duennwald et al., 2012; Shorter and Lindquist, 2004), which allows proteins that have 
been sequestered into amyloid fibrils to be extracted and either refolded correctly or 
degraded (Dobson, 2003; Hartl and Hayer-Hartl, 2002).  This process forms part of the 
Unfolded Protein Response pathway (UPR).  The major component of the UPR is to degrade 
misfolded or damaged proteins into their constituent amino acids, releasing them into the 
cytosol were they can be reused, thereby maintaining homeostasis.  The UPR works via the 
attachment of ubiquitin to proteins, which targets them for degradation by the 
proteosome (Lecker et al., 2006).  If the UPR cannot rectify the protein misfolding issues of 
the cell then its final response is to signal for apoptosis of the cell (Walter and Ron, 2011).  
The ability of a cell or organism to cope with protein misfolding is inextricably linked to age 
which also fits with the pathology of amyloid disease progression and its associated 
 ‘ŝŶĐƵďĂƚŝŽŶƚŝŵĞ ? ?
Although the formation of amyloid deposits is a specific process involving the 
polymerisation of monomers into fibrils, it is possible for other proteins to be incorporated 
into the aggregates.  Once these interactors have been removed from the cells ? accessible 
proteome, the cells mechanism for dealing with protein misfolding may be overwhelmed 
(Olzscha et al., 2011). 
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1.10   Prions 
In the 1800s, the work of Gregor Mendel, the father of modern genetics, described the 
guidelines for the inheritance of traits from one organism to its offspring.  The theory of 
Mendelian inheritance is gŽǀĞƌŶĞĚďǇ  ? ůĂǁƐ ?DĞŶĚĞů ?Ɛ ůĂǁs, and explains the transfer of 
dominant and recessive characteristics from parents to offspring.  Since then, DNA has 
been shown to be the molecule which carries the information of inheritance.  
Many infectious agents, such as viruses, work by hijacking a cells own 
transcriptional/translational machinery to propagate and therefore require the 
transmission of DNA from one cell to another.  In 1982, Stanley Prusiner suggested, 
controversially, that the source of toxicity/neurodegeneration observed in the spongiform 
encephalopathy Scrapie was due to a protein only mechanism.  This mechanism requires 
the transmission of a proteinaceous particle from one cell to another (Prusiner, 1982).  The 
term prion was coined by Prusiner and is a portmanteau of the words Proteinaceous and 
Infectious.  Subsequent work by Prusiner has since shown that the causative prion 
proteinaceous material consists of amyloid aggregates (Prusiner et al., 1983). 
After the discovery that a protein only mechanism is responsible for the transmission of 
scrapie, it was soon confirmed that other spongiform encephalopathies, such as bovine 
spongiform encephalopathy (BSE), Creutzfeld-Jackob Disease (CJD) and Kuru, followed this 
process.  
1.10.1  Yeast Prions 
In 1994 Reed Wickner noted that the yeast protein Ure2p exhibited the characteristics of a 
prion.  In fact its conversion to a prion state, [URE3], offered an advantage to the organism 
when placed in an environment with poor nitrogen sources (Wickner, 1994).  Ure2p is a 
protein of the yeast Saccharomyces cerevisiae that regulates the catabolism of nitrogen 
sources via binding of the transcription factor Gln3p GATA.  In the presence of good 
nitrogen sources such as ammonia and glutamine, Ure2p prevents the utilisation of poor 
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nitrogen sources such as ureidosuccinate (USA) by preventing their uptake into the cell by 
repressing the transcription of permeases (Lian et al., 2006; Xu et al., 1995).  Ure2p binds to 
Gln3p GATA and stops its movement to the nucleus therefore repressing transcription.  The 
conversion from [ure3] to [URE3] was shown to follow the conversion of Ure2p from 
soluble monomer to amyloid (Wickner et al., 2004).  When Ure2p is monomeric it blocks 
Glnp3 GATA from entering the nucleus but in its amyloid state the interaction is inhibited 
and the Gln3p GATA is free to move to the nucleus and allows permease transcription.  The 
net result of this epigenetic regulation is the ability for the organism to utilise poor nitrogen 
sources such as ureidosuccinate (USA) under diminished nutrient conditions.  
 
The work showing the prion like properties of [URE3] also drew parallels with the [PSI+] 
phenotype in Saccharomyces cerevisae and postulated that it also was a prion of the yeast 
protein Sup35 (Wickner, 1994).  
The [PSI+] phenotype in Saccharomyces cerevisae was reported by Brian Cox in 1965 as 
evidence of a non-Mendelian trait (Cox, 1965). The observation of prions, in particular 
 
Figure 1.19 Prion Transmission Through Amyloid Fragmentation. 
In Saccharomyces Cerevisae the chaperone (Hsp104) mediated fragmentation of Sup35 fibrils 
generates propagon particles.  The transfer of these particles from mother to daughter is 
required for transfer of the [PSI+] phenotype. 
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[PSI+], in yeast, a highly tractable model organism, has allowed for great advances in 
understanding the processes involved in prion initiation and transmission.  Using the yeast 
model system, it has been shown that transmission of the [PSI+] phenotype from mother to 
ƉƌŽŐĞŶǇ ŝƐ ĚĞƉĞŶĚĞŶƚ ŽŶ ƚŚĞ ĨŽƌŵĂƚŝŽŶ ŽĨ ƐŵĂůů  ‘WƌŽƉĂŐŽŶ ? ƉĂƌƚŝĐůĞƐ ďǇ ƚŚĞ ĂĐƚŝŽŶ ŽĨ
chaperone proteins such as Hsp104 (Fig. 1.19) (Byrne et al., 2009; Cox et al., 2003).   
The link of prion phenotypes with the aggregation of proteins into amyloid deposits also 
offers an explanation for the existence of strains observed in prion systems due to their 
propensity to form different morphologies of fibrils.  The morphological variation observed 
in this instance could be due to differences in assembly and lateral association of the fibrils.  
Sup35 is a 76kDa protein with 3 different domains: the N-domain is required for the 
formation of the amyloid state, the M-domain contains polar solubilising residues and the 
C-domain is responsible for the translation termination activity of the protein.  One of the 
potential mechanisms of amyloid associated disease is the loss of activity of the aggregated 
proteins so a loss of translation termination would be expected on formation of Sup35 
fibrils.  The C domain of Sup35 is outside of the fibril core and exposed to solvent (Baxa et 
al., 2011) and can therefore potentially interact with other translation termination factors.  
Recent work has demonstrated that fibrils can indeed still take part in translation 
termination but the size of the aggregate has a significant role in the ability of the C-
domain to carry out this process (Pezza et al., 2014). 
The work in yeast has shown that contrary to the aggressive, life-threatening phenomenon 
observed in human prion diseases, the yeast equivalents are useful epigenetic switches 
enabling the conversion between phenotypes (True and Lindquist, 2000; True et al., 2004). 
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1.11   Functional Amyloids 
The conversion of native protein to amyloid state is not necessarily detrimental to cells.  As 
highlighted in table 1 there are several proteins that enable cells and whole organisms to 
perform functions which allow them to survive and spread. 
Spidersilk is a multifunctional material used by spiders to suspend themselves in webs, 
catch prey and protect their offspring and requires an incredibly strong material.  Spidroin, 
one of the components of dragline silk, undergoes a pH sensitive conversion from 
monomer to fibrillar form (Askarieh et al., 2010).  The silk formed is incredibly strong, 
thought to be in the region of Kevlar, and is very flexible (Xu and Lewis, 1990), properties 
which allow it to fulfil its function. 
1.12   Nanomaterials 
Materials science is a field which develops and analyses novel materials with properties 
that are potentially useful, and has underpinned many of the technological advances in the 
past 100 years, e.g. polymers.  The origin of nanomaterials can be traced back to the work 
of Sumio Iijima, in 1991, on the identification and characterisation of carbon nanotubes 
(Fig. 1.20) (Iijima, 1991). 
The ability to generate materials with different properties on the nanoscale (<100nm) has 
the potential for impacting on many areas of research such as drug delivery and 
diagnostics, and is an area of great current interest.  The size and relative surface area of 
nanomaterials make them different to traditional materials and also allows them to be 
used in conjunction with other materials, as a coating, to enhance or add properties such as 
conductance and water resistance. 
In the macroscale, the determination of the strength of a material, its ability to withstand 
an applied load without failure, is an important characteristic of the substance.  There are 
many different types of strength, i.e. yield strength and tensile strength, which is indicative 
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of the force in Newtons per metre (Nm-1) at which a material fails to return to its 
unstressed state when the force is removed.  The ability of a material to return to its 
original state after deformation is known as eůĂƐƚŝĐŝƚǇ ? ĂŶĚ ŝƐ ĚĞƐĐƌŝďĞĚ ďǇ ƚŚĞ zŽƵŶŐ ?Ɛ
DŽĚƵůƵƐ ?ůĂƐƚŝĐDŽĚƵůƵƐŽĨĂŵĂƚĞƌŝĂů ? ) ?dŚĞĐŚĂƌĂĐƚĞƌŝƐĂƚŝŽŶŽĨĂŵĂƚĞƌŝĂů ?ƐƉƌŽƉĞƌƚŝĞƐ
on the nanoscale requires a different set of techniques to those required on the 
macroscale.  Electron Microscopy and Atomic Force Microscopy have been utilised to great 
effect for analysing the structure of nanomaterials, and AFM also offers the ability to 
directly measure physical properties of nanomaterials through the application of force 
(Adamcik and Mezzenga, 2012).  
 
Nanomaterials derived from biological materials have the potential to offer many 
advantages over other materials including cost, readily available starting materials and the 
potential of using host organisms to generate the materials but it is their strength (Fig. 
1.21) and relative ease of assembly that make amyloid an interesting starting point for 
bespoke nanomaterials (Knowles and Buehler, 2011).  
 
Figure 1.20 First Generation Nanomaterials. 
Electron micrographs of graphitic carbon microtubules, a- tube of 5 graphitic sheets, b- tube 
of 2 graphitic sheets and c- tube of seven graphitic sheets.  Adapted from (Iijima, 1991) 
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The ability to make changes to the structures and properties of the products with relative 
ease by genetic modification of the organisms means that this field has a large overlap with 
the emerging fields of Chemical Biology and Synthetic Biology and has led to the formation 
of modified fibrils with different functionality (Knowles and Buehler, 2011).  For example 
amyloid designs have allowed for the capture of carbon dioxide (Li et al., 2014), the 
addition of electrical conducting groups (Scheibel et al., 2003) and retroviral transduction 
(Li et al., 2014).  
 
 
Figure 1.21 Amyloid has Exceptional Physical Properties. 
ŐƌĂƉŚĐŽŵƉĂƌŝŶŐƚŚĞĚŝĨĨĞƌĞŶƚƉŚǇƐŝĐĂůƉƌŽƉĞƌƚŝĞƐ ?^ƚƌĞŶŐƚŚǀƐzŽƵŶŐ ?ƐDŽĚƵůƵƐ )ŽĨŬŶŽǁŶ
materials varying from biological polymers to plastics and modern manufacturing materials, 
amyloid fibrils are one of the strongest nanomaterials.  Adapted from (Knowles and Buehler, 
2011) 
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1.13   Aims of thesis 
The overall goals of the project were to find generic structural and mechanical properties of 
fibrils and how this affects their stability towards fragmentation.  This study has important 
implications for understanding the response to breakage of different fibril types and how 
this then impacts on disease, infectivity and the properties as a nanomaterial. 
To achieve these goals the project was separated into three main aims: 
The aim of the first part was to develop quantitative and reproducible methods for the 
preparation of amyloid fibrils in vitro either from commercial protein sources or via the 
bacterial expression and purification of protein monomers, and to develop AFM imaging 
methods for quantitative imaging of these amyloid systems. 
The second part aimed to investigate the resistance of fibrils to mechanical stress in vitro 
by monitoring the size distributions of amyloid fibrils subjected to fragmentation by 
stirring, and AFM imaging and subsequent MATLAB analysis to quantify particle size 
distributions and generate a model of fibril fragmentation. 
The third part of the project was to develop novel methods of determining the population 






Materials and Methods 
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2.1   Materials 
All media was sterilised in a Prestige Medical Desktop autoclave at 121oC, 15lb/in2 for 11 
mins.  All E.coli liquid cultures were incubated at 37oC and shaken at 180rpm and solid 
cultures were incubated overnight at 37oC overnight or for 48 hours at room temperature.  
 
For media requiring antibiotic selection an appropriate antibiotic was added to the media 
post sterilisation.  For this thesis only ampicillin resistant strains were used therefore media 
was supplemented with 100mg/ml ampicillin to give a 0.1% w/v concentration. 
Table 2.2  E.coli Strains Utilised 
Role Name Competence type Genotype 
Expression BL21[DE3] 
pLysS 





Top10 Chemical F- mcrA ȴ ? mrr-hsdRMS-
mcr )Ɍ ? ?lacȴD ? ?
ȴ lacX74 recA1 araD139 
ȴ ?araleu)7697 galU galK rpsL 
(StrR) endA1 nupG 
 
Table 2.3 Plasmids Used 
Insert Vector Restriction sites for 
insert 
Source 
Sup35NMC pET15b NdeI/BamHI R. Melki (Krzewska and Melki, 
2006) 
Sup35NM pET15b NdeI/BamHI This Study 
Sup35NM-Cys pET15b NdeI/BamHI This Study 
Sup35NM-LCys pET15b NdeI/BamHI This Study 
Sup35NM-
LLCys 
pET15b NdeI/BamHI This Study 
ɲ-Synuclein pRSETB NdeI /HindIII D. Smith (Cappai et al., 2005a) 
Table 2.1   Lysogeny broth composition 
Substance g/100ml 
Tryptone 1 
Yeast extract 0.5 
NaCl 1 
Agar (for solid media) 2 
 








Table 2.5 Antibodies used for Western Blotting 
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Table 2.6 Chemicals  







Fluorescein Isothiocyanate Isomer 1 F4247 Sigma-
Aldrich 
389.382  








N-Succinimidyl iodoacetate (SIA) 22349 Thermofisher 283.02  









Dichloromethane  Fluka 84.93 1.33 
DMF  Sigma 73.09 0.944 
Diethyl ether  Fluka 74.12 0.713 
Diisopropylethylamine  Sigma 129.24 0.742 
Pyridine  Fluka 79.1 0.982 
Sodium Ascorbate A7631 Sigma 198.11  
Tris(3-
hydroxypropyltriazolylmethyl)amine 
762342 Sigma 434.5  
4,4,4-Trifluorobut-2-en-1ol 007510 Fluorochem 126.08  
1-Ethynyl-3,5,-
bis(trifluoromethyl)benzene 
630241 Sigma 238.13 1.346 
NHS-PEG12-Azide 26131 Thermo 
Scientific 
740.79  
Copper (II) Sulphate pentahydrate 209198 Sigma 249.69  
2.2   DNA Agarose Gel 
Table 2.7 Composition of 50 x TAE Buffer 
Compound Amount 
Tris base 242g 
0.5M EDTA 100ml 
Glacial acetic acid 57.1ml 
mQ Water Upto 1L 
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Tris base was dissolved in 600ml of mQ H2O and treated with glacial acetic acid (57.1ml) 
and 0.5M EDTA (100ml).  The resulting solution was then diluted to 1L by the addition of 
mQ water. 
Table 2.8 Composition of a Typical 1% Agarose gel 
Material Amount 
1 x TAE buffer 50ml 
Agarose 0.5g 
Ethidium bromide 1µl 
2.2.1   Electrophoresis Conditions 
The agarose (Melford, MB1200) was dissolved in 1 x TAE buffer by microwaving on full 
power for a total of 80 seconds punctuated by careful swirling to mix the solution.  The gel 
was allowed to cool slightly before addition of 1µl of 10mg/ml ethidium bromide in H2O 
(Sigma Aldrich, E1510) per 50ml of solution.  Ethidium bromide was replaced with 5µl of 
10000 x DMSO concentrate of SYBR® Safe (Invitrogen, S33102) for gel imaging only.  A lane 
comb was then added and the gel was allowed to cool and set solid.  The gel was aligned so 
that the lane comb is at the anode of the gel tank and then covered with 1 x TAE buffer. 
DNA samples were treated with 5 x sample loading buffer (Bioline, BIO-37045) and loaded 
ŝŶƚŽ ƚŚĞ ŐĞů ? ĂůŽŶŐ ǁŝƚŚ  ?A?ů ŽĨ ŝŽůŝŶĞ ,ǇƉĞƌůĂĚĚĞƌ ?  ?Ŭď  ?ŝŽůŝŶĞ, BIO-33053) before 
running at 80V until loading dye passes the mid-point of the gel. 
SYBR® Safe stained gels were imaged using a Fujifilm FLA-5100 scanner and Image Reader 
FLA-5000 with FITC absorption and emission characteristics whilst ethidium bromide 
stained gels were visualised on a UVP transilluminator for band excision. 
2.3   Agarose Gel Extraction 
The appropriate bands were excised from the gel using a clean, sharp scalpel and placed in 
eppendorf tubes of known mass.  The amount of gel in the tubes was calculated and the 
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EĞǆƚƌĂĐƚĞĚĨƌŽŵƚŚĞŐĞůĨŽůůŽǁŝŶŐƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ?ƵƐŝŶŐĞŝƚŚĞƌYŝĂŐĞŶ ?Ɛ
Y/ƋƵŝĐŬ'ĞůWƵƌŝĨŝĐĂƚŝŽŶ<ŝƚŽƌdŚĞƌŵŽĨŝƐŚĞƌ ?Ɛ'ĞŶĞ:d'ĞůǆƚƌĂĐƚŝŽŶ<ŝƚ ? 
2.4   DNA Quantification 
The concentration of DNA samples was measured using an Eppendorf Biophotometer or a 
BMG Labtech LVis plate in conjunction with a BMG labtech Spectrostar Nano or FluorStar 
Omega platereader, by monitoring the absorbance of the sample at 260nm and correcting 
against a blank sample.  The extinction coefficient of double stranded DNA is 0.02(µg/ml)-
1cm-1 ƚŚĞƌĞĨŽƌĞĂĐĐŽƌĚŝŶŐƚŽƚŚĞĞĞƌ>ĂŵďĞƌƚ >Ăǁ  ?A?ɸĐů )ĂŶĂďƐŽƌďĂŶĐĞ ƌĞĂĚŝŶŐŽĨ  ? ŝƐ
equal to 50 µg/ml. 
2.5   Preparation of Competent E.coli cells 
An E.coli strain (Top10 or BL21 [DE3] pLysS) (50µl) was inoculated into LB (Top10 - without 
antibiotic and pLysS with chloramphenicol) (4ml) and incubated at 37oC overnight. 
This overnight culture was then diluted 1 in 50 into 100ml of LB (antibiotic as above) and 
incubated at 37oC until the OD600 was between 0.4 and 0.45.  The culture was then placed 
on ice for 10 mins, all subsequent manipulations were carried out on ice, in a cold room 
and using a pre-chilled centrifuge.  The culture was harvested by centrifugation at 3000rpm 
for 8 minutes at 4oC and the supernatant discarded.  The cell pellet was resuspended (by 
swirling and not pipetting) in 100mM sterile calcium chloride (25ml) and incubated on ice 
for 10 mins.  The resulting suspension was clarified by centrifugation at 3000rpm for 8 
minutes at 4oC and the supernatant discarded.  The cell pellet was resuspended in sterile 
100mM calcium chloride, 30% (v/v) glycerol (2ml) and then divided into 100µl aliquots in 
prechilled 1.5ml eppendorf tubes and then stored at -80oC. 
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2.6   E.coli Transformation 
A 100µl aliquot of competent cells (Top10 or BL21[DE3] pLysS) were removed from -80oC 
storage and placed on ice to thaw.  1µl of circular plasmid DNA (~100ng/µl) was added to 
the sample and the cells were incubated on ice for 30 minutes before subjecting to heat 
shock at 42oC, in a water bath, for 60 seconds.  The heat shocked cells were immediately 
placed back on ice and then diluted with 1ml of LB (without antibiotic) and incubated at 
37oC for 1 hour.  100µl of this transformation mixture was then spread onto an antibiotic 
selective LB plate, antibiotic choice is dependent on plasmid transformed, and incubated at 
37oC overnight or room temperature over the weekend. 
2.7   Polymerase Chain Reaction (PCR) general 
method 
PCR reactions were carried out using a Roche High Fidelty PCR kit (Roche, Cat. no. 
11732641001) according ƚŽ ƚŚĞ ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ ƵƐŝŶŐ ďĞƐƉŽŬĞ ĨŽƌǁĂƌĚĂŶĚ
reverse primers (Table 2.5) and a parent DNA sample (Table 2.3) with the following 
compositions (Table 2.9). 
Table 2.9 Typical PCR Reaction Composition 
Material Concentration Volume 
Parent DNA (plasmid)  >50ng/µl 2µl 
Primer 1 100pmol/µl 1µl 
Primer 2 100pmol/µl 1µl 
dNTP mixture See Table 2.10 5µl 
PCR buffer 10 x 
concentrate 
5µl 
Taq Polymerase 1U/µl 1µl 
H2O  35µl 
 
Table 2.10 Deoxynucleotide Triphosphate (dNTP) mixture 
Material Volume 
Deoxyadenosine Triphosphate (dATP) 100mM 2µl 
Deoxythymidine Triphosphate (dTTP) 100mM 2µl 
Deoxyguanosine Triphosphate (dGTP) 100mM 2µl 
Deoxycytidine Triphosphate (dCTP) 100mM 2µl 
Double distilled water 98µl 
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The above reagents were combined, with the enzyme added to the mixture last.  The 
samples were then heated using a Techne TC-3000 thermocycler with these basic 
parameters (Table 2.11), but the melting temperature of the primer guiding the choice of 
annealing temperature used. 
 
Table 2.11 Typical Thermocycler Parameters 
Program method Temperature (
o
C) Time 
Lid temperature 105  
Initial 
denaturation 
94 3 minutes 
Annealing 55 45 seconds 
Extension 72 3 minutes 
Cycle (30 times)   
Final extension 72 5 minutes 
 
The samples were then purified following the PCR purification protocol. 
2.8   PCR Purification 
WƵƌŝĨŝĐĂƚŝŽŶŽĨWZƌĞĂĐƚŝŽŶƐǁĂƐĂĐŚŝĞǀĞĚƵƐŝŶŐĞŝƚŚĞƌYŝĂŐĞŶ ?ƐY/ƋƵŝĐŬWZƉƵƌŝĨŝĐĂƚŝŽŶ
Ŭŝƚ Žƌ dŚĞƌŵŽĨŝƐŚĞƌ ?Ɛ 'ĞŶĞ:d WZ ƉƵƌŝĨŝĐĂƚŝŽŶ Ŭŝƚ ? ĨŽůůǁŝŶŐ ƚŚĞ ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ
instructions. 
2.9   DNA Digestion using Restriction Enzymes 
EĚŝŐĞƐƚŝŽŶƐǁĞƌĞĐĂƌƌŝĞĚŽƵƚƵƐŝŶŐWƌŽŵĞŐĂĞŶǌǇŵĞƐĂŶĚĨŽůůŽǁŝŶŐƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ
guidelines, briefly the DNA was diluted with mQH2O and a buffer appropriate for the 
enzymes to be used.  According to the Promega Restriction Enzyme Tool the appropriate 
buffer for the combination of restriction enzymes NdeI/BamHI is the Promega buffer D 
(Table 2.12). 
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Table 2.12 Table Showing the Promega Buffer Compatibility of BamHI and NdeI* 
 
*This table shows the appropriate choice of Promega buffer for the digestion of DNA with the 
Promega BamHI and NdeI restriction enzymes.  Adapted from the Promega Restriction Enzyme tool. 
 
The composition of the reaction mixtures were the same as described by the 
manufactuƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ  ?dĂďůĞ  ? ? ? ? ) ?  dhe enzymes, stored on ice at all times, were 
then added to a solution of the DNA and buffer, mixed and centrifuged.  The resulting 
solutions were then incubated at 37oC for 2 hours. 
Table 2.13 Typical Restriction Enzyme Reaction Composition 
Component Concentration Volume 
DNA sample >50ng/µl 15µl 
Restriction Enzyme 1 10U/µl 1µl 
Restriction Enzyme 2 10U/µl 1µl 
Buffer 10 x concentrate 4µl 
mQH2O  20µl 
Total volume  41µl 
 
The digestion samples were then purified either by preparative agarose gel and extraction 
of the DNA from the gel or by PCR purification (depending on the size of the DNA sample). 
2.10   DNA ligation 
>ŝŐĂƚŝŽŶ ŽĨ ĚŝŐĞƐƚĞĚ E ĨƌĂŐŵĞŶƚƐ ƚŽŐĞƚŚĞƌ ǁĂƐ ĂĐŚŝĞǀĞĚ ƵƐŝŶŐ ZŽĐŚĞ ?Ɛ Rapid DNA 
Ligation kit (Roche, 11635379001) ĂĐĐŽƌĚŝŶŐ ƚŽ ƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ ?  ƌŝĞĨůǇ ?
insert and vector were combined in a 10:1 ratio following equation 1. 
Equation 1 Equation for calculating the amount of insert required for ligation 
reactions. 
(Amount of vector (ng) x Size of insert (kb))/ Size of vector (kb) x Ratio of insert/Vector = ng 
of insert 
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This was then diluted with water and DNA dilution buffer added, mixed and then 
centrifuged.  Ligation buffer was added to this solution followed by T4 DNA ligase and the 
reaction mixed, centrifuged and incubated at room temperature for 2 hours. 
The standard reaction composition, where X comes from equation 1 and the DNA 
concentration and Y is the amount required to make the total volume 20.5µl is shown in 
Table 2.14. 
Table 2.14 Typical Restriction Enzyme Reaction composition 
Material  Concentration Volume 
Vector As above 2µl 
Insert As above Xµl 
T4 Ligation Buffer  2 x concentrate 10µl 
DNA dilution buffer 5 x concentrate 2µl 
T4 DNA Ligase 5U/µl 0.5µl 
mQH2O  Yµl 
Total volume  20.5µl 
 
10µl of this solution was then transformed into Top10 competent cells according to the 
transformation protocol (2.6).  100µl of the transformation culture was spread onto 
antibiotic LB plates and the residual 900µl of the transformation mixture was pelleted at 
3000rpm for 5 mins, 800µl of the supernatant removed and the cell pellet was gently 
resuspended in the remaining solution and spread onto a separate plate to make sure 
transformants were observed. 
2.11   Plasmid isolation and purification (miniprep) 
Isolation and purification of plasmid DNA from E.coli cultures was achieved using either 
YŝĂŐĞŶ ?Ɛ Y/ƉƌĞƉ ? ^ƉŝŶ DŝŶŝWƌĞƉ Ŭŝƚ Žƌ dŚĞƌŵŽĨŝƐŚĞƌ ?Ɛ 'ĞŶĞ:d WůĂƐŵŝĚ DŝŶŝWƌĞƉ Ŭŝƚ ?
ĨŽůůŽǁŝŶŐƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? 
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2.12   DNA sequencing 
DNA sequencing was carried out with primers described in the Table 2.6 using the service 
provided by Beckmann Coulter Genomics and the sequence analysis was carried out using 
the ApE  W A Plasmid Editor software. 
2.13   Sodium Dodecylsulphate Polyacrylamide Gel 
Electrophoresis - SDS PAGE 
2.13.1  General SDS PAGE Reagents 
Table 2.15 4x Sample Loading Buffer Composition 
Material Amount   
0.5M Tris-HCl, pH 6.8 1ml   
10% w/v Sodium Dodecylsulphate (SDS) 1.6ml   
50% v/v Glycerol 5ml   
Bromophenol blue A few grains   
2-Mercaptoethanol (added just before use) 5% v/v volume   
 
 
Table 2.16 Coomassie Stain Composition 
Material Amount 
Coomassie Brilliant Blue (R or G) 0.4g 
Methanol 100ml 




Table 2.17 Commassie Destain Composition 
Material Amount 
Methanol 500ml 
Glacial Acetic Acid 200ml 
H2O 500ml 
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Table 2.18 General SDS PAGE materials 
Material 




30% Acrylamide solution (29:1 acrylamide:bisacrylamide)  ? from Biorad, 161-0156 
40% Acrylamide solution (37.5:1 acrylamide:bisacrylamide)  ? from Biorad, 161-0148 
70% v/v Ethanol solution 
Tetramethylethylenediamine (TEMED)  ? from Sigma Aldrich, T8133 
2-Mercaptoethanol  ? Sigma Aldrich, M6250 
Bromophenol blue  ? Fisher Chemicals, B/4630/46 
Coomassie Brilliant blue R250  ? BioRad, 161-0400 
70% v/v Glycerol 
 
2.13.2 Tris-Glycine gel 
Table 2.19 Stacking Gel Buffer Composition 
Material 
1M Tris 




Table 2.20 Resolving Gel Buffer Composition 
Material 
1.5M Tris 









1.5% w/v SDS 
 
 
Chapter 2:  Materials and Method 
 
44 
Table 2.22 Resolving gel composition* 
Material 7.5% 10% 12.5% 15%  
30 % Acrylamide 2.7ml 3.6ml 4.5ml 5.4ml  
H2O 5.4ml 4.5ml 3.6ml 2.7ml  
Resolving gel buffer 2.7ml 2.7ml 2.7ml 2.7ml  
40% w/v APS 40µl 40µl 40µl 40µl ADDED LAST 
TEMED 5 µl 5 µl 5 µl 5 µl ADDED LAST 
*The choice of % gel is dependent on molecular weight of protein analysed.  APS and TEMED added 
simultaneously. 
Table 2.23 Stacking Gel composition 
Material   
30 % Acrylamide 1ml  
H2O 4.2ml  
Stacking gel buffer 1.75ml  
40% w/v APS 40µl ADDED LAST 
TEMED 5 µl ADDED LAST 
 
2.13.2.1  Tris-Glycine Electrophoresis conditions 
The gels were prepared and run using either a Biorad Protean 3 system or Invitrogen Novex 
Mini Cell system (with empty Novex cartridges).  The resolving gel was placed in to the 
cassette first, leaving enough space for the lane comb, and 70% w/v ethanol placed on top 
of the gel solution.  When the gel had set the ethanol solution was disposed of and any 
residue was removed using filter paper.  The stacking gel was then placed on top of the 
resolving gel and the lane comb was inserted into the solution and the gel was left to set. 
The samples were treated with 4 x sample loading dye, treated with 5% v/v 2-
mercaptoethanol added just prior to use, to give an overall 1 x concentration.  The samples 
were heated to 95oC for 5 mins and then centrifuged at 2000rpm for 30 seconds. 
The gel was placed into the gel tank and the internal chamber filled with 1 x Tris-Gly 
Running buffer and the external chamber was filled with 1 x Tris-Gly Running buffer so that 
the electrode was covered.  The gel was loaded with 3µl of PageRuler Prestain Ladder 
(Thermofisher, 26616) and treated samples prior to connecting to a power pack and 
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running at 180V until the Bromophenol blue from the sample loading buffer was about to 
exit the gel. 
The gel was removed from the cartridge and either scanned for fluorescent bands (FITC) 
using a Fujifilm FLA-5100 scanner and Image Reader FLA-5000 with the appropriate filters 
selected or stained with Coomassie stain for 1 hour and then destained with coomassie 
destain until the background blue colour was sufficiently removed to give good sample 
band definition.  The gel was then scanned using a flat bed scanner, either an Epson 
Perfection V33 or Epson Perfection 3200 photo in conjunction with Epson Scan software. 
 
2.13.3  Tris-Tricine gel 
Method from http://wolfson.huji.ac.il/purification/Protocols/Tricine.html 
Table 2.24 Gel Buffer Composition 
Material 
3M Tris-HCl 





Table 2.25 Composition of Tris-Tricine Running Buffers 
10 x Cathode Buffer 10 x Anode Buffer 
1M Tris-base 2.1M Tris base 
1M tricine pH8.9 
pH 8.25  
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Table 2.26 Tris-Tricine Gel Composition 
Solutions Resolving gel Stacking gel  
40% Acrylamide solution 5ml 1.05ml  
Gel Buffer 5ml 2.5ml  
70% v/v Glycerol  2ml 0ml  
H2O 3.1ml 6.7ml  
40% w/v APS 16.5µl 20µl ADDED LASTa 
TEMED 6.6µl 8µl ADDED LASTa 
aAPS and TEMED added simultaneously. 
2.13.3.1  Electrophoresis conditions 
The gels were prepared using an Invitrogen Novex Mini Cell system with empty novex 
cartridges.  The gel was prepared and run according to the same method as the tris-glycine 
gel (2.13.2.1) except that the inner gel compartment was filled with 1 x Cathode buffer, the 
outer compartment was filled to above the electrode with 1 x Anode buffer and the gel was 
run at 4oC. 
2.14   Western Blot 
2.14.1  Buffers 
 
Table 2.27 Composition of Transfer Buffer 
Material Amount  
Glycine 2.9g  
Tris base 5.8g  
SDS 0.37g  
Methanol 200ml Added just before use 
mQ H2O 800ml  
 
Table 2.28 Composition of Western Blotting Buffers 
10 x Tris Buffered 
Saline (TBS) 
TBS-T TBS-M 
500mM Tris 1 x TBS 1 x TBS 
1.5M NaCl 0.05% w/v 
Tween-20 
5% w/v Marvel 
skimmed milk 
powder 
pH 7.8   
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2.14.2  Transfer Conditions 
An unstained acrylamide gel was acquired according to the SDS PAGE protocol 2.13 and the 
gel removed from the cassette. 
Hybond ECL (Enhanced Chemiluminesence) membrane (GE Healthcare, RPN303D) and 
blotting paper (2 pieces) were cut to the same size as the acrylamide gel (8.25cm x 5cm).  
The ECL membrane and acrylamide gel were incubated together in transfer buffer for 20 
minutes. 
A piece of blotting paper was soaked in transfer buffer and placed onto the metal plate of 
the western transfer apparatus and rolled to remove air bubbles.  The ECL membrane was 
placed on top of the blotting paper, the acrylamide gel was placed on top of this and the 
stack completed by the addition of the last piece of blotting paper, soaked in transfer 
buffer, to the top.  The assembly was completed, after removal of air bubbles from the 
stack, by placing the metal top plate on the western transfer apparatus.  Transfer from the 
acrylamide gel to the ECL membrane was achieved by applying a current of 10V to the stack 
for 40 minutes. 
dŚĞ ŵĞŵďƌĂŶĞ ǁĂƐ ƌĞŵŽǀĞĚ ĨƌŽŵ ƚŚĞ ƐƚĂĐŬ ĂŶĚ  ‘ďůŽĐŬĞĚ ? ǁŝƚŚ d^-M for 10 minutes 
before incubating with a primary antibody, diluted appropriately, Table 2.5, in 15ml of TBS-
M, for 2 hours at room temperature or overnight/over the weekend at 4oC.   The primary 
antibody was then removed and the membrane was washed with fresh TBS-M before 
incubating with an appropriate secondary antibody, diluted in 15ml of TBS-M, for 1 hour at 
room temperature.  The antibody solution was removed and the membrane was washed 
with TBS-T for five minutes.  The wash was repeated a further two times before 
visualisation. 
FITC labelled secondary antibody visualisation was achieved using a Fujifilm FLA-5100 
scanner and Image Reader FLA-5000 with the appropriate filters selected. 
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2.15   Protein Concentration determination 
Protein concentration was measured using an Eppendorf Biophotometer or BMG Labtech 
LVis plate (S/N 680-0194) in conjunction with a BMG labtech platereader (either FLUOstar 
Omega or SPECTROstarNano) by monitoring the absorbance of the sample at 280nm and 
correcting against a blank sample.   
The protein concentration is linked to the absorbance of the sample through the Beer 
>ĂŵďĞƌƚ >Ăǁ  ?A?ɸĐů )ǁŚĞƌĞ ƚŚĞĞǆƚŝŶĐƚŝŽŶ ĐŽĞĨĨŝĐŝĞŶƚŽĨ ƚŚĞƉƌŽƚĞŝŶ ŝƐĚĞƉĞŶĚĞŶƚŽŶ ƚŚĞ
amino acid residues contained in the protein and can be predicted (Table 2.29). 
The concentration derived, mg/ml, can then be converted to molarity using the molecular 
weight of the protein. 
Table 2.29 Extinction Coefficients and Molecular Weights of Proteins Used in This 
Thesis 
Protein ࡭૛ૡ૙࢔࢓૙Ǥ૚ ?  Molecular 
Weight 
Data Source 
Sup35NMC 0.945 78714.2 Expasy ProtParama 
Sup35NM 0.971 30681.8 Expasy ProtParama 
Sup35NM-LCys 0.949 31388.5 Expasy ProtParama 
ɲ-Synuclein 0.412 14460.1 Expasy ProtParama 
ɴ-Lactoglobulin 0.96 18276 Sigma MSDS / (Croguennec et al., 
2004) 
Lysozyme 2.64 14307 Sigma MSDS 




Sigma MSDS / Expasy ProtParama 
a http://web.expasy.org/protparam/ 
2.16   Protein Expression 
A single colony from a freshly streaked ampicillin selective LB plate was inoculated into 
30ml of ampicillin selective LB and incubated at 37oC overnight.   




1M Isopropyl-ɴ-D-1-thiogalactopyranoside (IPTG) 
Liquid LB medium (see Table 2.1) 
Ampicillin (see Table 2.1) 
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20ml of the overnight culture was removed and centrifuged at 3000rpm for 10 minutes and 
the supernatant was removed before the cell pellet was resuspended in 5ml of fresh LB 
medium.  This suspension was then used to inoculate 1L of LB with ampicillin medium 
which was then incubated at 37oC until the OD600 of the culture was ~0.6.  Protein 
expression in the culture was then initiated by addition of 1ml of 1M IPTG, 1mM working 
concentration, to the culture and then incubated at 37oC for 4 hours.  The cells were 
harvested by centrifugation at 4000rpm for 10 minutes and then either taken on to 
purification or snap frozen and stored at -80oC until purification. 
2.17   Protein Purification 
2.17.1  Buffers and Reagents 
Table 2.31 Reagents required for Protein Purification 
Material 
100mM Phenylmethanesulphonyl fluoride in propan-2-ol 
200mM Nickel (II) chloride (NiCl2) 
 
Table 2.32 Composition of Sup35 Purification Buffers* 
Melki Lysis Buffer (MLB) Melki Lysis Buffer 
Denaturing (MLBG) 
Denaturing Sizing Buffer 
(DSB) 
20mM Tris-HCl 20mM Tris-HCl 20mM Tris-HCl 
1M NaCl 1M NaCl 0.5M NaCl 
20mM imidazole 20mM imidazole 6M guanidine HCl 
100mM PMSF (added just 
prior to usage) 
6M guanidine HCl  
pH8 pH 8 pH 8 
*For eluting from the Ni-NTA resin the concentration of imidazole in the buffers was 
increased to 0.5M. 
 
Table 2.33 ŽŵƉŽƐŝƚŝŽŶŽĨɲ-Synuclein Purification Buffers 
ɲ -Synuclein Lysis Buffer 
(SLB) 
ɲ-Synuclein Ion 
Exchange Entry Buffer 
(SEB) 
ɲ -Synuclein Ion 
Exchange Elution 
Buffer (SElB) 
20mM Tris 20mM Tris 20mM Tris 
100mM NaCl  1M NaCl 
pH 7.5 pH 7.5 pH 7.5 
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2.17.2  Nickel Affinity Resin (Ni-NTA) 
The Ni-NTA resin was prepared by washing GE Healthcare Chelating SepharoseTM Fast Flow 
resin, 17-0571-01, with 2 column volumes of mQH2O, 1 column volume of 200mM NiCl2, 1 
column volume of mQH2O and finally 2 column volumes of lysis buffer. 
2.17.3  Sup35 Full length 
2L of E.coli cell pellet containing Sup35NMC was resuspended in 20ml of MLB, cooled to 
4oC, and lysed by sonication at 18µm amplitude for four 30 second bursts with 30 second 
intervals between each burst.  The lysate was then clarified by centrifugation at 15000rpm 
for 30 minutes at 4oC and the supernatant was incubated with 1ml of Ni-NTA resin at 4oC 
for 30 minutes.  The resin was collected by centrifugation at 4000rpm for 5 minutes, the 
supernatant placed to one side, and the resin washed with 10ml of MLB.  The resin was 
then washed with 15ml of MLBG prior to elution of the protein with 1ml of MLBGE. 
5ml of material from the Ni-NTA purification was further purified by size exclusion 
chromatography using a HiLoadTM 16/600 SuperdexTM 200pg, from GE Healthcare (28-9893-
35), using DSB on an ÄktaPrime Plus system at a flow rate of 0.3ml/minute.  The 
appropriate fractions were combined and frozen at -80oC. 
2.17.4  Sup35NM 
2L of E.coli cell pellet containing Sup35NM was resuspended in 20ml of MLBG and lysed by 
sonication at 18µm amplitude for six 30 second bursts with 30 second intervals between 
each burst.  The lysate was then clarified by centrifugation at 15000rpm for 30 minutes and 
the supernatant was incubated with 1ml of Ni-NTA resin at room temperature for at least 2 
hours.  The resin was collected by centrifugation at 4000rpm for 5 minutes, the 
supernatant placed to one side, and the resin washed with 15ml of MLBG.  The protein was 
eluted from the Ni-NTA resin by washing the resin with 1ml of MLBGE. 
5ml of material from the Ni-NTA purification was further purified by size exclusion 
chromatography using a GE Healthcare HiLoadTM 16/600 SuperdexTM 200pg, from GE 
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Healthcare (28-9893-35), using DSB on an ÄktaPrime Plus system at a flow rate of 
0.3ml/minute.  The appropriate fractions were combined and frozen at -80oC. 
2.17.5  Sup35NM-LCys 
2L of Sup35NM cell pellet were resuspended in 20ml of MLBG + 2.5mM 2-Mercaptoethanol 
and lysed by sonication at 18µm amplitude for six 30 second bursts with 30 second 
intervals between each burst.  The lysate was then clarified by centrifugation at 15000rpm 
for 30 minutes and the supernatant was incubated with 1ml of Ni-NTA resin at room 
temperature for at least 2 hours.  The resin was collected by centrifugation at 4000rpm for 
5 minutes, the supernatant placed to one side, and washed with 15ml of MLBG.  The 
protein was eluted from the Ni-NTA resin by washing the resin with 1ml of MLBGE. 
5ml of the sample from the Ni-NTA purification was defrosted and 2M dithiothreitol (DTT) 
added to a final concentration of 50mM and incubated at RT for 1 hour.  This material was 
further purified by size exclusion chromatography using a GE Healthcare HiLoadTM 16/600 
SuperdexTM 200pg, from GE Healthcare (28-9893-35), using DSB on an ÄktaPrime Plus 
system at a flow rate of 0.3ml/minute.  The appropriate fractions were combined and 
frozen at -80oC. 
2.17.6  Ƚ-Synuclein 
1L of E.coli cell pellet containing ɲ-synuclein was resuspended in 20ml of SLB + Roche 
Complete Protease Inhibitor tablets (Roche, 11697498001) and sonicated on ice at 18µm 
amplitude for 10 second bursts with 10 second intervals for a total of 180 seconds.  The 
lysate was centrifuged at 13000rpm for 30 minutes at 4oC and the supernatant collected 
and acidified to pH3.5 using 1M HCl.  The suspension was then rolled at room temperature 
for 30 minutes and the precipitate collected by centrifugation at 13000rpm for 10 minutes.  
The supernatant was then neutralised, using 1M NaOH, and then treated with ammonium 
sulphate, (NH4)2SO4, to give a 30% solution, as determined using saturation tables 




aldrich/docs/Sigma/Bulletin/a5479bul.pdf), and then incubated at 4oC for 20 minutes.   
The suspension was then clarified by centrifugation at 13000rpm for 20 minutes and the 
supernatant treated with further (NH4)2SO4 to give a 50% solution overall (using the same 
table) and then rolled for 30 minutes at 4oC.  The resulting precipitate was collected by 
centrifugation at 13000rpm for 30 minutes at 4oC and then dissolved in 2.5ml SEB and the 
excess ammonium sulphate was removed by buffer exchange into SEB using a PD10 
column, GE Healthcare 17-0851- ? ? ?ĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? 
The resulting material was then purified by ion exchange chromatography on an ÄktaPrime 
Plus system with a strong anion exchange HiTrapTM Q FF 5ml cartridge (GE Healthcare, 17-
5156-01) and the standard ion exchange method with a linear gradient from SEB to SElB.  
The desired protein fractions were collected and assessed by SDS PAGE analysis. 
The sample was then snap frozen and stored at -80oC or transferred directly into fibril 
ĨŽƌŵŝŶŐďƵĨĨĞƌƵƐŝŶŐĂW ? ?ĐŽůƵŵŶĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? 
2.18   In vitro Polymerisation 
 




Table 2.34  Composition of Fibril forming buffers 
Sup35 fibril forming buffer 
(SFFB) 
ɲ -Synuclein fibril forming 
buffer (SyFFB) 
>ǇƐŽǌǇŵĞ ? ɴ-lactoglobulin 
and insulin B chain fibril 
forming buffer 
20mM Sodium phosphate 25mM Sodium phosphate 10mM HCl 
50mM NaCl   
pH 7.4 pH 7.5 pH2 
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All buffers were filtered using a 0.2µm syringe filter prior to use in polymerisation 
reactions. 
 
Table 2.35 Commercial Proteins Utilised for in vitro Polymerisation 
Protein Purity Supplier Catalogue No. 
Lysozyme from chicken egg 
white 
A? ? ?A? Sigma Aldrich L6876 
ɴ-Lactoglobulin B, from 
bovine milk 
A? ? ?A? Sigma Aldrich L8005 
Insulin Chain B Oxidised, 
from bovine pancreas 
A? ? ?A? Sigma Aldrich I6383 
 
2.18.2  Sup35 Full length, Sup35NM, Sup35NM-LCys 
Polymerisation 
2.5ml of pure protein in DSB was exchanged into 3.5ml of SFFB using a PD10 column 
according to ƚŚĞ ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ ?  dŚĞ ŵĂƚĞƌŝĂů ǁĂƐ ƚŚĞŶ ĚŝůƵƚĞĚ ƚŽ ƚŚĞ
appropriate concentration (10µM, 5µM etc) and incubated at 37oC without agitation.  Post 
buffer exchange, using a PD10 column, all manipulations of the Sup35 solutions were with 
low bind tips (VWR 53503-294 (with SpidersilkTM surface)), and Protein LoBind 1.5ml tubes 
(Eppendorf, 022431081). 
2.18.3  Ƚ-Synuclein 
2.5ml of pure protein in SElB was buffer exchanged into SyFFB using a PD10 column 
ĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ ? dŚĞƐĂŵƉůĞǁĂƐƚƌĞĂƚĞĚǁŝƚŚ  ? ? ? ? ? ?A?ǁ ?ǀ
sodium azide, syringe filtered using a 0.2µm filter and incubated at a concentration 
>200µM and at 37oC with orbital agitation (160rpm) for 2 weeks. 
2.18.4  Lysozyme (pH2) 
Lysozyme was dissolved in 10mM HCl to give a protein concentration of ~20mg/ml and 
then syringe filtered through a 0.2µm membrane.  The resulting solution was diluted to 
give a concentration of at least 699µM (10mg/ml), heated to 60oC for 144 hours in a heat 
block and then allowed to cool to room temperature. 
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2.18.5  Ⱦ-Lactoglobulin (pH2) 
ɴ-Lactoglobulin was dissolved in 10mM HCl to give a protein concentration of ~20mg/ml 
and then rolled for 1 hour.  The solution was filtered through a 0.2µm membrane and the 
resulting solution was diluted to give at least 300µM (5.5mg/ml), and then heated to 90oC 
for 5 hours in a heat block and then allowed to cool to room temperature. 
2.18.6  Insulin chain B (pH2) 
Insulin chain B was dissolved in 10mM HCl to give a protein concentration of ~10mg/ml and 
then syringe filtered through a 0.2µm membrane.  The resulting solution was diluted to 
give a concentration of at least 500µM (1.7mg/ml), and then heated to 60oC for 48 hours in 
a heat block and then allowed to cool to room temperature. 
2.19   Fibril Fragmentation 
500µl of a 120µM fibril suspension (according to initial monomer concentration) was put 
into a clear HPLC vials (HPLS, Chromacol, V944/950) with a stirring bar (cylindrical 8 x 3mm, 
VWR, 442-4520) and placed onto the centre of an IKA color squid stirrer plate (IKA, 
0003671000), held in position by double sided tape.  The sample was then stirred at 
1000rpm under the cover of an aluminium foil covered plastic box to prevent the 
interaction of light with the sample.  At appropriate time points aliquots of the 
fragmentation were removed, diluted appropriately and adsorbed onto freshly cleaved 
mica surfaces. 
The surfaces were then imaged according 2.33. 
2.20   Residual Monomer Assay 
100µl of 120µM unfragmented fibrils and of the fibril fragmentation were centrifuged at 
75000rpm for 15 minutes using a Beckman Coulter Optima Max Ultracentrifuge.  The top 
10µl of the supernatant from each was removed and then treated with 4 x SDS PAGE 
sample loading dye and heated to 95oC for 5 minutes.  These samples were then loaded 
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onto a tris-tricine or 15% tris-glycine SDS PAGE along with a serial dilution of the 
monomeric protein from 60µM to 1.875µM.  The gel was then run according to the SDS 
PAGE protocol, 2.2.13, with Coomassie staining. 
The stained gel was then scanned on a flat bed scanner, either an Epson Perfection V33 or 
Epson Perfection 3200 photo in conjunction with Epson Scan software.  The resulting image 
was then analysed using the densitometry component of the Aida Image Analyzer V4.15 
software. 
The fibril and fragmented fibril samples were then compared with the serial dilution and 
each other to show any change in the amounts of monomers not incorporated into 
aggregates. 
2.21   Fibril Formation Kinetics Ȃ Thioflavin T (ThT) 
Assay 
Monomeric protein solutions were transferred into fibril forming buffer using a PD10 
column accorĚŝŶŐ ƚŽ ƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ ?  dŚĞ ƐĂŵƉůĞƐ ǁĞƌĞ ĚŝůƵƚĞĚ ƚŽ ƚŚĞ
appropriate concentration, typically 10µM, 5µM and 2.5µM, with fibril forming buffer.  1µl 
of 1mM ThT solution was added to 100µl of protein monomer solution.  The final volume is 
100µl per well using a black 96-well plate (BRANDplate, Brand GMBH, 781608).  Each plate 
contains reference samples of fibril forming buffer and ThT with no protein.  The plates are 
sealed using a transparent film (X-Clear Advanced Polyolefin StarSeal, Star Lab, E2796-
9795) and placed into a BMG labtech platereader (Omega) with filters for 440nm and 
480nm (BMG 440BP10 and BMG 480BP10 respectively).  The samples were mixed with 
double orbital shaking and the fluorescence measured every 30 minutes by excitation at 
440nm and monitoring the emission of the sample at 480nm. 
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2.22   SDD-AGE of In vitro Derived Polymers 
2.22.1  Reagents 
Table 2.36 Composition of SDD AGE Buffers 
3 x SDD AGE Sample 
Buffer 
Buffer G Laemmli Buffer 
180mM Tris-HCl 20mM Tris Base 20mM Tris-base 
15% v/v glycerol 200mM glycine 200mM glycine 
6% w/v SDS  0.1% w/v SDS 
0.15% w/v bromophenol 
blue 
  
pH 6.8   
 
Table 2.37  Composition of SDS-Agarose Gel  
Material 
1.5% w/v agarose 
0.1% w/v SDS 
All dissolved in Buffer G 
 
2.22.2  Procedure 
The agarose was suspended in Buffer G and then microwaved on full power for 20 second 
bursts, until the agarose is dissolved.  A stirrer bar is added and the mixture is stirred, 
whilst 20% w/v SDS was added to give a final concentration of 0.1%.  The gel was poured 
into an empty DNA gel holder, with a lane comb inserted.  The gel was allowed to set and 
then orientated so that the gel is in line with the electrodes with the comb at the negative 
end (cathode) of the gel.  The gel was covered with Laemmli buffer and incubated for 30 
minutes. 
The samples were prepared by treatment with 3 x SDD AGE sample buffer and then 
incubated for 5 minutes prior to loading into the gel lanes. 
The gel was then connected to a powerpack and run at 125V until the bromophenol blue 
from the sample buffer had travelled 7cm. 
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The gel was removed and imaged using a flat bed scanner, either an Epson Perfection V33 
or Epson Perfection 3200 photo in conjunction with Epson Scan software, if fluorescently 
labelled fibrils were used. 
 
2.23   Protein Ligation through Amide formation 
 
Hen egg lysozyme, >500µM, in pH 7.8 phosphate buffered saline (PBS) was cooled to 4oC 
and mixed by rolling.  To this cooled solution 1.1 molar equivalents of a 10mM DMSO stock 
of NHS PEG12 N3 was added.  The samples were mixed by rolling for 2 hours at 4
oC and then 
quenched with 200µl of 1M tris(hydroxymethyl)aminomethane and rolled for 30 minutes. 
The residual reagents were removed by buffer exchange into pH 8, 20mM sodium 
phosphate using a PD10 column according ƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? 
2.24   Protein Ligation By Iodoacetamide 
displacement 
 
A denatured solution of a cysteine containing mutant (20mM phosphate, 50mM NaCl, 6M 
guanidine, pH 7.5) was defrosted from -80oC and then treated with a stock solution of an 
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Iodoacetamide reagent (5 molar equivalents in DMSO) and then incubated in a flask, 
protected from light by silver foil, for 2 hours. 
The sample was then purified by buffer exchange into fibril forming buffer using a PD10 
ĨŽůůŽǁŝŶŐŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐŽƌƐƚŽƌĞĚĂƚ-80oC until purification/further reaction 
in a vial protected from light by silver foil. 
2.25   Protein Ligation using CuAAC chemistry 
 
This method is applicable to both azide modified lysozyme and Sup35 although if the 
material is at pH2 the pH should be raised to at least pH5 for the duration of the 
experiment and then re-acidified at its conclusion.  The presence of denaturant (guanidine) 
also seems to slow the rate of the conjugation. 
2.25.1  General method for CuAAC reaction 
 
The tris(3-hydroxypropyltriazolylmethyl)amine was added to a solution of the azide 
containing monomer and alkyne.  The CuSO4 was then added to this solution with the 
sodium ascorbate being added last.  The reactions were then incubated with mixing, on a 
roller, for 2 hours at room temperature. 
The excess reagents could be removed by PD10 purification according to the 
ŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐŽƌƚŚĞƌĞĂĐƚŝŽŶƋƵĞŶĐŚĞĚďǇůŽǁĞƌŝŶŐƚŚĞƉ,ŽĨƚŚĞƐŽůƵƚŝŽŶƚŽ
pH2. 
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Table 2.38 General CuAAC Reaction Composition 
Material Molar equivalent 




Sodium ascorbate 100 
 
2.26   Protein Ligation Using SPAAC Chemistry 
 
2.26.1  General method for SPAAC reaction 
The azide containing monomer was treated with a stock solution of the BCN labelled 
material and incubated at room temperature for 4 hours. 
Excess reagents could then be removed by buffer exchange using a PD10 column according 
to ŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? 
Table 2.39 General SPAAC Reaction Composition 
Material Molar Equivalents 
Azide containing monomer 1 
Bicyclononyl (BCN) 10 




2.27   Synthesis of FITC-Alkyne 

















Mol. Form.     = C21H11NO5S
Form. Weight = 389.38074
Mol. Form.      = C3H5N
Form. Weight = 55.0785
Mol. Form.     = C24H16N2O5S
Form. Weight = 444.45924
 
Table 2.40 Reagent table for the synthesis of FITC-Alkyne 
Reagent Molar equivalent Density 
(g/ml) 
Amount mmoles 
FITC 1 - 5mg 0.0128 
Progargylamine 55 0.86 45µl 0.703 
DMF Solvent  55µl  
The FITC (5mg/0.01mmoles) was dissolved in DMF (55µl) and treated with propargylamine 
(45µl, 0.703mmoles) and stirred overnight at room temperature in the dark.  To this 
solution 950µl of 1:1 MeCN:H2O were added to give a 12.8mM stock solution of the alkyne 
labelled dye (assuming complete and successful reaction of the FITC). 
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2.28   Synthesis of N-(2-{2-[2-(2-
azidoethoxy)ethoxy]ethoxy}ethyl)-2-iodoacetamide Ȃ 























Mol. Weight  = 218.25















Mol. Weight  = 283.02
Mol. Weight   = 386.19

















1.05 1.10 1.16mg 0.0053 
SIA 1 - 1.94mg 0.00505 
DCM Solvent  200µl  
 
The amine (1.16mg/0.0053mmoles) and succinimidyl iodoacetate (SIA) 
(1.94mg/0.00505mmoles) were dissolved separately in (50µl and 100µl respectively) 
dichloromethane (DCM) and cooled to 4oC.  The solutions were mixed and incubated on ice 
for 5 minutes before rolling at room temperature for 2 hours. 
The DCM was evaporated under a stream of N2(G) and then redissolved in DMSO to give a 
stock solution (~20mM). 
LC-MS  W shows one peak MS (ES): (MH+) 387.0511 
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2.29   Synthesis of 2-iodo-N-(4,4,4-



















Molecular Weight  = 127.1082296






Molecular Weight  = 295.0414396
Molecular Formula  = C6H9F3INO
 
Table 2.42 Reagent table for the synthesis of Iodoacetamide CF3 
Reagent Molar equivalent Density (g/ml) Amount mmoles 
4,4,4-Trifluorobutylamine 1.05 0.93 1.18mg 0.0092 
SIA 1 - 3.4mg 0.0088 
DCM Solvent  200µl  
 
The amine (1.18mg/0.0092mmoles) and succinimidyl iodoacetate (SIA) 
(3.4mg/0.0088mmoles) were dissolved separately in (2 x 100µl) DCM and cooled to 4oC.  
The solutions were mixed and incubated on ice for 5 minutes before rolling at room 
temperature for 2 hours. 
The DCM was evaporated under a stream of N2(g) and then redissolved in DMSO to give a 
stock solution (~20mM). 
LC-MS shows one peak MS (ES): (MH+) 295.9665 
2.30   Synthesis of 3,3,3-trifluoro-N-(prop-2-yn-1-











Molecular Weight  = 146.4955896








Molecular Weight  = 165.1131496







Molecular Weight = 55.0785
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1 1 146µl 0.001 
Propargylamine 2.5 0.86 160µl 0.0025 
Diethyl ether Solvent  2ml  
 
Propargylamine (160µl/0.0025mmoles) was dissolved in diethyl ether (2ml) and cooled to 
4oC.  The acid chloride (146µl/0.001mmole) was then added to this solution in three 
portions and the reaction incubated at 4oC for 10 minutes before mixing at room 
temperature for 20 minutes. 
The reaction was diluted with diethyl ether (3ml) and then washed with 700µl 1M HCl 
solution (x2) and then a saturated NaCl solution (x2).  The diethyl ether was then 
concentrated under a stream of N2(g) to give a gummy solid.  The material was then 
dissolved in DMSO to give a 100mM stock solution. 
LC-MS shows one major component with some small impurities MS (ES): (MNa+)188.0321 
2.31   Synthesis of N-[(1R,8S,9s)-Bicyclo[6.1.0]non-4-
yn-9-ylmethyloxycarbonyl]-1,8-diamino-3,6-dioxaoctane FITC 
























Mol. Weight = 324.415















Form. Weight = 389.38
Mol. Weight = 713.796
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- 2.1mg 0.0065 
FITC 1.05 - 2.66mg 0.00683 
DCM Solvent  100µl  
DMF Solvent  50µl  
 
The BCN amine (2.1mg/0.0065mmoles) was dissolved in DCM (100µl) and the FITC 
(2.66mg/ 0.00683mmoles) was dissolved in DMF (50µl).  The two solutions were cooled to 
4oC, combined and then incubated at 4oC for 5 minutes before mixing, by rolling, at room 
temperature for 2 hours. 
The DCM was removed by evaporation under a stream of N2(g) and the resulting DMF 
solution was diluted with DMSO to give an ~60mM stock solution. 
LC-MS shows one major component with some small impurities MS (ES): (MH+) 714.2371 
2.32   Synthesis of N-[(1R,8S,9s)-Bicyclo[6.1.0]non-4-
yn-9-ylmethyloxycarbonyl]-౽-(1,1,1)trifluoropropionyl-1,8-




















Mol. Weight = 324.415








Mol. Weight = 46.496







Mol. Weight = 434.45
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- 2mg 0.00615 
3,3,3-Trifluoropropionyl Chloride 1.6 1.00 1.44mg 0.00984 
Pyridine 40 0.982 19.8µl 0.246 
DCM Solvent  190µl  
 
The BCN amine (2mg/0.00615mmoles) was dissolved in 100µl DCM, cooled to 4oC and then 
treated with a 50µl DCM solution containing pyridine (19.8µl/0.245mmoles).  The acid 
chloride (1.44mg/0.00984mmoles) was dissolved in 40µl DCM, cooled to 4oC and then 
added to the amine solution slowly.  The reaction was then incubated at 4oC for 5 minutes 
and then mixed at room temperature for 2 hours. 
The material was then diluted with 300µl DCM and washed with 300µl pH2 HCl three times.  
The organics were then evaporated under a stream of N2(g) and the resulting material was 
dissolved in DMSO to give a concentration of about 20mM. 
LC-MS very small peak which looks like two peaks MS (ES): (MH+) 435  
2.33   Electron Microscopy 
2.33.1  Surface Deposition 
Fibril samples were diluted appropriately, typically 1:4 with double distilled H2O, 20µl was 
then placed onto a 400 mesh carbon/formavar coated copper surface and incubated for 30 
seconds.  The excess solution from the surface was removed by a pipette attached to a 
water vacuum pump.  The surface was then incubated with 20µl of 2% w/v uranyl acetate 
solution for 1 minute.  The excess uranyl acetate was then removed by vacuum and the 
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sample allowed to air dry for 10 minutes before storing in a grid box until use.  The vacuum 
manifold was washed with copious amounts of H2O to remove uranium residues. 
2.33.2  Imaging 
Surfaces were imaged using a Jeol JEM 1230 transmission electron microscope, at 
an accelerating voltage of 80kV, with Gaitan Multiscan camera Model 791 and Digital 
Micrograph software.  Images were captured at multiple magnifications with and without 
scale bars. 
2.34   Atomic Force Microscopy (AFM) 
2.34.1  Deposition 
A mica disc (Agar scientific, F7013) was attached to a steel surface (Agar scientific,) using 
double sided tape.  The top layer of mica was removed using tape. 
20µl of a fibril sample diluted appropriately in fibril forming buffer was incubated on the 
cleaved mica surface for an appropriate length of time (Table 2.46).  The excess sample was 
then washed away with an appropriate volume of mQH2O (Table 2.46).  The surface was 
then dried under a stream of N2(g) (Standard) or by removing residual water with a filter 
paper placed on the extreme edge of the mica surface held vertically and then the drying 
was finished with a very gentle stream of N2(g) (Gentle).  











10µM 5 minutes 1000µl Standard 
Sup35 NM 10µM 5 minutes 1000µl Standard 
Sup35NM  ? 
LCys 
10µM 5 minutes 1000µl Standard 
Insulin B  chain 3µM 5 minutes 1000µl Standard 
ɲ-Synuclein 0.48µM 5 minutes 1000µl Gentle 
ɴ-Lactoglobulin 0.6µM 5 minutes 1000µl Standard 
Lysozyme 3µM 5 minutes 1000µl Standard 
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2.34.2  Imaging 
Prepared samples were imaged using a Bruker Multimode AFM with a Nanoscope V 
controller.  Samples were imaged using a ScanAsyst probe (A silicon nitride triangular tip 
with tip height = 2.5-8µm, nominal tip radius = 2nm, nominal spring constant 0.4N/m and 
nominal resonant frequency 70kHz) and the ScanAsyst experiment in the Nanoscope 8.15 
software. 
Typically images were captured at a resolution of 9.77nm per pixels scanned (typically 
10µm x 10µm at 1024 x 1024 pixels or 20µm x 20µm at 2048 x 2048 pixels).  All images are 
processed using the Nanoscope Analysis software.  The image baseline was flattened using 
3rd order correction, the streaks removed from the fibrils by lowering the z threshold % and 
the data then saved as a PNG file and a processed image file with a file extension of .001 
for recognition by the tracing software. 
2.34.3  MatLab Analysis 
The processed image file, with a file extension of .001, was opened in the fibre tracing 
MatLab application and Auto Trace Polymers was selected.  The apparent width, search Phi 
and z cutoff values were inputted into the software and the tracing was initiated (Table 
2.47).  The completed traces were saved.  The optimum values of each parameter were 
determined by trial and error modification of each value until the most accurate trace was 
achieved. 






) Z cutoff (nm) 
Lysozyme 3 50 1 
ɲ-Synuclein 4 40 1.5 
ɴ-Lactoglobulin 2 60 1 
 
The resulting image file was saved and the fibril data extracted using the PolProp app (Beal, 
Appendix 1).  
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The persistence lengths were calculated from the traced polymers using the CalcLp app 
(Xue, unpublished).  The method of bias correction was calculated by taking the combined 
fragmentation data and inputting into the LcBiasCorr app (Xue, unpublished).  This 
correction method was then used in conjunction with the same data using the PlotLcDistr 
app (Xue, unpublished) to give the corrected data. 
2.35   Liquid Chromatography - Mass Spectrometry 
(LC-MS) Ȃ Electrospray 
LC-MS of samples was achieved using an Agilent series 1100 HPLC system controlled by 
Bruker Compass Hystar 3.2 software.  The instrument was primed with appropriate buffers 
prior to the appropriate column being attached.  The samples were placed in a HPLC vial 
(HPLS, Chromacol, V944/950) which where necessary (particularly protein samples) 
contained an insert (Verex Insert, 5mm diameter, 175µl, conical bottom, with spring 
bottom, Phenomenex, ARO-4521-13) allowing for the use of low volumes. 
2.35.1  Protein 
Table 2.48 Protein electrospray LC-MS conditions 
Column Phenomenex, 00B-4167-130, Jupiter, 5µm, C4, 300Å, 50 x 2.00mm 
Buffer A 95.95% v/v H2O, 0.05% v/v trifluoroacetic acid 
Buffer B 4.955% v/v H2O, 95% v/v acetonitrile, 0.045% v/v trifluoroacetic acid 
 
The column was equilibrated with Buffer A at a flow rate of 0.2ml/min and a column 
temperature of 30oC.  A sample table was prepared using the Hystar software.  The generic 
protein desalt method (desalt.m) was used as the chromatography method, the generic 
protein mass spec method (peptide_lc_nomsms.m) was used for the mass spectrum 
capture and the generic protein processing method (protein.m) was used for processing. 
Sample analysis was carried out using the Bruker Compass DataAnalysis 4.1 software.  A 
datafile was opened, and an average of the MS data under a peak was selected giving a 
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charge envelope which was smoothed using a Savitsky-Golay function.  The resulting 
charge envelope was then deconvoluted to give the deconvoluted molecular weight. 
 
2.35.2  Small molecule 
Table 2.49 Protein electrospray LC-MS conditions 
Column Phenomenex, 00B-4387-130, Synergi, 2.5µm, Hydro-PR 100Å, 50 x 2.00mm 
2µm 
Buffer A 95.95% v/v H2O, 0.05% w/v ammonium formate 
Buffer B 4.955% v/v H2O, 95% v/v methanol, 0.045% w/v ammonium formate 
 
The column was equilibrated with Buffer A at a flow rate of 0.2ml/min and a column 
temperature of 30oC.  A sample table was prepared using the Hystar software.  The generic 
small molecule method (Small molecule.m) was used as the chromatography method and 
the generic small molecule mass spec method (Small_start.m) was used for the mass 
spectrum capture.  
Sample analysis was carried out using the Bruker Compass DataAnalysis 4.1 software.  A 
datafile was opened, and an average of the MS data under a peak was selected giving and 
smoothed using a Savitsky-Golay function.  No charge deconvolution is required for small 
molecules. 
2.36   Nuclear Magnetic Resonance spectroscopy 
(NMR) 
2.36.1  Sample preparation 
Samples are diluted to an appropriate concentration with fibril forming buffer, volume of 
500µl, D2O (60µl) was also added to samples as well, dioxane (varied amount depending on 
the sample concentration) and a fluorinated reference sample (either trifluoroethanol or 
4,4,4-trifluorobut-2-en-1-ol) (varied amount depending on the sample concentration). 
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2.36.2  Acquisition conditions 
All spectra were acquired at 25oC using a 4-channel, 14.1 T (600 MHz 1H) Bruker Avance III 
NMR spectrometer equipped with a 5mm QCI-F cryoprobe and Bruker TopSpin software by 
Michelle Rowe.  The parameters and experiments used for each experiment are shown in 
Table 2.50. 
Table 2.50 NMR Parameters for Spectra Acquisition 

















stegp1s1d 8192 4096 80.5136 -95 0.0901120 
Lysozyme Fibrils 
with TFE (19F) 
stegp1s1d 8192 4096 80.5136 -95 0.0901120 
Lysozyme 
Monomer (1H) 




stebpgp1s191d 32768 128 7211.539 4.700 2.2719147 
Unlabelled Fibrils 
(1H) 
stebpgp1s191d 32768 128 7211.539 4.700 2.2719147 
Sup35NM 19F 
Labelled (1H) 
stebpgp1s191d 32768 4096 7211.539 4.700 2.2719147 
 
2.36.3  Data Analysis 
The captured spectra were processed using an exponential window function with varying 
levels of line broadening, phased using the automated 0th order correction algorithm 
(apk0), then manually baseline corrected using the Bruker Topspin 3.2 software and 
exported as a textfile.  The data was then imported into MatLab and concatenated to give a 
data set containing the NMR spectra of the sample with gradient strength of between 5% 
and 95% maximum.  A single peak is selected from the data and the area under the 
appropriate peak calculated.  The decay of peak intensity with increasing gradient strength 
was fitted to the Stejskal-Tanner equation (Equation 5.2) using the MatLab curve fitting 
tool.  
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2.37   Confocal Microscopy of Fluorescent Fibrils 
2.37.1  Sample Preparation 
A mica surface was attached to a microscope slide using double-sided tape and then 
cleaved using electrical tape.  20µl of neat Sup35NM LCys N3 BCN FITC was incubated for 5 
minutes before washing with 1ml of syringe filtered mQH2O and drying under a stream of 
N2(g). 
2.37.2  Acquisition conditions 
Samples were visualized, by Dr Dan Mulvihill, using an Olympus IX71 microscope with 
PlanApo 100x OTIRFM-SP 1.45 NA lens mounted on a PIFOC z-axis focus drive (Physik 
Instrumente, Karlsruhe, Germany), and illuminated using LED light sources (Cairn Research 
Ltd, Faversham, UK) with appropriate filters (Chroma, Bellows Falls, VT). Samples were 
visualized using a QuantEM (Photometrics) EMCCD camera, and the system was controlled 
with Metamorph software (Molecular Devices). Each 3D-maximum projection of volume 
data was calculated from 31 z-ƉůĂŶĞ ŝŵĂŐĞƐ ? ĞĂĐŚ  ? ? ? ʅŵ ĂƉĂƌƚ ? ƵƐŝŶŐ DĞƚĂŵŽƌƉŚ Žƌ
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3.1   Introduction 
The rise of molecular biology since the early 1930s, the subsequent identification of the 
structure of DNA by Franklin, Watson and Crick in the 1950s and the unlocking of the 
genetic code by Crick et al in 1961 (Crick et al., 1961) are key landmarks in the development 
of recombinant DNA technologies (rDNA) as a tool for both the understanding of biological 
systems and the curing of disease (Kellenberger, 2004).  rDNA technology has evolved from 
the seminal work of Jackson et al (Jackson et al., 1972) which describes the strategy and 
techniques required to incorporate exogenous DNA into cell systems (Struhl, 2008). 
 
The work of Edward Jenner, 1796, on the use of bovine pox to vaccinate against small pox 
showed the power of biological materials for the treatment of disease (Riedel, 2005) but it 
 
Figure 3.1 The Process of rDNA Material Production 
Bacterial plasmid DNA is digested by the action of Restriction Enzymes (Digestion) which is 
followed by recircularisation of the plasmid DNA by ligation of a DNA fragment encoding for 
the required product into the plasmid (Ligation).  Insertion of the plasmid DNA into a 
competent bacterial strain (Transformation) is followed by induction of product synthesis 
(Induction of Product Purification) and then purification of the generated product (Product 
Purification). 
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was not until 1976 with the funding of Genentech and their subsequent use of rDNA to 
produce somatostatin, 1977, in E. coli that the modern biotechnology era started (Itakura 
et al., 1977).  rDNA has become integral to the study of biochemistry, interactions of 
proteins (Rosano and Ceccarelli, 2014) and the production of biotherapeutics such as the 
highly specific monoclonal antibodies and has led to a dramatic rise in the market share of 
biologics compared to their small molecule counterparts (Goodman, 2009). 
For all rDNA technologies, the purification of the produced material from the cellular milieu 
is paramount to their use, whether as therapeutics or for biochemical and biophysical 
studies (Fig. 3.1).  Purification of molecules, small or large, often relies on using their 
physical/chemical properties to differentially partition between two mediums i.e. size 
exclusion chromatography and ion exchange chromatography.  One of the major benefits 
of the rDNA technology is the ability to genetically encode modifications to proteins for 
multiple purposes including the addition of tags which allow for affinity capture of the 
product onto a resin i.e. His, GST and FLAG tags (Young et al., 2012). 
As previously discussed the aggregation of proteins into amyloid is important biologically.  
Industrially, the aggregation of synthetic biomolecules during their synthesis and storage 
causes a significant loss in yield associated with the drug (Wang et al., 2009b), and more 
worryingly, the development of localised amyloidosis can be associated with their 
administration, for example Insulin (Yumlu et al., 2009).  Considering the hypothesis that all 
proteins under the appropriate conditions can convert into the amyloid state (Chiti et al., 
1999; Dobson, 1999), these processes are not surprising, but they highlight another reason 
why understanding and prevention of amyloid is important.   
The conversion of protein into amyloid fibrils follows a nucleated growth mechanism which 
requires a change from native monomer conformation to one which contains a larger 
proportion of beta sheet (Serpell, 2000).  The optimal conditions required for this 
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conformational change and subsequent polymerisation can vary considerably, for example 
different pH, and temperature change.  The generation of high concentrations of pure 
protein, as expected with rDNA, also increases the probability that two misfolded proteins 
will come into contact and therefore the potential for nucleation also increases. 
rDNA technology is utilised to generate some of the amyloid forming proteins investigated 
ŝŶƚŚŝƐƚŚĞƐŝƐ ?ŝŶĐůƵĚŝŶŐɲ-^ǇŶƵĐůĞŝŶ ?^ƵƉ ? ? ?>ǇƐŽǌǇŵĞ ?ɴ-Lactoglobulin and Insulin B chain. 
3.1.1   Ƚ-Synuclein 
ɲ-Synuclein is a 14.6kDa intrinsically disordered protein (IDC) (Fig. 3.2) whose aggregation 
into amyloid fibrils has been associated with the onset of the neurological disorder 
WĂƌŬŝŶƐŽŶ ?Ɛ ĚŝƐĞĂƐĞ ?  dŚĞ E-terminal domain of ɲ-synuclein has been shown to interact 
with other proteins like chaperones (Rekas et al., 2004; Souza et al., 2000) and the C-
terminal domain provides solubility but also has a role in affecting the rate of amyloid 
formation (Uversky et al., 2001).  The early stages of ɲ-synuclein fibril formation is 
promoted by the presence of dopamine (Cappai et al., 2005b) and fibrils formed have been 
shown to be a major component of Lewy bodies, found in dopaminergic neurons at disease 
onset (Li et al., 2001).  The disease is commonly found in older patients but the faster 
aggregating A30P and A53T point mutants of the protein have been found to cause the 
early onset forms of the disease (Conway et al., 1998; Li et al., 2001)(Fig. 1.3 and Fig. 3.2).  
 
3.1.2   Sup35 
The aggregation of the yeast translation termination factor eRF3, alternatively known as 




Figure 3.2 ŵŝŶŽĐŝĚƐĞƋƵĞŶĐĞŽĨɲ-Synuclein  
dŚĞƉƌŝŵĂƌǇĂŵŝŶŽĂĐŝĚƐĞƋƵĞŶĐĞŽĨɲ-Synuclein with the position of the A30P (red) and the 
A53T (green) mutants marked. 
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an example of a prion (Tuite and Cox, 2006).  Polymerisation of Sup35 into amyloid 
aggregates and their subsequent chaperone mediated fragmentation into propagons is key 
to their transmission from one cell to another (1.10.1) (Byrne et al., 2009; Cox et al., 2003).  
The Sup35 amino acid sequence can be split into 3 domains, each with different functions, 
and separated by methionine residues (Fig. 3.3).  The N terminal domain is the amyloid 
forming region, the M domain contains polar residues thought to be important for 
solubility and the C terminal domain is responsible for the ATP dependent translation 
termination activity of the protein (Glover et al., 1997).  As the [PSI+] phenotype is a facet 
of the N and M domains, and not affected by the C domain, a lot of the research into the 
initiation and propagation of the phenotype have been carried out on the truncated form 
of the protein containing only the N and the M domains, Sup35NM.  Recent work has 
raised the importance of the C domain showing that mutations within its sequence can 
affect the phenotype observed in yeast showing the importance of considering the full 
length protein, Sup35NMC (Krzewska and Melki, 2006; Krzewska et al., 2007).  The 
threonine residue at position 341 in the C domain of the protein is remote from the fibril 
forming region and therefore should not affect the [PSI+] phenotype observed but mutation 
to aspartate or alanine causes lethality and [PSI+] phenotype weakening respectively 













Figure 3.3 Amino Acid Sequence of Sup35NMC/NM 
The primary amino acid sequence of Sup35NMC with the sequence N domain coloured 
purple, M domain coloured red and the C domain in black.  The methionine residues 
contained in the protein are coloured green and the cysteine residues blue. 
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3.1.3   Insulin 
Insulin is a hormone common to many organisms that regulates blood sugar levels (Fig. 3.4, 
Left).  The human protein consists of two chains, A and B, covalently joined through three 
disulfide bonds and has a molecule weight of 5808Da.  Insulin has been observed to form 
amyloid aggregates as the heterodimer but also each of the constituent peptide chains has 
been shown to convert into amyloid when isolated (Devlin et al., 2006).  The failure of a 
body to regulate blood sugar levels by producing enough or any insulin are the hallmarks of 
ƚǇƉĞ ?ŽƌƚǇƉĞ ?ĚŝĂďĞƚĞƐƌĞƐƉĞĐƚŝǀĞůǇ ?ŝĂďĞƚĞƐŝƐŚŝŐŚůǇƉƌĞǀĂůĞŶƚŝŶƚŽĚĂǇ ?ƐƐŽĐŝĞƚǇĂŶĚ
one of the methods of treatment is to subcutaneously inject insulin into the body 
(http://www.diabetes.co.uk/diabetes-causes.html).  Before rDNA technology therapeutic 
insulin was derived from animal sources, which do not have the same amino acid sequence 
as human insulin (Fig. 3.4, Right), this has led to allergic responses as well as requiring a 
large amount of animal material.  In 1978 a collaboration between City of Hope Medical 
Centre, California, and Genentech led to a bacterial strain capable of producing the two 
chains of human insulin which could then be converted into the therapeutic agent 
(Genentech, 1978).   
 
 
Figure 3.4 3 Dimensional Representation of the Insulin Hormone and 
Sequence Homolgy Between Species 
Left - The structure of insulin with the B-Chain in blue and the A-Chain in red.  (Devlin et al., 
2006).  Right  W Comparison of the amino acid sequences  of the two chains of Insulin derived 
from three species; Human, Porcine and Bovine. 
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The individual chains of the insulin hormone can be isolated and prevented from forming 
homodimers by oxidation of the sulphur atoms in the cysteine residues to sulfonic acids as 
observed in the commercial form of bovine insulin B-chain (Fig. 3.5).  
 
3.1.4   Lysozyme 
Lysozyme (Fig. 3.6, Left) was first observed by Alexander Fleming in 1922 as a material 
capable of lysing bacteria, an ability stemming from its primary function as an enzyme 
ǁŚŝĐŚĐĂƚĂůǇƐĞƐ ƚŚĞŚǇĚƌŽůǇƐŝƐŽĨɴ-1,4 glycosidic linkages between N-acetylmuramic acid 
and N-acetylglucosamine, which are found in bacterial cell walls.  The determination of 
ůǇƐŽǌǇŵĞ ?Ɛ3D structure by X-ray diffraction was the second protein structure solved by this 
method and the first for an enzyme (Blake et al., 1965; Johnson, 1998).   
 
In its native state, the 14.3kDa protein has two domains containing alpha helices and beta-
sheet motifs (Merlini and Bellotti, 2005) of which the glutamic acid in position 35 is the 
residue responsible for its catalytic activity (Strynadka and James, 1991) (Fig. 3.6, Right).  
 
Figure 3.6 3D Structure and Amino Acid Sequence of Hen Egg White Lysozyme 
Left  W 3D structure of Hen Egg White Lysozyme, Right  W Amino Acid sequence of Hen Egg 
White Lysozyme with the catalytic Glutamic acid residue labelled in red.  Structure and 
sequence from RCSB PDB record 4RLM. 
FVNQHLC(SO3H)GSHLVEALYLVC(S03H)GERGFFYTPKA 
Figure 3.5 Amino Acid Sequence of Sigma Bovine Insulin B-Chain with Cysteine 
residues oxidised to sulphonic acids  
The primary amino acid sequence of Insulin B-Chain separated from the A-Chain and disulfide 
bond formation limited by oxidation of the cysteine sulfurs to sulfonic acids (highlighted in 
green), as supplied by Sigma Aldrich (I6383) 
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The unfolding of Lysozyme can cause the generation of amyloid aggregates and this is 
associated with the systemic amyloidosis (Mossuto et al., 2010).  
3.1.5   Ⱦ-Lactoglobulin 
ɴ-Lactoglobulin  ?&ŝŐ ?  ? ? ? ) ŝƐĂĚŝŵĞƌŝĐƉƌŽƚĞŝŶĂŶĚĂŵĂũŽƌĐŽŵƉŽŶĞŶƚŽĨĐŽǁ ?ƐŵŝůŬǁŚĞǇ
but has no known function apart from a propensity to bind retinol (Hamada and Dobson, 
2002) and is the main allergen associated with dairy intolerance (Sélo et al., 1999).  Under 
acidic conditions, the dimeric complex collapses into monomeric protein, and when 
monomers are denatured they convert into amyloid fibrils (Hamada and Dobson, 2002).  
 
3.1.6   Chapter Aims 
This part aims to develop expression and purification protocols for the generation of these 
model proteins thus allowing for the investigation of the conditions required for conversion 
of the protein monomers into fibrillar aggregates suitable for atomic force microscopy 
analysis.  The generation of high quality samples reproducibly will allow investigation of 
some of the physical characteristics of amyloid fibrils such as height, contour length and 
persistence length.  These fibril stocks will then be used to examine the resistance of 
different fibril types to mechanical stress, see Chapter 4. 
 
Figure 3.7  ?^ƚƌƵĐƚƵƌĞĂŶĚĂŵŝŶŽĂĐŝĚƐĞƋƵĞŶĐĞŽĨɴ-Lactoglobulin  
Left- 3D structure of b-Lactoglobulin Right  W Amino acid sequence ŽĨɴ-Lactoglobulin.  
Structure and sequence both from RCSB PDB record 4IB9. 
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3.2   Results 
The in vitro assembly of proteins into fibrillar structures requires the generation of protein 
monomers prior to assembly.  Due to the different conditions required to convert the 
monomeric protein into fibrils, the availability and purification of these materials also 
ǀĂƌŝĞƐ ĐŽŶƐŝĚĞƌĂďůǇ ?  /ŶƐƵůŝŶ  ĐŚĂŝŶ ? ůǇƐŽǌǇŵĞ ĂŶĚ ɴ-lactoglobulin all require unfolding 
conditions to convert them to their amyloid form and the protein monomers are supplied 
ŝŶ ƚŚĞŝƌ ŵŽŶŽŵĞƌŝĐ ĨŽƌŵ ĐŽŵŵĞƌĐŝĂůůǇ ?  dŚĞ ĨŽƌŵĂƚŝŽŶ ŽĨ ɲ-synuclein and the Sup35 
proteins all convert to their fibrillar form at room temperature and neutral pH and require 
synthesis and purification prior to assemblǇ ?ƵĞƚŽɲ-ƐǇŶƵĐůĞŝŶĂŶĚ^ƵƉ ? ? ?ƐƉƌŽƉĞŶƐŝƚǇƚŽ
aggregate under ambient conditions their purification strategies need to be tailored to 
their individual properties to enable isolation of pure monomers. 
3.2.1   Protein Purification 
3.2.1.1   Ƚ-Synuclein 
DuĞƚŽƚŚĞƐŝŐŶŝĨŝĐĂŶĐĞŽĨɲ-sǇŶƵĐůĞŝŶƚŽƚŚĞƉĂƚŚŽůŽŐǇŽĨWĂƌŬŝŶƐŽŶ ?ƐĚŝƐĞĂƐĞƚŚĞƐƚƵĚǇŽĨ
this protein and its fibrillar form has been undertaken on numerous occasions.  Our studies 
ŽĨƚŚĞďƌĞĂŬĂŐĞŽĨɲ-synuclein amyloid fibrils require the generation of reproducible and 
homogeneous samples of fibrils from monomers prepared following published methods 
(Cappai et al., 2005b; Smith et al., 2008; Wu et al., 2009).  Briefly, transformation of the 
chemically competent E.coli expression cell line BL21[DE3] pLysS with a pET23a vector 
ĐŽŶƚĂŝŶŝŶŐƚŚĞŐĞŶĞĨŽƌǁŝůĚƚǇƉĞɲ-synuclein with T7 promoter under the control of the lac 
operon, obtained from (Smith et al., 2008), gave an expression system yielding large 
amounts of the full length wild type protein.  A modified purification protocol where acid 
precipitation of the cellular residue was followed by a stepped ammonium sulphate 
precipitation, from 30% to 50% gave very pure material (Fig. 3.8).  Salt removal by buffer 
exchange allowed final purification by strong anion exchange chromatography to remove 
higher molecular weight materials evident on the interface of the stacking and resolving 
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components of the SDS PAGE (Fig. 3.8), any large aggregates could also be removed by 
filtering through a 0.2µm membrane.  The purity and identity of the protein was confirmed 
by SDS PAGE and LC-MS analysis which after deconvolution gave the desired molecular 
weight of 14459.52Da. 
ĞƐƉŝƚĞ ɲ-ƐǇŶƵĐůĞŝŶ ?Ɛ ĂďŝůŝƚǇ ƚŽ ĐŽŶǀĞƌƚ ƚŽ ƚŚĞ ĂŵǇůŽŝĚ ƐƚĂƚĞ Ăƚ ĐůŽƐĞƚŽ ĂŵďŝĞŶƚ
temperature the expression and purification of the protein is possible under native 
conditions giving very high yields of pure protein, 28mg/L. 
 
The high yield and ease of ƉƵƌŝĨŝĐĂƚŝŽŶĂƐƐŽĐŝĂƚĞĚǁŝƚŚɲ-synuclein production is not a facet 
shared with the Sup35 derived proteins. 
3.2.1.2   Sup35NM 
Study of the protein Sup35NMC, whose conversion to an amyloid state is at the heart of 
the [PSI+] phenotype observed in yeast, is commonly performed on constructs containing 
only the N terminal and middle domains of the protein, Sup35NM.  The removal of the C 
 
Figure 3.8 ɲ-Synuclein Purification 
Left  W ŚƌŽŵĂƚŽŐƌĂŵƐŚŽǁŝŶŐƚŚĞĞůƵƚŝŽŶƉƌŽĨŝůĞŽĨɲ-synuclein eluting from the HiTrap Q FF 
anion exchange column under a sodium chloride gradient (%B).  Right  W SDS PAGE, 15% Tris-
Glycine, analysis of the ƉƵƌŝƚǇŽĨƚŚĞɲ-synuclein at different stages of the purification.  Ladder 
not shown but position of markers indicated by number indicative of mass in kDa of marker. 
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terminal, translation termination domain simplifies protein production but also leads to in 
vitro assembled fibrils which can cause the [PSI+] phenotype when introduced to yeast cells.  
It is therefore a good surrogate for the full length protein (King and Diaz-Avalos, 2004; 
Tanaka et al., 2004). 
/Ŷ ĐŽŵƉĂƌŝƐŽŶ ƚŽɲ-synuclein, the majority of Sup35NM expressed in the cell is found in 
insoluble inclusion bodies, which are postulated to exist in its amyloid form (Ventura 2012). 
It is therefore necessary to purify the protein under denaturing conditions (Glover et al., 
1997).  The purification of amyloidogenic proteins, particularly those whch polymerise at 
pH7, in denaturing conditions offers the advantage of inhibiting the assembly of monomers 
into fibrils. 
 
An N-terminally his-tagged DNA construct of Sup35NM was cloned, using a plasmid 
containing the full length Sup35 DNA sequence, obtained from (Kabani et al., 2011; 
Krzewska and Melki, 2006; Krzewska et al., 2007), and ligated into a pET15b vector.  
 
Figure 3.9 Purification profile of Sup35NM 
Left  W Äkta purification profile of Sup35NM lysed under denaturing conditions and then 
subjected to affinity purification before further purification using size exclusion 
chromatography at a 0.3ml/min.  The start of fraction collection and every 10th fraction was 
marked with a red dotted line.  A broad peak was eluted with the left hand side of the peak 
containing purest material (the fractions highlighted blue were pooled).  Right  W Invitrogen 4-
12% Bis-Tris SDS PAGE run in MOPS buffer at 180V was used to analysis the fractions from the 
purification, which were diluted 1 in 3, to reduce interference of the guanidine on running, 
prior to loading onto the gel.  Fractions 19-27 were the right hand side of the peak post 
pooling.  Äkta trace and SDS PAGE supplied by Tracey Purton. 
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Transformation of this plasmid into an E.coli expression strain, BL21 [DE3] pLysS produced a 
clone capable of Sup35NM expression.  Protein purification was achieved using a 
modification to published protocols (Tanaka, 2010).  Briefly, cell disruption by sonication in 
Lysis buffer containing 6M guanidine followed by centrifugation removed cell debris and 
the resulting supernatant was affinity purified (Ni-NTA with imidazole elution) followed by 
size exclusion chromatography in buffer containing 6M guanidine.  The material obtained 
from the size exclusion chromatography gave a very broad peak with no baseline resolution 
between the Sup35NM material and the lower molecular weight material (Fig. 3.9).  The 
material to the left of the peak contained the purest protein.  LC-MS analysis of the product 
shows formation of the desired product, 30549.62Da, with removal of the N-terminal 
methionine residue by methionine aminopeptidase (MAP) (Frottin et al., 2006). 
3.2.1.3   Sup35NMC Ȃ Full length protein 
It has recently become apparent that the C terminal domain of Sup35 can influence  its 
polymerisation and cause phenotypic variation (Kabani et al., 2011; Krzewska and Melki, 
2006; Krzewska et al., 2007). 
To investigate fibril assembly of Sup35NMC, a pET15b vector containing the gene for 
Sup35NMC, obtained from (Kabani et al., 2011; Krzewska and Melki, 2006; Krzewska et al., 
2007), was transformed into competent BL21 [DE3] pLysS E. coli to give an expression 
system capable of producing full length Sup35. 
Previously published work on the generation of Sup35NMC fibrils has utilised a low yielding 
native purification strategy (Baxa et al., 2011; Krzewska and Melki, 2006; Krzewska et al., 
2007) to produce the protein.  Following the success of the purification of Sup35NM using 
denaturing conditions, the same denatured purification approach was attempted with 
Sup35NMC.  However utilising a completely denaturing purification strategy from lysis 
onwards not only solubilises more of the Sup35NMC but other cellular material.  These 
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proved difficult to remove in subsequent affinity purification (Ni-NTA) and size exclusion 
chromatography steps. 
While Sup35NM is almost entirely contained in insoluble inclusion bodies during expression 
in E. coli (Glover et al., 1997) some Sup35NMC remains soluble.  The purity of Sup35NMC 
from affinity purification of lysate generated under native, folded, conditions is cleaner 
than protein isolated from a denatured lysis.  Therefore in order to maintain the 
advantages of the denatured material, a hybrid purification was attempted.  Consequently 
cells were disrupted under native conditions in the presence of protease inhibitor, PMSF, 
followed by Ni-NTA affinity purification.  The protein was then unfolded on the resin by 
washing and eluting with buffer containing 6M guanidine.  This resulted in a Sup35NMC 
solution with much higher purity prior to the final size exclusion chromatography step and 
allowed successful purification (Fig. 3.10). 
 
The purification was also attempted using the native conditions previously published but 
the disadvantage of this process is the continual polymerisation of material during the 
purification means the whole procedure needs to be completed at low temperature and as 
 
Figure 3.10 Purification profile of Native -Denaturing Purification 
Left  W Äkta purification profile of Sup35NMC lysed under native conditions and then 
denatured during affinity purification and then further purified using size exclusion 
purification, 0ml elution = injection, giving rise to a single major peak eluted between 20 and 
30mls with the start of fraction collection, the 10th fraction and 20th fraction marked with a 
dotted line.  Right  W 10% Tris-Glycine SDS PAGE analysis of the fractions from the purification 
diluted 1 in 3 prior to loading onto the gel.  The lane numbers are numbered according to the 
fraction number seen in the Äkta trace. 
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quickly as possible.  Disruption of the E.coli in the presence of phenylmethanesulfonyl 
fluoride, PMSF, and 2-mercaptoethanol allowed initial purification by affinity purification, 
Ni-NTA, allowing analysis by LC-MS and showed the protein was modified by the addition 
of 2-mercaptoethanol, presumably by disulfide formation. 
 
To avoid this modification the 2-mercaptoethanol used in the lysis buffer was replaced with 
dithiothreitol (DTT), a stronger reducing agent whose oxidation results in the formation of a 
cyclic product through intra-molecular disulfide bond formation and therefore has a lower 
propensity to modify proteins.  Using a concentration of DTT low enough not to reduce the 
Ni(II) based affinity matrix the modification of Sup35NMC was limited, as determined by 
LC-MS, but the final purification of the protein by size exclusion chromatography was 
complicated by apparent association of the protein with the gel matrix.  The 2ml of injected 
Sup35NMC was eluted across 80ml with the majority eluted after almost one column 
volume, 120ml (Fig. 3.11). 
 
Figure 3.11 Purification of Sup35NMC with DTT in Lysis buffer 
Left  W Äkta purification profile of Sup35NMC purified natively at 1ml/min after lysis in the 
presence of Dithiothreitol giving rise to a broad elution profile with a major peak at about 115 
minutes, in contrast to the purification with no thiol added.  The position of every 10 fractions 
collected are marked on the graph with a dotted red line.  Right  W 10% Tris-Glycine SDS PAGE 
analysis of the fractions from the purification with the run through, wash and elu1 and elu 2 
from the Ni-NTA purification.  The fractions are then labelled according to the appropriate 
fraction number from the Äkta spectra. 
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Due to the problems associated with the addition of reducing agents purification in the 
absence of a thiol seemed, by FPLC trace, to give a better elution profile, more akin to the 
native denaturing protocol, where the protein does not interact with the matrix (Fig. 3.12, 
Left).  Analysis of the protein material by SDS PAGE showed that in fact the material 
contained a lower molecular weight impurity, which is co-purified due to its association 
with the Sup35NMC (Fig. 3.12, Right).  LC-MS comparison of the material from the 
purification with the same material treated with 5mM DTT prior to injection into the 
spectrometer suggests that the material is covalently modified, via a disulphide bond as the 
only trace of the desired material is in the presence of DTT (Fig. 3.13). This potentially 
explains the relatively large amount of impurity observed in the material from the size 
exclusion purification.  
 
The presence of a reducing agent in the purification obviously has some effect on the 
ƐƚƌƵĐƚƵƌĞĂŶĚĂďŝůŝƚǇŽĨƚŚĞƉƌŽƚĞŝŶƚŽ ‘ƐƚŝĐŬ ?ƚŽƚŚĞƐize exclusion matrix.  To determine if 
this is a property of reduced material on the sepharose column, despite its potential to 
modify the protein, 2-mercaptoethanol was used in the purification and progressed to size 
 
Figure 3.12 Purification of Sup35NMC without thiol treatment 
Left  W Äkta purification profile of Sup35NMC purified by affinity purification and then size 
exclusion purification, in native buffer at 1ml/min, after lysis giving rise to a single major peak 
at about 50 minutes.  1ml fractions were collected from injection with every 10th fraction 
marked with a dashed line.  Right  W 10% Tris-Glycine SDS PAGE analysis showed the material 
from the Ni-NTA purification: Run Through, Wash, Elution 1 and Elution 2 followed by fractions 
from the size exclusion purification labelled according to their fraction number. 
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exclusion chromatography.  In the presence of 2-mercaptoethanol the normal elution 
profile was returned and the lower molecular weight impurities were diminished although 




Figure 3.14 Purification of Sup35NMC with Lysis in the presence of 2-
mercaptoethanol 
Left  W Äkta purification profile of Sup35NMC purified after lysis in the presence of 2-
Mercaptoethanol giving rise to a major peak at about 50 minutes, as observed in the 
purification with no thiol added.  The start of fraction collection and every 10th fraction were 
marked with a red dashed line.  Right  W 10% Tris-Glycine SDS PAGE analysis of the elution from 
the Ni-NTA purification  W Lysate, Run Through, Wash and Elu1 followed by the fractions eluted 
from the size exclusion column labelled according to the fraction from the Äkta purification. 
 
Figure 3.13 MS analysis of Sup35NMC with and without Thiol 
Sup35NMC purified in the absence of thiol was analysed by LC-MS with (C and D) and without 
5mM DTT (A and B).  The deconvoluted MS spectra displaying m/z (mass/charge) on the x 
axis, where z=1, and therefore m/z is equal to the mass in Da.  The two main components 
earlier (A and C) and later (B and D) observed in the LC were deconvoluted to give parent 
ions.  The data shows that only in the later eluting (higher molecular weight) material which 
had been treated with DTT is the correct ion, 78583Da, for the product observed see the red 
box in D. 
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In contrast to the MS analysis pre-size exclusion purification, the material obtained 
afterwards showed no evidence of a 2-mercaptothanol adduct but also N-terminal 
methionine cleavage, 78583.92Da, by MAP as observed in the purification of Sup35NM. 
3.2.2   In Vitro Assembly 
The conditions required to convert monomers to fibrils varies considerably between 
proteins and can potentially affect the morphology of the fibrils formed.  The amyloid fibrils 
physical properties and fragmentation requires formation of polymers and deposition 
conditions for AFM imaging which allow for automated tracing. 
3.2.2.1   Ƚ-Synuclein 
ƵĞƚŽƚŚĞŝŶƚƌŝŶƐŝĐĂůůǇĚŝƐŽƌĚĞƌĞĚŶĂƚƵƌĞŽĨɲ-synuclein, the conversion to amyloid fibrils is 
straight forward.  The dynamic ŶĂƚƵƌĞŽĨɲ-synuclein means that it may spend some time in 
a conformation susceptible to amyloid formation therefore harsh conditions are not 
ƌĞƋƵŝƌĞĚ ƚŽ ƵŶĨŽůĚ ŵŽŶŽŵĞƌŝĐ ɲ-synuclein into amyloid fibrils.  In fact, incubation of 
>150µM ɲ-synuclein at physiological temperature, 37oC, in a neutral buffer for 1 week is 
ĞŶŽƵŐŚƚŽĐŽŶǀĞƌƚɲ-synuclein into its fibrillar form. 
  
dŚĞƉƵƌŝĨŝĞĚɲ-synuclein monomers were converted in to fibrils by first removing the high 
salt solution from the anion exchange medium by buffer exchange using PD10 column into 
25mM sodium phosphate, pH7.5.  The sample was incubated at 37oC, and agitated at 
 
Figure 3.15 ɲ-Synuclein Polymerisation into Fibrils 
Left  W A negatively stained, uranyl acetate (UOAc2) ?dDŵŝĐƌŽŐƌĂƉŚŽĨɲ-synuclein fibrils with 
0.2µm scale bar, Middle  W An AFM image, 20µm x 20µm at 2048 pixels x 2048 pixels with a 
1µm scale bar, Right - An AFM image, 2µm x 2µm at 1024 x 1024 pixel resolution with a 
500nm scale bar, focussing on an example ŽĨ Ă ŚŝŐŚůǇ ĐŽŝůĞĚ ɲ-synuclein fibre.  The AFM 
height scale is set between -10 and 10nm. 
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160rpm for one week.  Confirmation that amyloid fibrils were formed in solution was 
achieved by negative stain TEM imaging as well as AFM imaging (Fig. 3.15). 
dŚĞĂƐƐĞŵďůǇƉƌŽŐƌĞƐƐŝŽŶŽĨŵŽŶŽŵĞƌŝĐɲ-synuclein to fibrillar material was shown to have 
gone almost to completion, 2.4% remaining, by SDS PAGE based residual monomer assay 
against a serial dilution of monomeric protein. 
AFM analysis of the fibrillar material identified the presence of fibrils with highly coiled 
fibril morphology (Fig. 3.15, Right) the absence of these structures in TEM analysis suggests 
that they are an artefact of deposition on to mica for AFM analysis and not how these 
samples exist in solution.  The automation of particle tracing using the MatLab application 
requires well dispersed particles where fibrils cross over is limited, this highly coiled 
morphology would make this process difficult and therefore alternative deposition 
conditions this were investigated. 
Optimisation of the conditions of ɲ-synuclein deposition onto mica for tracing purposes 
(Fig. 3.16) highlighted that the drying process after sample incubation and washing was 
causing fibril breakage.  
This breakage would give rise to error in subsequent particle length analysis so reduction of 
this artefact was also important.  To minimise breakage, the drying process was modified 
such that most of the excess water on the mica surface was removed by filter paper placed 
at the very edge of the mica surface and then carefully dried with a gentle stream of 
ŶŝƚƌŽŐĞŶŐĂƐ ? dŚĞ ĨŝŶĂůĐŽŶĚŝƚŝŽŶƐ ĨŽƌɲ-synuclein deposition, which give the appropriate 
particle density for particle length measurement, whilst minimising coiling and particle 
breakage on the surface involved the dilution of the fibril sample to 0.48µM with fibril 
forming buffer, incubation for 5 minutes prior to washing with 1ml of syringe filtered 
mQH2O and drying using the modified procedure.  




3.2.2.2   Sup35NM and Sup35NMC 
The N and M domains of Sup35NM and Sup35NMC are relatively disordered meaning they 
ĐĂŶ ĞǆŝƐƚ ŝŶ ŶƵŵĞƌŽƵƐ ĐŽŶĨŽƌŵĂƚŝŽŶĂů ƐƚĂƚĞƐ ? ƐŝŵŝůĂƌ ƚŽ ɲ-synuclein, and do not require 
harsh conditions for fibril assembly.  Conversion of denatured Sup35NM and Sup35NMC to 
their fibrillar form was initated by buffer exchange using PD10 column into fibril forming 
 
Figure 3.16 Mica Depostion Conditions 
AFM images showing the development of AFM deposition conditions.  2µm scale bar in each 
image.  A  W 1 in 50 dilution into fibril forming buffer, 5 minutes incubation, 1 ml wash and 
dried with N2(g).  B  W 1 in 50 dilution into fibril forming buffer, with 0.001% Sarkosyl, 5 minutes 
incubation, 1ml wash and dried with N2(g).  C  W 1 in 50 dilution, with 400µM NiCl2, 5 minutes 
incubation, 1ml wash and dried with N2(g).  D  W 1 in 1000 dilution, 10µl dried onto mica 
surface, washed with 1ml and dried under a stream of N2(g).  E  W Similar conditions to D but 
highlighting the problems with drying sample onto the mica surface.  F  W Fibrillar material 
diluted with pH2 HCl and incubated on mica before washing with water.  The AFM height 
scales set so as to show fibril height and ranges from -5 to 5nm and -10 to 10nm. 
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buffer containing 20mM sodium phosphate, 50mM sodium chloride, pH7.5 solution.  The 
resulting solution was incubated at 30oC, a temperature that mimics the conditions that the 
Sup35 protein is exposed to in the optimum growth environment of Saccharomyces 
cerevisiae. 
 
The kinetics of fibril formation can be followed by measuring the fluorescence associated 
with the binding of the profluorescent dye thioflavin T to the cross-beta sheet core of the 
amyloid backbone.  The de novo conversion of monomeric Sup35NM into amyloid fibrils, 
follows the classic sigmoidal shaped curve associated with a nucleated growth mechanism.  
The assembly has a lag phase of about 10 hours which is followed by an exponential phase 
where the proportion of cross-beta sheet in solution increases rapidly (Fig. 3.17).  The lag 
phase of fibril growth is dominated by the formation of critical nuclei, as observed in the de 
novo assembly of Sup35NM but can be completely removed when a seed, a small amount 
 
Figure 3.17 Kinetics of Denatured Sup35NM and Sup35NMC Conversion to 
Amyloid 
Thioflavin T curves showing the polymerisation of Sup35NM and Sup35NMC from denatured 
purification.  3 repeats of a blank corrected de novo polymerisation of Sup35NM (Blue) (10uM 
Sup35NM, Thioflavin T and buffer), seeded Sup35NM polymerisation (Red) (10uM Sup35NM, 
1% sonicated Sup35NM seed, Thioflavin T and buffer) and de novo Sup35NMC from 
denatured purification polymerisation (Green) (10uM Sup35NMC, Thioflavin T and buffer).  
The emission of Thioflavin T was monitored at 493nm.  Black dotted line signifying 10 hours of 
polymerisation. 
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or preformed fibrillar material, is added to the reaction mixture (Fig. 3.17).  The 
polymerisation of Sup35NMC from the denatured purification showed no increase in ThT 
fluorescence over the course of the reaction even when seeded with fragmented Sup35NM 
fibrils (Fig. 3.17, de novo only shown).  As the polymerisation of Sup35NMC has been 
observed previously using monomeric protein derived from a native purification the lack of 
polymerisation is potentially due to the failed refolding of the C domain of Sup35NMC and 
the non specific association of these unfolded materials into amorphous aggregates. 
Comparison of the natively purified Sup35NMC in the absence of thiol, in the presence of 2-
mercaptoethanol and also material isolated from the final peak of material eluted from the 
DTT purification were compared by thioflavin T assay.  The change in fluorescence over 
time for these experiments shows that the material purified in the presence of DTT does 
not polymerise, like the denatured Sup35NMC, where-as the material formed in the 
absence of thiol and the presence of 2-mercaptoethanol gives rise to an increase in beta-
sheet composition over time (Fig. 3.18).   
The potential modification of the material generated in the absence of thiol does not seem 
to alter its propensity to form amyloid fibrils and a lag phase of about 10 hours was 
observed (Fig. 3.18, A) similar to Sup35NMC purified with 2-mercaptoethanol (Fig. 3.18, B), 
Sup35NM (Fig. 3.17) and the data shown by  Krzewska et al (Krzewska et al., 2007). 
Not only does the incorporation of 2-mercaptoethanol in the lysis buffer return the Äkta 
elution profile back to that of the material purified without thiol but its ability to form 
amyloid fibrils was also returned.  Although thioflavin T binding showed that the de novo 
formation had a lag phase of just less than 10 hours in comparison to the thioflavin T 
curves for Sup35NM and Sup35NMC without thiol the lag phase exhibited a decrease in 
fluorescence prior to the exponential phase which means the curves are flatter in look but 
do exhibit the sigmoidal shape (Fig. 3.18, B).   




This abnormal profile is potentially due to the defrosting of the monomer solution prior to 
fibril formation and the sample being partially aggregated before it depolymerises as it 
warms up in the plate reader, although it is unclear exactly what is happening.  The 
 
Figure 3.18 Kinetics of Native Purified Sup35NMC Conversion to Amyloid 
Thioflavin T curves showing the polymerisation of Sup35NMC derived from native purification 
protocols.  The emission of Thioflavin T was monitored at 493nm.  The black dotted line signifies 
10 hours of polymerisation. 
A  W No thiol in purification - 3 repeats of blank corrected de novo polymerisation (Blue) (10uM 
Sup35NMC, Thioflavin T and buffer) and seeded polymerisation (Red) (10uM Sup35NMC, 1% 
sonicated Sup35NM seed, Thioflavin T and buffer). 
B  W 2-mercaptoethanol purification - 3 repeats of blank corrected de novo polymerisation (Blue) 
(10uM Sup35NMC, Thioflavin T and buffer) and seeded polymerisations (red) (10uM Sup35NMC, 
1% sonicated Sup35NM seed, Thioflavin T and buffer). 
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addition of Sup35NM seed molecules to both the experiments removed the lag phase 
completely as would be expected with a nucleated growth mechanism. 
   
 
Figure 3.19 AFM Analysis of Fibrils Derived from Sup35NM 
AFM imaging of Sup35NM polymerisation 1 = Sup35NM 10µM de novo polymerisation, 2 = 
Sup35NM 10µM seeded with Sup35NM fibrils (1% seed, sonicated at 20% amplitude for 4 
minutes, 5 second pulses and on ice).  A = Peak force error image showing 10µm x 10µm area 
with 1µm scale bar, 1µm insert which is magnified 3x with a 250nm scale bar and a peak force 
scale on the left hand side; B = Height based image showing a 5µm x 5µm area with a 1µm 
scale bar, 1µm insert which is magnified 2x with a 250nm scale bar and a height scale on the 
left hand side; C  W Microscope image from the 10x optical microscope attached to the AFM 
showing a 1mm scale bar showing the presence of large aggregates on the mica surface; D  W 3 
separate 2µm sections were compared to show consistency in height between different 
purification methods.  The scale bar for the peak force error spectra is set between 100 and -
100mV and the height phase is set between 10 and -10nmm. 




AFM analysis of the Sup35NM and Sup35NMC materials after the assembly has reached the 
stationary phase of the assay shows the presence of fibrillar structures but in contrast to 
the dispersed nature of ɲ-synuclein fibrils the fibrils of Sup35NM and Sup35NMC, purified 
without thiol and with 2-mercaptoethanol, exist in a highly associated state in clumps of 
fibrils which are also visible using the optical microscope used for AFM laser alignment, 
 
Figure 3.20 AFM Analysis of Sup35NMC polymerisation 
AFM imaging of de novo (unless stated) Sup35NMC polymerisation 1 = Sup35NMC purified 
without thiol added, 2 = Sup35NMC purified in the presence of 2-mercaptoethanol.  A = Peak 
force error image showing 10µm x 10µm area with 1µm scale bar, 1µm insert which is 
magnified 3x with a 250nm scale bar and a peak force scale on the left hand side; B = Height 
based image showing a 5µm x 5µm area with a 1µm scale bar, 1µm insert which is magnified 
2x with a 250nm scale bar and a height scale on the left hand side; C  W Microscope image 
from the 10x optical microscope attached to the AFM showing a 1mm scale bar showing the 
presence of large aggregates on the mica surface; D  W 3 separate 2µm sections were 
compared to show consistency in height between different purification methods (3D contains 
a dashed line at 10nm).  The scale bar for the peak force error spectra is set between 100 and 
-100mV and the height phase is set between 10 and -10nmm. 
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almost 400µm in height (Fig. 3.19 and 3.20, 1-2C).  AFM imaging of these aggregates by 
peak force and height showed that the internal structure is that of a large network of fibrils 
(Fig. 3.19 and 3.20, 1-2A and 1-2B).   
By comparison material, taken at the same point from the denatured Sup35NMC 
polymerisation showed that large aggregates were formed but unlike those formed by 
Sup35NM, which were formed by the association of amyloid fibrils, these were amorphous 
in agreement with ThT data.  AFM imaging of the assembly reactions derived from the DTT 
purified material did not give rise to any aggregates, fibrillar or otherwise but the seeded 
sample gave rise to large amorphous aggregates still visible by the optical microscope but 
not a complex association of fibrils. 
3.2.2.3  Insulin B-Chain 
Literature precedence shows that the conversion of insulin B-chain into amyloid fibrils can 
be readily and reproducibly achieved by heating pH2 solutions of insulin B-chain to 60oC for 
periods of 1 day (Devlin et al., 2006; Hong and Fink, 2005).  
   
A 1.8mM solution of insulin B-chain was syringe filtered and heated to 60oC for 48 hours at 
which time conversion to amyloid was confirmed by AFM and TEM imaging (Fig. 3.21). 
 
Figure 3.21 AFM and EM Analysis of Fibrils derived from Insulin B-Chain 
Insulin B-chain fibrils Left - deposited onto a mica surface, washed, dried and imaged at 20µm 
x 20µm at a resolution of 2048 pixels x 2048 pixels, with a 1µm scale bar and 1µm insert 
magnified x5 containing a 250nm scale bar.  The AFM height scale is set from -10 to 10nm.  
Right  W Fibrils deposited onto a carbon/formavar coated copper surface and then imaged 
using TEM, with a 1µm scale bar. 
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Recent work by Piejko et al (Piejko et al., 2015) has shown that the conversion of Insulin 
under acidic conditions is promoted by limited proteolysis with Pepsin and the generation 
of smaller, more amyloidogenic, peptides is the root cause of the conversion of insulin into 
amyloid fibrils.  The amide bonds which make up the peptide back bone are usually robust 
but under heated acidic conditions are susceptible to breakage and therefore a hydrolytic 
mechanism can also explain the conversion of insulin and its component chains, A and B, 
into fibrils in the absence of Pepsin. 
3.2.2.4   Lysozyme 
The conversion of Lysozyme into amyloid fibrils also follows an acid-promoted mechanism.  
Following similar conditions to insulin B-chain, the heating of syringe filtered monomer 
solution to 60oC for 48 hours at pH2 yielded fibrils but far less efficiently than observed 
with Insulin B-Chain. 
Assuming that amide hydrolysis is the key step in converting monomers to amyloid the 
efficiency of fibril formation could be improved by increasing the amount of hydrolysis in 
the system.  An increase in the hydrolysed proportion of the protein can be achieved by 
lengthening the heating time or by increasing the temperature of the reaction (Fig. 3.22).  
Increasing the incubation time and temperature will both increase the amount of 
hydrolysis experienced by the sample but this does not necessarily correlate with an 
increase in the amount of fibrils formed.  As a rule of thumb, derived from the Arrhenius 
equation, the rate of a thermodynamically controlled reaction doubles for every 10oC 
increase in reaction temperature.  By increasing the temperature for 60oC to 90oC an eight 
fold increase in the speed of fibril formation would be expected but the result observed is 
of no fibril formation (Fig. 3.22, C).  




There are several possible explanations for the absence of fibrils:  
1. The increase in temperature gives a higher rate of hydrolysis but also rate of critical 
nucleus formation such that it is the overwhelming process and therefore retards fibril 
elongation. 
2. The increase in reaction temperature amplifies the rate of hydrolysis but to a degree 
which hydrolyses the key sequences required to interact for fibril formation. 
3.  The increase in reaction temperature could also cause any amyloid formed to 
disaggregate. 
 
Figure 3.22 Temperature and Incubation Time Affect Lysozyme Fibril Formation 
10µm x 10µm AFM scans at 1024 pixels x 1024 pixels resolution with a height scale of 
between -10 and 10nm showing the change in composition of fibril forming reactions after 
heating at pH2 for A = 60oC for two days, B = 60oC for six days and C = 90oC for 18 hours.  
699µM (10mg/ml) Lysozyme was heated then diluted 1 in 1500 in pH2 HCl and deposited 
onto mica according to 2.34.1.   
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Rather than trying to augment the hydrolysed proportion by increasing the rate of 
hydrolysis it could be altered by heating the samples for longer.  By extending the 
incubation time at 60oC to six days the degree of polymerisation observed in the reaction 
was amplified, as seen by a greater number of particles observed on the mica surface (Fig. 
3.22, A and B), giving the final conditions for fibril assembly. 
To qualitatively examine the role of hydrolysis in fibril formation for lysozyme, monomeric 
protein and fibrillar samples were examined by SDS PAGE (Fig. 3.23).  Two different 
denaturation temperatures, 70oC and 95oC, were examined in the presence and absence of 
2-mercaptoethanol, to ƐŚŽǁƚŚĂƚŐĞůƐĂŵƉůĞƉƌĞƉĂƌĂƚŝŽŶŝƐŶ ?ƚƚŚĞĐĂƵƐĞŽĨƚŚĞĚĞŐƌĂĚĂƚŝŽŶ
observed (Fig. 3.23).  The fibril samples show that the process of fibril formation generates 
a large amount of lower molecular weight materials, and confirms the hydrolytic 
mechanism.   
 
Due to the hydrolytic mechanism of fibril formation at pH2 and elevated temperature the 
efficiency of fibril formation can be linked to the consumption of lysozyme, SDS PAGE 
comparison of the supernatant of an ultracentrifuged, 75000rpm for 15 minutes, fibril 
 
Figure 3.23 SDS PAGE analysis of the degradation of Lysoyme during fibril 
formation 
15% Tris-Glycine gel run at 180V showing the stability of Lysozyme monomers to SDS PAGE 
sample preparation (left 4 lanes) and the hydrolysis of the monomers during fibril formation 
(right 4 lanes). 
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sample to a serial dilution of the parent protein can give a percentage conversion of 
monomer to fibrils (Fig. 3.24).  Densitometry of the serial dilution bands and comparison to 
the fibril samples shows that the conversion is 55-60% complete. 
It has subsequently be shown that the mechanism for conversion of lysozyme from 
monomer to fibril does indeed occur via a hydrolytic mechanism whereby heating in acid 
breaks the amide linkages in the protein (Frare et al., 2006) and if heated long enough the 
major component of the fibrils is in fact a 6 residue peptide, ILQINS, (Lara et al., 2011a, 







Figure 3.25 Amino Acid sequence of Hen Egg White Lysozyme with Core 
Amyloid Region Highlighted 
The primary amino acid sequence of Hen Egg White Lysozyme with the amino acid sequence 
found to form fibrils highlighted in yellow. 
 
Figure 3.24 SDS PAGE Analysis of the Conversion of Lysozyme Monomer to 
Fibril 
Residual monomer assay showing the diminishing of Lysozyme monomer under the 
conditions used to form amyloid fibrils.  Ladder on the left followed by a serial dilution of 
Lysozyme and then (far right) the top 10µl of a 120µM centrifuged fibril sample was diluted 1 
in 10 and then analysed on a Tris-Tricine gel SDS PAGE.  The assays shows 54µM residual 
monomer therefore the reaction has progressed to 54% completion.  The Frag sample is of 
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3.2.2.5   Ⱦ-Lactoglobulin 
dŚĞ ĐŽŶǀĞƌƐŝŽŶ ŽĨ ɴ-lactoglobulin into amyloid fibrils can also be achieved by heating in 
acidic medium similar to insulin B chain ĂŶĚ ůǇƐŽǌǇŵĞ ?  ɴ-Lactoglobulin forms a dimeric 
structure at neutral pH but at pH2 the dimeric structure collapses into monomer (Hamada 
and Dobson, 2002).  Initial experiments using the same conditions as insulin B chain, pH2 at 
60oC for 48 hours, did show evidence of some fibril formation but this, like lysozyme, was 
very inefficient. 
Previous experiments (Bolisetty et al., 2011; Gosal et al., 2004; Krebs et al., 2009) have 
ƐŚŽǁŶƚŚĂƚƚŚĞĐŽŶǀĞƌƐŝŽŶŽĨɴ-lactoglobulin to fibrils required a higher temperature, 80oC, 
for 24 hours.  Modification of these conditions to heating at 90oC in pH2 for 24 hours 
showed no evidence of monomeric proteins in the sample (Fig. 3.26) and a much higher 
efficiency of fibril formation as observed by the number of fibrils observed by AFM and 
TEM (Fig. 3.27). 
 
Similar to the observation that the hydrolysis of Lysozyme and Insulin are important for 
ĨŝďƌŝůůŽŐĞŶĞƐŝƐ ?ƚŚŝƐĂůƐŽƐĞĞŵƐƚŽďĞĂŶŝŵƉŽƌƚĂŶƚĂƐƉĞĐƚŽĨɴ-lactoglobulin and the recent 
work of Akkermans et al (Akkermans et al., 2008) has confirmed this hydrolytic mechanism. 
 
Figure 3.26 ^^W'ŶĂůǇƐŝƐŽĨƚŚĞŽŶǀĞƌƐŝŽŶŽĨɴ-Lactoglobulin Monomer 
to Fibrils 
ZĞƐŝĚƵĂů ŵŽŶŽŵĞƌ ĂƐƐĂǇ ƐŚŽǁŝŶŐ ƚŚĞ ĚŝŵŝŶŝƐŚŝŶŐ ŽĨ ɴ-Lactoglobulin monomer under the 
conditions used to form amyloid fibrils.  Ladder on ƚŚĞůĞĨƚĨŽůůŽǁĞĚďǇĂƐĞƌŝĂůĚŝůƵƚŝŽŶŽĨɴ-
Lactoglobulin and then (second from right) the top 10µl of a 120µM centrifuged fibril sample 
was then analysed on a Tris-Tricine gel SDS PAGE.  The assays shows 2µM residual monomer 
therefore the reaction has progressed to 98% completion.  The Frag sample is the same as for 





















3.2.3   AFM Imaging and Comparison of Fibril Structures 
3.2.3.1   Qualitative Comparison 
Comparison of the fibril species formed through in vitro polymerisation shows that the 
fibrils of Sup35NM and Sup35NMC aggregate into extremely large clusters whereas all 
other fibrils species examined form discrete particles (Fig. 3.28).   
sŝƐƵĂů ŝŶƐƉĞĐƚŝŽŶ ŽĨ ƚŚĞ ƐƵƌĨĂĐĞƐ ƐŚŽǁƐ ƚŚĂƚ ɴ-lactoglobulin forms straight fibrils of a 
ŵĂǆŝŵƵŵůĞŶŐƚŚŽĨƌŽƵŐŚůǇ ?A?ŵŝŶĐŽŵƉĂƌŝƐŽŶƚŽɲ-synuclein, lysozyme and insulin fibrils 
which form longer, more flexible particles with rough maximum length of 10µm, 10µm and 
15µm respectively (Fig. 3.28). 
To compare the heights of fibril samples cross sections were taken (Fig. 3.29).  The large 
aggregated state of Sup35NM and Sup35NMC fibrils means that the edges of the 
aggregates is the only place where individual fibrils are visible and therefore 2µm sections 
around this region were taken.  Sup35NM and Sup35NMC fibrils both appear to have an 
approximate height of about 7-8.5nm (Fig. 3.29).  The discrete particles observed for insulin  
 
Figure 3.27 dDĂŶĚ&DŶĂůǇƐŝƐŽĨɴ-Lactoglobulin Fibrils 
ɴ-Lactoglobulin fibrils Left - deposited onto a mica surface, washed, dried and imaged at 
20µm x 20µm at a resolution of 2048 pixels x 2048 pixels, with a 1µm scale bar and a 1µm 
insert magnified x5 containing a 250nm scale bar.  The AFM height scale is set between -5 and 
5nm. Right  W Fibrils deposited onto a carbon/formavar coated copper surface and then 
imaged using TEM, with a 1µm scale bar.  The AFM height scale bar is set between -5 and 
5nm. 




Figure 3.28 AFM Images of Fibrils Produced 
AFM images of fibrils produced.  Sup35NM and Sup35NMC - 10µm x 10µm images at 1024 x 1024 
pixels with 2µM scale bar and a 1µm insert magnified x 3.  The other proteins imaged at 20µm x 
20µm and 2048 x 2048 pixel resolution and 1µm scale bar and 1µm insert magnified x 5 and a 
250nm scale bar.  ^ƵƉ ? ?ED ? ^ƵƉ ? ?ED ? ɲ-synuclein and insulin B-chain have height scales of 
between - ? ? ĂŶĚ  ? ?ŶŵǁŚĞƌĞ ĂƐ ƚŚĞ ƐĐĂůĞ ĨŽƌ ɴ-Lactoglobulin and lysozyme are between -5 and 
5nm. 




Figure 3.29 Cross Section Analysis of Fibril Heights 
For Sup35NM and Sup35NMC 3 x 2µm cross sections were selected to analyse the edges of the 
fibrillar aggregates where the most unclumped examples exist.  For the other proteins 3 x 10µm 
cross sections were taken.  To each graph a dotted line at 7.5nm was added to show the differences 
in fibril samples. 
 
ĐŚĂŝŶ ?ɲ-ƐǇŶƵĐůĞŝŶ ?ɴ-lactoglobulin and lysozyme allowed 10µm cross section areas to be 
ĞǆĂŵŝŶĞĚ ?  dŚĞĚĂƚĂ ƐŚŽǁƐ ƚŚĂƚɲ-synuclein and insulin B chain are slightly thinner than 
Sup35 fibrils with heights of 7nm and 5- ?ŶŵƌĞƐƉĞĐƚŝǀĞůǇĂŶĚɴ-lactoglobulin and lysozyme 
fibrils are the thinnest with heights from 2-4nm (Fig. 3.29).   
3.2.3.2   Quantitative Analysis 
Quantitative analysis of fibril properties such as contour length, height and persistence 
length can be calculated by transfer of AFM images to a MatLab application, Tracey (Xue, 
unpublished). 
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The MatLab application locates and traces the fibrils by first finding the ends of fibrils and 
then connecting them following predefined parameters such as approximate fibril width in 
ƉŝǆĞůƐĂŶĚĂŶĂŶŐůĞ  ?ɽ )ǁŚŝĐŚĚĞĨŝŶĞƐŚŽǁ  ‘ǁĂǀǇ ?ƚŚĞ ĨŝďƌŝůƐĂƌĞƐƵĐŚƚŚĂƚ ƚŚĞĂƉƉůŝĐĂƚŝŽŶ
can differentiate between overlaps/breakages of fibrils (Fig. 3.30).  These values are 
changed between fibrils of different proteins but are fixed for samples derived from the 
same protein.  The application traces the particles and allows particle information such as 
height along the particle and contour length to be extracted. 
 
The height of the amyloid fibrils is a better representation of the diameter of amyloid fibrils 
than their width due to the tip radius of the probe making the observed width larger than 
the actual diameter.  The contour length of a polymer is the length from one terminus to 
the other following the path of the polymer.  A polymer of contour length L can be divided 
into smaller rigid units, the length of which is the persistence length, Lp.  A smaller value for 
Lp indicates a less stiff species due to it consisting of more, small rigid species rather than 
less, larger ones.  The Lp is therefore a quantifiable property of a polymer used to describe 
its stiffness.  The persistence length Lp can be calculated in several ways (Equation 1).  The 
top equation is a probability based method for defining Lp where as the middle equation 
 
Figure 3.30 MatLab Input Parameters 
dŚĞ ƌĞƋƵŝƌĞĚƉĂƌĂŵĞƚĞƌƐɽĂŶĚ ĨŝďƌŝůǁŝĚƚŚ ŝŶƉŝǆĞůƐ ĐĂŶďĞĂĚũƵĚŐĞĚďǇ ŝŶƐƉĞĐƚŝŽŶŽĨ&D
images and trial and error analysis of surfaces using the application to see which conditions 
ŐŝǀĞ ƚŚĞďĞƐƚ ƌĞƐƵůƚƐ ? ɽ ŝƐ ƚŚĞĂŶŐůĞŽĨďĞŶĚĂůůŽǁĞĚ ŝŶ ƚŚĞ Ĩŝďƌŝů ? ƐĞe left , whilst the fibril 
width in pixels can be judged by zooming in on a fibril at the resolution scanned, see zoom in 
section and yellow line.  Adapted from Adamcik and Mezzenga (2012) (Adamcik and 
Mezzenga, 2012) 
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determines the Lp by looking for the point on a fibre when correlation between two 
tangents starts to diminish and the lower equation utilises the end to end distance of 
individual particles to generate the Lp.  The Lp is calculated here using a MatLab script (Xue, 
unpublished) which utilises the first equation (Equation 3.1).   
Multiple images, processed to remove image curvature and streaking, per protein were 
traced using MatLab and the particles from each concatenated before assessment of 
variables such as longest fibril, weight average contour length (which is an alternative to 
the arithmetic mean which places a larger emphasis on longer particles, 
 ?൫஼௅మ൯ሺ ?஼௅ሻమ), weight 
average contour length standard error of mean (SEM), mean height and mean height 
standard deviation (Table 1).  The height and contour length data is in agreement with the 
qualitative assessment of their dimensions.  The persistence length quantifies the stiffness 
ŽĨƚŚĞƉĂƌƚŝĐůĞƐĂŶĚƚŚĞƌĞĨŽƌĞƚŚĞ ‘ǁĂǀŝŶĞƐƐ ?ŽďƐĞƌǀĞĚŽŶƚŚĞŵŝĐĂƐƵƌĨĂĐĞĂŶĚƐŚŽǁƐƚŚĂƚ
ɴ-ůĂĐƚŽŐůŽďƵůŝŶĨŽƌŵƐƚŚĞŵŽƐƚƌŝŐŝĚƉŽůǇŵĞƌƐĨŽůůŽǁĞĚďǇŝŶƐƵůŝŶĂŶĚƚŚĞŶɲ-synuclein and 
lysozyme, whose similar persistence lengths make them the most flexible polymers.  This 
stiffness information is in agreement with visual inspection of the morphology of particles 
observed on the mica surface. 
  
ܲ൫ߠଶ஽ሺܮሻ൯ ൌ ඨ ܮ௣ ?ߨܮ ݁ି௅೛ఏమವమଶ௅  
ۃሺߠଶ஽ሻۄ ൌ ݁ି ௅ଶ௅೛ ۃܴଶ஽ଶ ۄ ൌ  ?ܮ௣ܮ ቈ ? െ ?ܮ௣ܮ ቆ ? െ ݁ି ௅ଶ௅೛ቇ቉ 
Equation 3.1 Determination of Fibril Persistence Length 
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Lp (µm) Np 
ɲ-Synuclein 7444.10 1862.10 56.02 6.94 2.42 1.86 1105 
ɴ-
Lactoglobulin 
3806.40 1117.80 23.97 2.49 1.18 5.12 2175 
Lysozyme 10970.00 2757.40 93.38 3.38 1.91 1.30 872 
Insulin B 
chain 
15983.00 5937.30 488.04 10.74 21.05 2.48 148 
*Table showing fibril dimensions and persistence length from a number of traced fibrils, Np. 
3.3   Discussion and Conclusion 
Despite the assumption that fibril formation is potentially a facet of all proteins the 
development of in vitro amyloid systems is complicated from synthesis and purification to 
conversion into fibrils.  Where the conversion from monomer to fibril occurs under mild 
conditions the generation and purification of these species can be complicated by their 
ĂŐŐƌĞŐĂƚŝŽŶ ?dŚĞĞǆƉƌĞƐƐŝŽŶĂŶĚƉƵƌŝĨŝĐĂƚŝŽŶŽĨɲ-synuclein, which although polymerises at 
the same temperature as the protein expression, gives rise to a large amount of pure, 
ŵŽŶŽŵĞƌŝĐ ƉƌŽƚĞŝŶ ?  /Ŷ ĐŽŶƚƌĂƐƚ ƚŽ ɲ-synuclein the purification of Sup35NM and 
Sup35NMC is complicated by a large amount of polymerisation during expression.  The 
purification of Sup35NM requires denaturing conditions to extract and purify the protein 
from the cellular residues but the subsequent fibril formation must also tolerate the 
protein coming from a denatured purification, which for Sup35NM is the case.  The C 
domain of Sup35NMC and its inability to refold post denaturation, appears, to seriously 
retard its ability to form fibrils.  Native purification enables, albeit in a lower yield, isolation 
of material susceptible to polymerisation and although a less subtle observation than the 
mutants observed to affect fibril formation by Kabani et al (Kabani et al., 2011) the folding 
of the C-terminal domain does indeed have a significant effect on the propensity of the 
protein to form fibrils. 




Whilst the conversion of monomer to fibril under mild conditions offers difficulties with 
purification pre-assembly, proteins which seem to require extra activation to polymerise 
offer the potential of easier purification but the problem of working out the conditions 
required for fibrils to form.  The hydrolytic mechanism of fibril formation has recently been 
shown with insulin (Piejko et al., 2015) ? ɴ-lactoglobulin (Akkermans et al., 2008) and 
lysozyme (Lara et al., 2011a, 2013, 2014) (Fig. 3.31). 
As proteins are a chain of amino acids covalently bonded together by amide groups the 
acidic conditions utilised promotes non-specific hydrolysis (Fig. 3.32) and therefore 
potentially leads to a highly heterogeneous monomer set.   
Although the hydrolytic mechanism of fibril formation is tempting it is also worth 
contemplating the protective nature of the cross-beta sheet core (Fig. 1.12) and is the final 
monomer unit of a fibril the same as the monomer required for fibril formation?  The 
hydrolysis of one or two amide bonds may well be enough to allow monomers to enter 
conformations not normally allowed and therefore form fibrils.  The cross-beta sheet 












Figure 3.31 Peptides at Core of Amyloid Fibrils Formed by Heating in Acid 
Top  W Bovine Insulin A (top) and B (bottom) with regions protected from hydrolysis in green.  
Middle  W Lysozyme sequence with peptide found at the core of the amyloid fibrils marked in 
yellow and the area around which observed in the fibrils marked in purple.  Bottom  W ɴ-
Lactoglobulin sequence with one of the regions at the core of the fibril marked in blue. 
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susceptible to further acidic hydrolysis.  The proposed hydrolytic mechanism when proteins 
are subjected to heat in an acidic environment means that the fibrils formed in this process 
are derived from the protein and not fibrils of the protein. 
 
dŚĞ ĐŽŶǀĞƌƐŝŽŶ ŽĨ ɴ-lactoglobulin, lysozyme and insulin B chain to fibrils can also be 
achieved in vitro using denaturing conditions and therefore potentially without hydrolysis: 
ɴ-lactoglobulin (Hamada and Dobson, 2002), lysozyme (Krebs et al., 2000) and insulin 
(Nielsen et al., 2001).  The tertiary structure of a protein protects it from hydrolysis as in its 
folded form some residues are not exposed to water and therefore protected.  Whilst 
denaturing conditions are not enough to break standard amide bonds the removal of 
protein tertiary structure exposes residues more susceptible to hydrolysis to water and 
therefore potentially increases hydrolysis.  Work by Vlad et al (Vlad et al., 2011) has shown 
that ɲ-synuclein has autoproteolytic activity which can liberate peptides, 71-140, from the 
amyloid forming region (Uéda et al., 1993), 61-95, whose reaction kinetics are enhanced 
when compared to the full length protein.  Although no evidence for this truncation was 
 
Figure 3.32 Reaction Mechanism Showing the Acid Catalysed Hydrolysis of a 
Peptide bond 
The acid catalysed addition of water to an amide bond with subsequent elimination of an 
amine molecule is shown.  The brackets denoting the interconversion of two tautomeric 
forms of the protonated amide bond before addition of water.  The amine is then eliminated 
leaving a carboxylic acid. 
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observed here it offers evidence that hydrolytic enhancement of amyloid assembly is a 
more common phenomenon than just for fibrils formed in an acidic environment. 
Whilst the evidence for the role of hydrolysis, whether chemical or enzymatic, in the 
preparation of in vitro ĂŵǇůŽŝĚĨŝďƌŝůƐĚĞƌŝǀĞĚĨƌŽŵɴ-lactoglobulin (Akkermans et al., 2008), 
insulin (Piejko et al., 2015), lysozyme (Frare et al., 2004, 2006; Lara et al., 2014) ?ɲ-synuclein 
(Vlad et al., 2011) is apparent its importance in vivo is unclear.  The identification of fibrillar 
materials in vivo tends to be via histological staining of tissue but the proteomic analysis of 
these samples can enlighten what the monomeric units of the fibrils are.  Ex vivo analysis of 
lysozyme fibrils, by N-terminal sequencing, derived from patients suffering from systemic 
lysozyme amyloidosis has shown that the monomers are mutated full length lysozyme 
(Booth et al., 1997; Pepys et al., 1993) (Fig. 3.33).   
HEWL    1   MRSLLILVLCFLPLAALGKVFGRCELAAAMKRHGLDNYRGYSLGNWVCAA     50 
                                 |||.|||||..:||.|:|.|||.||.||:|.| 
Human Lys 1   ------------------KVFERCELARTLKRLGMDGYRGISLANWMCLA     32 
 
HEWL      51  KFESNFNTQATNRNT-DGSTDYGILQINSRWWCNDGRTPGSRNLCNIPCS     99 
               |:||.:||:|||.|. |.|||||..|||||:|||||:|||:.|.|::.|| 
Human Lys 33  KWESGYNTRATNYNAGDRSTDYGTFQINSRYWCNDGKTPGAVNACHLSCS     82 
 
HEWL      100 ALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDVQAWIRGCRL       147 
              |||..:|..:|.|||::|.|..|:.|||||||||:..||:.:::||.: 
Human Lys 83  ALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV       130 
Figure 3.33 Comparison of the human and hen egg white lysozyme sequences. 
A sequence alignment of hen egg white lysozyme (HEWL, Top) and human lysozyme (Lower).  The 
HEWL sequence labelled with the ILQINS sequence determined by Lara et al (Lara) in red and the 
positions susceptible to acidic hydrolysis as shown by Frare et al (Frare) in green.  The residues of 
human lysozyme whose mutations are central to conversion to amyloid fibrils without hydrolysi in 
vivo by Pepys et al (Pepys) are highlighted in yellow. 
Frare et al (Frare et al., 2004, 2006) have shown that wild type human and hen egg 
lysozyme do not enter the conformations required for amyloid formation without 
hydrolysis where as the mutated forms found in systemic amyloidosis are capable of 
entering this conformation and therefore converting to the amyloid state.  Insulin derived 
amyloidosis is observed at the injection sites of recombinant insulin.  Storage of the insulin 
formulations over time have shown that the protein structure is the subject of amide 
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hydrolysis, both side chain and peptide backbone (Brange et al., 1992; Nilsson and Dobson, 
2003). 
Beyond the proteins studied here there is evidence that hydrolysis can play a role in the 
aggregation of other proteins such as the S52P mutant of transthyretin (TTR) (Bergström et 
al., 2005; Mangione et al., 2013) ĂŶĚɴ ?-microlglobulin (Heegaard et al., 2005; Linke et al., 
1989; Stoppini and Bellotti, 2015). 
Aside from the differences observed in fibril formation conditions the dimensions and 
properties of the fibrils varies despite the same core cross-beta sheet.  The Sup35 proteins 
are the largest in terms of monomer size at 35kDa and 78kDa for Sup35NM and Sup35NMC 
respectively but by qualitative analysis form fibrils of a similar diameter 7-8.5nm.  In 
comparison insulin B chain is the smallest protein investigated at 5.8kDa and yet gives rise 
to fibrils of comparable height with a mean traced height of 10.74nm and a particle height 
mean of 8.18nm, both values appear high when compared to the qualitative assessment, 5-
6nm, and this is due to ƚŚĞƉƌĞƐĞŶĐĞŽĨƐŽŵĞǀĞƌǇŚŝŐŚŵĂƚĞƌŝĂůƐŬĞǁŝŶŐĐĂůĐƵůĂƚŝŽŶƐ ?ɲ-
ƐǇŶƵĐůĞŝŶ ? ɴ-lactoglobulin and lysozyme are all similar molecular weights as protein 
monomer, ~15kDa, yet give rise to fibrils of different height at 6.94nm, 2.49 and 3.38nm 
respectively.  This suggests that there is no association between monomer size and fibril 
diameter but this assessment is based on the starting monomers size and does not take 
into account hydrolysis observed during conversion or fibrils propensity to laterally 
associate. 
The quantitative assessment of the longer fibril particles is in agreement with the 
qualitative assessment of their length and the length trend concurs with the order of fibrils 
weight average contour length. 
Finally, characterisation of the polymers in terms of there nanomechanical properties was 
carried out.  The elasticity of a material, its non permament deformation, is quantified by 
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ƚŚĞ zŽƵŶŐ ?Ɛ ŵŽĚƵůƵƐ  ?WĂ ) ŽĨ ƚŚĞ ŵĂƚĞƌŝĂů, the smaller the value the more elastic the 
polymer.  The persistence length (Lp) of a polymer is the length where the correlation 
between two tangent angles starts to diminish and is a measure of the rigidity of a 
ƉŽůǇŵĞƌ ?dŚĞƌĞůĂƚŝŽŶƐŚŝƉďĞƚǁĞĞŶzŽƵŶŐ ?ƐŵŽĚƵůƵƐĂŶĚƉĞƌƐŝƐƚĞŶĐĞůĞŶŐƚŚŝƐĚĞĨŝŶĞĚďǇ
Equation 3.2. 
Equation 3.2  The ĐŽƌƌĞůĂƚŝŽŶŽĨzŽƵŶŐ ?ƐŵŽĚƵůƵƐĂŶĚ>p ܮ௣ ൌ ܧܫߢ஻ܶ 
A?zŽƵŶŐ ?ƐŵŽĚƵůƵƐ ?/A?DŽŵĞŶƚŽĨ/ŶĞƌƚŝĂŽĨƚŚĞƉĂƌƚŝĐůĞĐƌŽƐƐƐĞĐƚŝŽŶ ?ĨŽƌƌŝŐŝĚƌŽĚƐŽĨĚŝĂŵĞƚĞƌZ ?/
A? ? ? ?ʋZ ) ?ʃB=Boltzmann constant and T = temperature (K). 
Calculation of the fibril persistence length of each type of fibril in this chapter shows that Lp 
ŝƐ ŶŽƚ ĐŽƌƌĞůĂƚĞĚ ǁŝƚŚ ƚŚĞ ĚŝĂŵĞƚĞƌ ŽĨ ƚŚĞ ĨŝďƌŝůƐ ? ĂƐ ƐŚŽǁŶ ďǇ ƚŚĞ ƚŚŝŶŶĞƐƚ Ĩŝďƌŝů ? ɴ-
ůĂĐƚŽŐůŽďƵůŝŶ ? ďĞŝŶŐ ƚŚĞ ŵŽƐƚ ƌŝŐŝĚ ĂŶĚ ƚŚĞ ǁŝĚĞƐƚ ? ɲ-synuclein, having an intermediate 
persistence length.  The size of the regions shown to be at the core of the amyloid 
ƐƚƌƵĐƚƵƌĞƐ ƐŚŽǁƐ ƚŚĂƚ ɴ-lactoglobulin has the largest region, ~30 residues (Fig. 3.31) 
(Akkermans et al., 2008), whilst lysozyme (Lara et al., 2014) and insulin B chain (Piejko et 
al., 2015) have the smallest, ~15 residues roughly following the order of decreasing Lp.  Is it 
possible that the number of inter-molecular interactions between monomers is key to the 
rigidity of the resulting polymer?  The observed Lp for a-synuclein and this trend suggests 
the size of the cross-beta sheet core would be similar/slightly smaller than insulin B chain.  
The core 35 residue seqƵĞŶĐĞ ĨŽƌɲ-synuclein is known, NAC (Uéda et al., 1993), and the 
work of Vlad et al (Vlad et al., 2011) shows that the actual core maybe slightly smaller, ~25 
residues, which suggests its Lp ƐŚŽƵůĚďĞŝŶƚŚĞƌĞŐŝŽŶŽĨɴ-lactoglobulin rather than insulin.  
This comparison though assumes that there is not further redundancy in the 25 residue 
cross-ďĞƚĂƐŚĞĞƚƌĞŐŝŽŶŽďƐĞƌǀĞĚĨŽƌɲ-synuclein.  For Sup35 the N domain is the amyloid 
forming region and is 254 residues in size but the importance of 16 residues, 8-24, on 
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phenotypes which promote and prevent fibril formation (ASU/PNM) suggests that this 
region is key to the cross-beta sheet (DePace et al., 1998). 
Table 3.2 Published peristence length data for the fibres generated in chapter 3 




ɴ-Lactoglobulin i 2nm 0.968µm 50 (Adamcik et al., 2010) 
ɴ-Lactoglobulin ii 3.5-4nm 1.62µm 108 (Adamcik et al., 2010) 
ɴ-Lactoglobulin iii 5.5-6.4nm 3.244µm 60 (Adamcik et al., 2010) 
ɴ-Lactoglobulin  2.3nm 3.818µm 110 (Schleeger et al., 2013) 
ɲ-Synuclein Curly <17nm൪ 0.17µm 50 (Bhak et al., 2010) 
ɲ-Synuclein Straight <17nm൪ 140µm 50 (Bhak et al., 2010) 
Lysozyme  2.4nm 2.5µm 66 (Lara et al., 2011b) 
Lysozyme 
peptide* 
 13nm 5.57µm - (Lara et al., 2014) 
Bovine Insulin  5-6nmੱ 42±30µm 76 (Smith et al., 2006) 
൪ Values extracted from TEM images in paper.ੱ Values extracted from the height scale of AFM 
images. 
*Fibrils derived from the synthetic ILQINS peptide. 
The persistence length ĚĂƚĂ ƉƌĞǀŝŽƵƐůǇ ƉƵďůŝƐŚĞĚ ĨŽƌ ĨŝďƌŝůƐ ŽĨ ɴ-lactoglobulin shows that 
the entwining of fibrils together into higher structures makes a significant difference to the 
rigidity of polymers (Table 3.2).  By associating two fibres together a doubling of the 
persistence length is observed and when three fibres interact the persistence lengths 
trebles (Adamcik et al., 2010).  Whilst the height of the single fibres observed in (Adamcik 
et al., 2010) ĂƌĞƐŝŵŝůĂƌƚŽƚŚĞŚĞŝŐŚƚƐŽĨɴ-lactoglobulin fibrils generated in chapter 3 the 
ĐĂůĐƵůĂƚĞĚ ƉĞƌƐŝƐƚĞŶĐĞ ůĞŶŐƚŚƐ ĚŝĨĨĞƌƐ ŐƌĞĂƚůǇ ? ĂƐ ĚŽ ƚŚĞ ǀĂůƵĞƐ ŽďƐĞƌǀĞĚ ĨŽƌ ɲ-synuclein 
(Bhak et al., 2010) and insulin (Smith et al., 2006).  Whilst those fibres differ from the 
previous literature, the data generated in chapter 3 is in good agreement with the 
previously published data for lysozyme (Lara et al., 2011b) and that of a separate 
ƉƵďůŝĐĂƚŝŽŶ ƌĞŐĂƌĚŝŶŐ ɴ-lactoglobulin fibrils (Schleeger et al., 2013).  In all cases the 
methodology used in chapter 3 has enabled the persistence length data to be generated on 
much larger populations of fibrils than has previously been possible which is of the utmost 
importance for generating accurate values of the persistence length. 
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The (Adamcik et al., 2010) data although apparently differing in rigidity to the data shown 
here does show that the structural organisation of fibres has a large influence on the 
persistence length of materials and suggests that height does play some role in determining 
persistence length. 
 
Figure 3.34  Bar chart showing a comparison of the fibrils formed in this 
chapter with other biological polymers 
A bar chart with a log plot showing published persistence length values (blue) for DNA 
(Hansma et al., 1996), RNA (Abels et al., 2005), actin fibres (Gittes et al., 1993) and 
microtubules (Gittes et al., 1993) compared to the persistence length values extracted from 
ƚŚĞĨŝďƌŝůƐŽĨůǇƐŽǌǇŵĞ ?ɴ-ůĂĐƚŽŐůŽďƵůŝŶ ?ɲ-synuclein and insulin B chain. 
 
Published analysis of apoliprotein-C II fibrils shows particles of Ă ŚĞŝŐŚƚ ƐŝŵŝůĂƌ ƚŽ ɴ-
lactoglobulin and lysozyme but have a significantly lower persistence length, 36nm (Hatters 
et al., 2003).  X-ray diffraction analysis of these particles showed that the core structure is 
that of a single protofilament with no further structural organisation (Hatters et al., 2003).  
Whilst (Adamcik et al., 2010) ƐŚŽǁ ƚŚĂƚ ɴ-lactoglobulin is susceptible to inter-fibril 
aggregation leading to differing persistence lengths, the particles generated in chapter 3 
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a much higher rigidity.  ɴ-Lactoglobulin has been shown to form two distinct morphologies 
of fibrils: worm like and straight with low (92.7nm) and high (3818nm) persistence length 
respectively, under different fibril formation conditions (VandenAkker et al., 2011).  The 
difference between worm like and straight fibrils ĚĞƌŝǀĞĚĨƌŽŵɴ-lactoglobulin was shown 
by vibrational sum frequency spectroscopy to be correlated with the the proportion of 
beta-sheet observed in the samples (Schleeger et al., 2013; VandenAkker et al., 2011).  The 
particles formed in this research have similar height (2.3nm) and persistence length values 
(3818nm) to the values generated here and are that of a single protofilament 
(VandenAkker et al., 2011).  These data suggest that the nanomechanical properties of 
amyloid fibrils are profoundly influenced by the molecular structure of the fibres. 
Although the values for Lp in Table 3.1 show that the Lp of the amyloid fibrils generated in 
this chapter are of different lengths, comparison to other biologically relevant polymers 
ƐƵĐŚ ĂƐ E ? ZE ? ĂĐƚŝŶ ĂŶĚ ŵŝĐƌŽƚƵďƵůĞƐ ƚŚĞ ĂŵǇůŽŝĚ ƐƚƌƵĐƚƵƌĞƐ ŽĨ ůǇƐŽǌǇŵĞ ? ɴ-
ůĂĐƚŽŐůŽďƵůŝŶ ?ɲ-synuclein and insulin B chain exhibit similar Lp values to each other (Fig. 
3.34, red bars).  The fibrils formed here are much more rigid than the polynucleotides DNA 
and RNA (Fig. 3.34, left hand blue bars) (Abels et al., 2005; Hansma et al., 1996) but more 
flexible than actin polymers and microtubules (Fig. 3.34, right hand blue bars) (Gittes et al., 
1993). 
To conclude expression and purification systems have been developed for the generation 
ŽĨɲ-synuclein, Sup35NM and Sup35NMC monomers.  Utilising these monomers as well as 
commercial souƌĐĞƐŽĨɴ-lactoglobulin, hen egg white lysozyme and bovine insulin B-chain 
an array of different fibrils have been generated, characterised in terms of their physical 
dimensions/properties.  Comparison of this data leads to interesting questions relating the 
structure of the cross-beta sheet and polymer properties such as Lp.  These fibril stocks will 
allow the investigation of their resistance to mechanical stress (Chapter 4).  
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3.4   Future Work 
To develop in vitro polymerisation conditions which do not result in the aggregation of 
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4.1   Introduction 
The formation of a nucleus from protein monomers and subsequent growth of amyloid 
fibrils by monomer addition are pivotal events in the nucleated growth mechanism of 
amyloid fibrils.  However, the kinetics of fibril formation are profoundly influenced by 
secondary processes such as surface nucleation and fibril fragmentation.  Without these 
secondary processes, the exponential phase of growth observed would be considerably 
slower. 
The influence of amyloid fibril fragmentation extends beyond the kinetics of fibril formation 
into their functional or deleterious roles in biological systems.  As discussed in 1.8.2 the 
chaperone mediated fragmentation of amyloid deposits is an integral component of the 
transmission mechanism associated with the prion phenotype (Byrne et al., 2009; Cox et 
al., 2003).  In yeast, this can provide an adaptive mechanism, for example the utilisation of 
different nitrogen sources, but in mammalian organisms so far only gives rise to disease 
association in for example CJD and Kuru.  A key observation associated with yeast prions, 
[prion+], is the presence of different phenotypes, weak and strong, caused by the formation 
of different fibril morphologies with different propagation propensities (Tanaka et al., 
2006).  The central role that fragmentation has on prion propagation and the potential 
differences of the morphologies with respect to their resistance to fragmentation poses an 
important question: ŽĞƐĂ “ǁĞĂŬĞƌ ?ŵŽƌƉŚŽůŽŐǇ of fibrils, more susceptible to breakage, 
give rise to a stronger prion phenotype?  (Tanaka et al., 2006) 
The fragmentation of fibrils also offers a potential explanation to the lack of correlation 
between amyloid load and the symptoms observed with sufferers of diseases such as 
ůǌŚĞŝŵĞƌ ?Ɛ ?DddĚǇĞƌĞůĞĂƐĞĂƐƐĂǇƐŚĂǀĞďĞĞŶƵƐĞĚƚŽĚĞŵŽŶstrate that the smaller fibril 
particles generated by fragmentation interact with membranes more efficiently and 
increase cytotoxicity compared to the unfragmented fibrils (Fig. 4.1) (Xue et al., 2009b).  
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ZĞĐĞŶƚ ǁŽƌŬ ƵƐŝŶŐ ƚŚĞ ƐĂŵĞ ɴ2-Microglobulin (B2m) fibril samples has shown that 
fragmented fibrils are internalised into the cell via endocytosis more efficiently than 
unfragmented longer particles, and the cytotoxicity observed is due to interaction of the 
particles with lysozomes and impairment of their function (Jakhria et al., 2014). 
 
As previously discussed, the properties of amyloid fibrils have marked them out as 
potential nanomaterials (Knowles and Buehler, 2011).  By correlating structural 
characteristics and physical properties with the composition of the material it is possible to 
build up a structure activity relationship, and generate rules that will enable the in silico 
design of new amyloid materials with enhanced properties (Li et al., 2014; Scheibel et al., 
2003).  The formation of fibrils of different morphologes from the same monomers can 
 
Figure 4.1 Fibril Fragmentation Increases Cytotoxicity 
A schematic showing that the fragmentation of amyloid fibrils increases the cytotoxicity of 
the particle by allowing greater interaction with, and disruption, of cell membranes.  The red 
arrow shows a fibril formation where fragmentation is an active process leading to shorter 
particles.  The blue arrow is an example of a fibril formation where fibril fragmentation is 
minimal leading to longer particles.  Fragmentation of these longer particles gives rise to an 
increase in cytotoxicity.  Taken from (Xue et al., 2009b) 
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generate different properties, as phenotypically observed with prions and shown in vitro 
ǁŝƚŚɴ-lactoglobulin (VandenAkker et al., 2011), suggesting that fibril formation conditions 
are also important in generating different amyloid types, which could be differentiated 
between by examination of their resistance to fragmentation.  Thus, the ease of 
fragmentation of a fibril can potentially be correlated to their yield strength and/or rigidity. 
 
Figure 4.2 ĞƐƚĨŝƚ&ƌĂŐŵĞŶƚĂƚŝŽŶDŽĚĞůĨŽƌɴ ?-microglobulin. 
The breakage of amyloid fibrils into smaller components could potentially occur in between 
monomers at any point on the fibril, length i, to give a fragment, length j (a).  The first order 
ĨƌĂŐŵĞŶƚĂƚŝŽŶ ƌĂƚĞƐ ŽĨ Ĩŝďƌŝů ďƌĞĂŬĂŐĞ ĚĞƌŝǀĞĚ ĨƌŽŵ ďĞƐƚ Ĩŝƚ ĂŶĂůǇƐŝƐ ŽĨ ɴ ?-microglobulin 
fragmentation which shows that breakage is length dependent with longer fibrils more likely to 
ďƌĞĂŬ ƚŚĂŶ ƐŚŽƌƚ  ?ď ) ?   ?Đ )  ŐƌĂƉŚ ƐŚŽǁŝŶŐ ƚŚĞ ĐŚĂŶŐĞ ŝŶ ĨƌĂŐŵĞŶƚĂƚŝŽŶ ƌĂƚĞ ŽĨ ɴ ?-microglobulin 
fibrils as a function of fibril length.  (d) A graph showing the rate of fragmentation as a function of 
position on the fibril with the middle exhibiting the faster rate.  Figure taken from (Xue and Radford, 
2013). 
 
dŚĞĨƌĂŐŵĞŶƚĂƚŝŽŶŽĨɴ2-microglobulin fibrils under mechanical perturbation has previously 
been investigated by analysis of the particle dimensions for the fibril population over the 
course of the fragmentation.  This was achieved by using the data from large numbers of 
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individually imaged fibrils using Tapping Mode Atomic Force Microscopy (TM-AFM) and an 
automated MatLab application which is capable of tracing fibrils in the images and 
extracting information about them (Xue, unpublished).  Applying different periods of 
fragmentation, by stirring, showed how these materials fracture over time (Xue and 
Radford, 2013; Xue et al., 2009b).  The change in contour length distribution over time 
enabled the generation of a model which best fits the contour length distribution profile 
ŽďƐĞƌǀĞĚ ĞǆƉĞƌŝŵĞŶƚĂůůǇ ǁŚĞŶ ɴ ?-microglobulin is fragmented, in which the rate of 
breakage for longer fibrils is faster than short and that it is more likely for the breakage 
occur in the centre of a fibril rather than the end of amyloid fibrils (Fig. 4.2)(Xue and 
Radford, 2013). 
4.1.1   Chapter Aims 
It is evident that fibril fragmentation and particle size are important considerations for 
understanding the biological function of amyloid fibrils and their future development as 
nanomaterials.  Therefore, the development of methods to quantify amyloid fibrils 
resistance to fragmentation is important.  In this chapter, the resistance of amyloid fibrils 
to mechanical stress for fibrils derived from different proteins, developed in chapter 3, will 
be assessed using the physical fragmentation assay described previously (Xue and Radford, 
2013; Xue et al., 2009b) and further developed here.  The data captured here will enable 
ƚŚĞĐŽŵƉĂƌŝƐŽŶŽĨĂŵǇůŽŝĚĨŝďƌŝůƐ ?ƐƚĂďŝůŝƚǇƚŽǁĂƌĚƐĨƌĂŐŵĞŶƚĂƚŝŽŶ ?ĂŶĚƐŚŽǁĨŝďrils derived 
from different monomers have altered physical strengths despite the same core cross-beta 
sheet architecture.  Results here will enable the fibril fragmentation and fibrils mechanical 
characteristics to be mathematically modelled.  Quantitative understanding of these 
properties will allow the prediction of fibril fragmentation for other assemblies and allow 
for in silico design of fibrils resistant to mechanical stress. 
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4.2   Results  
To enable comparison between experimental studies the conditions used to fragment the 
fibrils generated in chapter 3 were identical to the work of Xue et al (Xue and Radford, 
2013; Xue et al., 2009b).  Briefly, 500µl of 120µM fibril solutions, in fibril forming buffer, 
were stirred at 1000rpm by a 3 x 8mm magnetic stirrer bar in a 1.5ml glass chromatography 
vial using an Ika Squid stirrer plate with a digital display (Fig. 4.3).  The fragmentation 
experiments were always carried out in fibril forming buffer as recent evidence has shown 
that altering the composition of buffer and temperature has the potential to change or 
disaggregate the fibrils formed (Ikenoue et al., 2014; Tipping et al., 2015).  
 
The analysis of the particle size distributions were achieved by AFM image analysis.   
At different time points aliquots of the fragmentation experiment were removed and 
diluted to concentrations previously shown to give good particle coverage, and incubated 
on a freshly cleaved mica surface before washing and drying under a stream of nitrogen 
gas.  20µm x 20µm scans at 2048 pixels x 2048 pixels resolution were captured and the 
images were flattened using the nanoscope analysis software, to remove any curvature of 
the image plane.  The processed image files generated could then be exported as a text file 
for recapitulation in MatLab or transferred directly to the MatLab application (See 3.2.3.2).  
 
Figure 4.3 Experimental Setup of Fibril Fragmentation 
A 1.5ml clear LC-MS vial containing a 3x 8mm PTFE stirrer bar and 0.5ml of a 120µM fibril 
solution were stirred at 1000rpm by an IKA Squid stirrer, the experiment was covered to 
avoid light damage of the sample.  Image courtesy of Wei-Feng Xue. 
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An important consideration for the successful analysis of fibril length distribution is to find 
fibril deposition conditions which allow for the capture of appropriate AFM data that gives 
a high density of discrete particles where overlap is minimised.  The aim of each timepoint 
is to generate a large number of particles, at least 500, across multiple images to minimise 
the potential that the data is not a true representation of the surface, and therefore the 
sample.  Calculation and subsequent plotting of mean fibril lengths against fragmentation 
time visualises the fragmentation and allows for calculation of rates of fragmentation 
under these conditions. 
4.2.1   Qualitative Assessment of Fibril Fragmentation 
Quantitative analysis of fibril size distributions is dependent on image quality and requires 
a large number of discrete particles where overlap is minimised to enable successful tracing 
of the fibrils.  The suitability of the fibril samples produced in chapter 3 to quantitative 
particle size analysis during fragmentation is investigated qualitatively in this section. 
4.2.1.1   Sup35 
As observed in 3.2.2.2 the polymerisation of Sup35NM and Sup35NMC gave rise to large 
networks of amyloid fibrils (Fig. 4.4, 1A and 1B), which were also visible by the optical 
microscope used for aligning the probe with the laser and the mica surface (Fig. 4.4, 1C).  
The concentration required for Sup35NM fibril assembly is in the region of 10µM and as 
such the targeted fragmentation experiment concentration of 120µM was not possible to 
reach without monomer or fibril concentration processes which further exacerbate 
aggregation problems.  Also, fragmentation of these aggregates was not possible by stirring 
as it was not powerful enough to break the inter fibril interactions holding the network 
together but mild sonication, 20% amplitude for 4 minutes on ice with 5 second bursts, did 
allow for the network to be dispersed.  After sonication, the large aggregates visible pre 
sonication were no longer visible using the optical microscope and had been broken into 
smaller clusters shown by AFM (Fig. 4.4, 2A, 2B and 2C). 
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. 
The large networks of fibrils at the beginning of the experiment and the material after 
sonication were not conducive to particle length analysis or fragmentation studies so were 
not progressed to quantitative size analysis. 
4.2.1.2   Insulin B-chain 
Exposure of fibrils derived from insulin B-chain, formed in 3.2.2.3, to fragmentation under 
the conditions used previously, and described in 4.2, resulted in a gradual loss of affinity of 
the particles to the mica surface (Fig. 4.5) which was not returned even with altered 
deposition conditions.  Whilst the disappearance of the fibrillar material from the mica 
surface was obvious another change in mica surface coverage is less evident and involves 
the deposition of a large amount of small material generated during the fragmentation 
onto the mica surface (Fig. 5, inserts).  This reproducible loss of affinity consistently 
occurred after about 9 hours of stirring and although the AFM background had changed 
TEM analysis showed the presence of fibrillar material in the fragmentation experiment still 
persisted (Fig. 4.6). 
 
Figure 4.4 Analysis of Fragmentation of Sup35NM 
1, 10uM Sup35NM Fibrils, unsonicated.  2, Sonication of 10uM Sup35NM fibrils on ice for 4 
minutes with 5 second bursts at 20% amplitude  A  W Peak force error scan of 10µm x 10µm at 
1024 x 1024 pixels with 1µm scale bar and 1µm insert magnified x 5 with 200nm scale bar.  B 
 W Height scan of the same image with 1µm scale bar and 1µm insert magnified x 5 with 
200nm scale bar.  C  W Optical microscope image of the mica surface.  The scale for the peak 
force error images are set between -100 and 100mV and the height scales are set between -
10 and 10nm. 
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There are several possibilities as to the origin of this difference.  The fibrils derived from 
insulin B-chain fragmentation may occur by a different mechanism compared to other 
ƉƌŽƚĞŝŶƐ ?ůŝďĞƌĂƚŝŶŐǀĞƌǇƐŵĂůů ‘ůƵŵƉƐ ?Žf material.  As the formation of insulin derived fibrils 
occurs at pH2 the fibrils are positively charged which aides binding to the negatively 
charged mica surface.  One explanation for fibril disappearance was that the small clusters 
 
Figure 4.5 AFM analysis of the Fragmentation of Insulin Fibrils 
A 120µM Insulin fibril suspension was stirred at 1000rpm and at different timepoints material 
was deposited onto a mica surface and a 20µm x 20µm area imaged at 2048 x 2048 resolution 
with a 1µm scale bar.  The height scale for each image is set between -10 and 10nm. 
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formed interact with the fibrils stopping the fibrils from binding to the mica surface but this 
mechanism is unlikely due to the pH of solution meaning that, like the fibrils, the small 
clumps are protonated and therefore will electrostatically repulse the fibrils.  A more 
probable explanation is that due to their positive charge the clumps and the fibrils are 
competing for binding to the negatively charged mica surface.  As the image appears to 
show a covering of the surface with this material it suggests the smaller material is more 
tightly bound to the surface essentially covering it with positive charges, which would repel 
the fibrils from the surface due to electrostatic repulsion. 
The inability to measure the height and length distributions of the insulin B-chain fibrils as 
the fragmentation proceeds meant the data generated was not suitable for particle size 
analysis during fibril fragmentation using this method. 
 
4.2.1.3   LyǡȾ-Ƚ-Synuclein 
dŚĞ ĨƌĂŐŵĞŶƚĂƚŝŽŶ ŽĨ ĨŝďƌŝůƐ ĚĞƌŝǀĞĚ ĨƌŽŵ ŚĞŶ ĞŐŐ ůǇƐŽǌǇŵĞ ? ɴ-ůĂĐƚŽŐůŽďƵůŝŶ ĂŶĚ ɲ-
synuclein were all achievable using the predefined conditions of 500µl of 120µM fibril 
solutions and using the appropriate deposition conditions gave rise to discrete particles 
observable by AFM (Fig. 4.7, 4.8, 4.9). 
 
Figure 4.6 TEM Analysis of Fibrils Pre and Post Fragmentation 
A  W TEM analysis of Insulin fibrils before fragmentation, with 1µM scale bar.  B  W TEM analysis 
of Insulin fibrils fragmented until after the disappearance of fibrils from the AFM surface was 
observed, with 1µm scale bar. 
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Figure 4.7 AFM Analyslsis of 
Lysozyme Fibril Fragmentation. 
Fibrils derived from lysozyme were 
subjected to fragmentation at 
1000rpm and at different time points 
(in seconds) material deposited onto 
mica for analysis by AFM imaging.  
Representative images of the 
fragmentation taken at different time 
points, with time shown above.  
Image properties - 20µm x 20µm at 
2048 x 2048 pixel resolution with 1µm 
scale bar and 1µm insert magnified x 
5 with a 200nm scale bar.  The AFM 
height scale is set between -5 and 
5nm. 
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Figure 4.8 AFM Analyslsis of 
ɴ-Lactoglobulin Fibril 
Fragmentation. 
&ŝďƌŝůƐ ĚĞƌŝǀĞĚ ĨƌŽŵ ɴ-lactoglobulin 
were subjected to fragmentation at 
1000rpm and at different time points 
(in seconds) material deposited onto 
mica for analysis by AFM imaging.  
Representative images of the 
fragmentation taken at different time 
points, with time shown above.  
Image properties - 20µm x 20µm at 
2048 x 2048 pixel resolution with 1µm 
scale bar and 1µm insert magnified x 
5 with a 200nm scale bar.  The AFM 
height scale is set between -5 and 
5nm. 
Chapter 4:  Comparative Analysis of the Fragmentation of Amyloid Fibrils 




Figure 4.9 AFM Analyslsis of 
ɲ-Synuclein Fibril Fragmentation. 
&ŝďƌŝůƐ ĚĞƌŝǀĞĚ ĨƌŽŵɲ-synuclein were 
subjected to fragmentation at 
1000rpm and at different time points 
(in seconds) material deposited onto 
mica for analysis by AFM imaging.  
Representative images of the 
fragmentation taken at different time 
points, with time shown above.  
Image properties - 20µm x 20µm at 
2048 x 2048 pixel resolution with 1µm 
scale bar and 1µm insert magnified x 
5 with a 200nm scale bar.  The AFM 
height scale is set between -10 and 
10nm. 
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Qualitative analysis of the fibrils observed in the first time point of the fragmentation show 
that hen egg lysozyŵĞĂŶĚɲ-synuclein both have a propensity to form longer, more coiled 
ĨŝďƌŝůƐǁŚĞƌĞĂƐɴ-lactoglobulin fibrils appear on the mica as shorter, straighter particles.  
tŚĞŶ ĚĞƉŽƐŝƚĞĚ ŽŶƚŽ ŵŝĐĂ ƵŶĨƌĂŐŵĞŶƚĞĚ ɲ-synuclein fibrils appear regularly as coiled 
structures (Fig. 9, 300s image), something that is observed with lysozyme rarely but not at 
Ăůů ǁŝƚŚ ɴ-lactoglobulin.  Inspection of the individual AFM images captured during the 
fragmentation of these three proteins showed the each change from long fibrils at the start 
of the experiment to much smaller particles at the end of the experiments (Fig. 4.7, 4.8, 
4.9). 
Of the five proteins successfully polymerised to amyloid fibrils in chapter 3 only three were 
suitable for assessment of their particle size distributions during mechanical perturbation: 
ůǇƐŽǌǇŵĞ ?ɴ-ůĂĐƚŽŐůŽďƵůŝŶĂŶĚɲ-synuclein. 
4.2.2   ǡȾ-
Ƚ-Synuclein Fibril Fragmentation 
dŚĞĨƌĂŐŵĞŶƚĂƚŝŽŶŽĨůǇƐŽǌǇŵĞ ?ɴ-ůĂĐƚŽŐůŽďƵůŝŶĂŶĚɲ-synuclein fibrils was carried out twice 
using different time points over a period of about two weeks to show reproducibility.  
 
Table 4.1 General Statistics for the Fragmentation of Fibril Samples 
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During this time a minimum of twelve aliquots were removed for deposition onto mica and 
imaging.  For each time point multiple images were captured so as to achieve the 500 
particles minimum target for analysis of the particle size (Table 4.1).  
4.2.2.1   Analysis of Changes in Monomer Composition 
dŽĐŽŶĨŝƌŵƚŚĂƚƚŚĞĨƌĂŐŵĞŶƚĂƚŝŽŶŽĨůǇƐŽǌǇŵĞ ?ɴ-ůĂĐƚŽŐůŽďƵůŝŶĂŶĚɲ-synuclein fibrils was 
by physical breakage and not an artefact of monomer shedding the composition of the 
supernatant pre- and post- fragmentation was compared by residual monomer assay. 
 
Figure 4.10 Lysozyme Fragmentation Residual Monomer Assay 
Left  W Coomassie stained SDS PAGE (Tris-Tricine) gel of a serial dilution of lysozyme and 120µM 
fibrils and fragmented fibrils centrifuged at 75k rpm with 10µl of the very top of the supernatant 
removed and diluted 1 in 10 for SDS PAGE analysis.  The gel was then Coomassie stained.  Right  W 
Intensity values of the coomassie stained bands, from Aida densitometry analysis, plotted against 
µm concentration of dilution.  Intensity of the fragmented and parent fibrils plotted onto the graph.  
Equation of line of best fit, y = 140.34x - 262.79 
The values obtained from lysozyme pre- and post- fragmentation were 61.8µM and 63.5µM 
ƌĞƐƉĞĐƚŝǀĞůǇ  ?&ŝŐ ?  ? ? ? ? ) ? ɴ-lactoglobulin less than 5µM ƌĞƐƉĞĐƚŝǀĞůǇ  ?&ŝŐ ?  ? ? ? ? ) ĂŶĚ ɲ-
synuclein 4.2µM and 5.7µM respectively (Fig. 4.12).  The different level of residual 
monomer composition before fragmentation for the different proteins is due to different 
efficiencies of conversion to fibrils.  With respect to the starting residual monomer 
concentration for the fragmentation experiment the fragmented samples exhibit similar 
monomer compositions with lysozyme differing by only 1.4% (pre- 51.5%, post-  ? ? ? ?A? ) ?ɲ-
synuclein by 1.25% (pre- 3.5%, post-  ? ? ? ?A? )ĂŶĚɴ-lactoglobulin showing no difference at all 
(pre-/post- 4%).These values show that the major process observed during mechanical 
agitation is fragmentation and not monomer release. 
Chapter 4:  Comparative Analysis of the Fragmentation of Amyloid Fibrils 




4.2.2.2   Analysis of Particle Size Distributions 
MatLab analysis of the fragmented fibril sample images allowed quantification of the 
particle size associated with individual particles in solution and allowed a distribution to be 
built based on combination of data from multiple fibrils imaged over multiple images.   
This data was used to generate mean and deviation values for the contour length and 
heights of the particles traced (Tables 4.2, 4.3, 4.4)  
 
Figure 4.11 ɴ-Lactoglobulin Fragmentation Residual Monomer Assay 
Left  W Coomassie stained SDS PAGE (Tris-dƌŝĐŝŶĞ ) ŐĞů ƐŚŽǁŝŶŐ Ă ƐĞƌŝĂů ĚŝůƵƚŝŽŶ ŽĨ ɴ-
lactoglobulin and 120µM fibrils and fragmented fibrils centrifuged at 75k rpm with 10µl of the 
very top of the supernatant removed and diluted 1 in 10 for SDS PAGE analysis.  The gel was 
then Coomassie stained.  Right  W Intensity values of the coomassie stained bands, from Aida 
densitometry analysis, plotted against µM concentration of dilution.  Intensity of the 
fragmented and parent fibrils plotted onto the graph.  Equation of line of best fit, y = 140.34x 
- 262.79.  
 
Figure 4.12 ɲ-Synuclein Fragmentation Residual Monomer Assay 
Left  W SDS PAGE (15% Tris-'ůǇĐŝŶĞ )ƐŚŽǁŝŶŐĂƐĞƌŝĂůĚŝůƵƚŝŽŶŽĨɲ-synuclein and 120µM fibrils 
and fragmented fibrils centrifuged at 75k rpm with 10µl of the very top of the supernatant 
removed and diluted 1 in 10 for SDS PAGE analysis.  The gel was then Coomassie stained.  
Right  W Intensity values of the coomassie stained bands, from Aida densitometry analysis, 
plotted against µM concentration of dilution.  Intensity of the fragmented and parent fibrils 
plotted onto the graph.  Equation of line of best fit, y = 10.81x + 0.5979  
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Table 4.3 Table Showing the Height and Weight Average Contour Length 
Details Extracted from the First ɴ-Lactoglobulin Fragmentation 
 
Table 4.2 Table Showing the Height and Weight Average Contour Length 
Details Extracted from the Second Lysozyme Fragmentation 
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The extracted data shows changes in the mean heights and lengths of traced particles over 
the time of fragmentation such as the decrease in weight average contour length for 
ůǇƐŽǌǇŵĞĨƌŽŵ ? ? ? ?A?ŵƚŽ ? ? ? ? ? ?Ŷŵ ?ɴ-lactoglobuůŝŶĨƌŽŵ ? ? ? ?A?ŵƚŽ ? ? ? ? ? ?ŶŵĂŶĚĨŽƌɲ-
synuclein from 1.86µm to 241.84nm.  This decay in contour length can also be observed by 
histograms (Fig. 4.13, 4.14, 4.15, Left). 
 
Table 4.4 Table Showing the Height and Weight Average Contour Length 
Details Extracted from the First ɲ-Synuclein Fragmentation 
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Figure 4.13 Height and Length Distribution of Amyloid Fibrils Analysed from AFM 
Analysis of a Lysozyme Fragmentation Experiment. 
Left   W Extraction of contour length data for the fibrils traced by MatLab from multiple images per 
time-point and plotted as a histogram with weight mean contour length shown with dotted red line 
and value with standard error mean in same colour.  Nfibril is the total number of particles traced to 
give this value.  Inserts were of the contour length region from 250nm to 3500nm with a lower 
normalised frequency to highlight the change in proportion of longer particles.  Right  W The 
distribution of heights of pixels traced by MatLab from multiple images per time point with the 
mean height shown by a dotted red line and the value and standard deviation in the same colour.  
Npixel is the total number of pixels traced to give this data 
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Figure 4.14 Height and Length Distribution of Amyloid Fibrils Analysed from AFM 
ŶĂůǇƐŝƐŽĨĂɴ-Lactoglobulin Fragmentation Experiment. 
Left   W Extraction of contour lengths for the traced fibrils from multiple images per time-point and 
plotted as a histogram, weight mean contour length shown with dotted red line and value with 
standard error mean in same colour.  Nfibril is the total number of particles traced to give this value.  
Inserts: contour length region from 100nm to 2000nm with a lower normalised frequency to 
highlight the change in proportion of longer particles.  Right  W The distribution traced heights with 
the mean height shown by a dotted red line and the value and standard deviation in the same 
colour.  Npixel is the total number of pixels traced to give this data.  The final height graph shows two 
normal distributions, coloured green, fitted to the data highlighting the two different populations 
contained in the sample.  The means of the two populations are also plotted in green. 
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Figure 4.15 Height and Length Distribution of Amyloid Fibrils Analysed from AFM 
ŶĂůǇƐŝƐŽĨĂɲ-Synuclein Fragmentation Experiment. 
Left   W Extraction of contour length data for the fibrils traced by MatLab from multiple images per 
time-point and plotted as a histogram with weight mean contour length shown with dotted red line 
and value with standard error mean in same colour.  Nfibril is the total number of particles traced to 
give this value.  Inserts were of the contour length region from 250nm to 2000nm with a lower 
normalised frequency to highlight the change in proportion of longer particles.  Right  W The 
distribution of heights of pixels traced by MatLab from multiple images per time point with the 
mean height shown by a dotted red line and the value and standard deviation in the same colour.  
Npixel is the total number of pixels traced to give this data. 
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Characterisation of the heights throughout the fragmentation experiment is important for 
subsequent analysis as any change in lateral association and therefore height alters the 
fibril concentration on the mica surface and makes bias correction difficult.  The mean 
ŚĞŝŐŚƚ ŽĨ ůǇƐŽǌǇŵĞ ĂŶĚ ɲ-synuclein fibrils was consistent between experiments and 
remained constant throughout the fragmentation with values of 3.15/3.28nm and 
6.71/7.04nm respectively.  The mean of the mean heights observed through the 
ĨƌĂŐŵĞŶƚĂƚŝŽŶ ĞǆƉĞƌŝŵĞŶƚƐ ǁĂƐ ĐŽŶƐŝƐƚĞŶƚ ďĞƚǁĞĞŶ ɴ-lactoglobulin fragmentation 
experiments with values of 3.93nm and 3.99nm but the shape of the distribution of heights 
showed that this mean is based on a disparity between the beginning and end of the 
fragmentation where the mean height increases during the fragmentation experiment (Fig. 
4.14, Right and 4.16) in both experiments, in fact both fragmentations show a 50% increase 
from the mean of the early time points to the later.  As well as the increase in mean height 
ŽĨ ƚŚĞ ƐĂŵƉůĞ ŽďƐĞƌǀĞĚ ĨŽƌ ƚŚĞ ůĂƚĞƌ ɴ-lactoglobulin fragmentation samples there is an 
increase in the proportion of a thinner subpopulation of particles.  The fitting of two 
normal distributions to the data shows that the thinner materials have a mean of 0.697nm 
and the larger particles have a mean of 4.099nm which is very similar to the mean of the 
entire sample.  The thinner particles formed are potentially protofilaments derived from 
the unentwining of the filaments observed at the beginning of the fragmentation, although 
this does not fit with the assessment that ɴ-lactoglobulin fibrils of this height are 
protofibrils (Schleeger et al., 2013; VandenAkker et al., 2011).  The liberation of these 
particles and then reattachement to the larger particles could give rise to the larger fibrils 
observed, in the later time points.  The process of fragmentation could promote this 
process and would explain the change in height profile during fragmentation.  Analysis of 
the distribution of traced heights (Fig. 4.13, 4.14, 4.15, Right) over the course of the 
ĨƌĂŐŵĞŶƚĂƚŝŽŶƌĞĂĐƚŝŽŶƐĨŽƌůǇƐŽǌǇŵĞĂŶĚɲ-synuclein (Fig. 4.13, 4.15, Right) suggests that 
there is no change in lateral association of the fibrils during fragmentation.  
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4.2.2.3   Analysis of Particle Length Decay During Fibril 
Fragmentation 
To visualise the breakage of fibrils over the course of the fragmentation experiments log-
log plots of the weight average contour length (nm) were plotted against fragmentation 
time, in seconds for every image in both fragmentations for each protein (Fig. 4.17, circles).   
ɴ-Lactoglobulin exhibits a linear decay (Fig. 4.17, middle) for the first part of the 
fragmentation until the point when the distortion in fibril height was observed.  Lysozyme 
ĂŶĚ ɲ-ƐǇŶƵĐůĞŝŶ ĚŝĨĨĞƌ ĨƌŽŵ ɴ-lactoglobulin as they are linear at the end of the 
fragmentation (Fig. 4.17, top and bottom, circles) but appear to have a flatter appearance 
and therefore slower decay at the beginning.  This biphasic rate of decay in weight average 
contour length over the duration of the fragmentation experiment, when visualised on a 
log/log plot, is similar to what is observed in the fragmentatioŶŽĨɴ ?-microglobulin (Xue 
and Radford, 2013).  To remove any skew in the data which could be derived from 
extremely high particles or materials which are less than the ability of the AFM to 
determine if they elongated any particles higher than 99% of the height distribution and 
less than 19nm in length were discarded from the analysis (Fig. 4.17, Top/Middle/Bottom, 
crosses).  The removal of these extremes did not alter the biphasic shape of the decay or 
the weight average contour length values of the samples.  There are two potential sources 
of bias associated with the automated tracing of AFM images which could alter the shape 
 
Figure 4.16 Comparison ŽĨ ƚŚĞ ,ĞŝŐŚƚ ŝƐƚƌŝďƵƚŝŽŶ ŽĨ ɴ-Lactoglobulin Fibrils 
During Different Fragmentation Experiments 
Left  W A plot of the probability of the different heights found in solution, CDF, showing the 
ĚŝƐƚƌŝďƵƚŝŽŶ ŽĨ ŚĞŝŐŚƚƐ ŽďƐĞƌǀĞĚ ŽǀĞƌ ƚŚĞ ĐŽƵƌƐĞ ŽĨ ƚŚĞ ĨƌĂŐŵĞŶƚĂƚŝŽŶ ŽĨ ɴ-lactoglobulin 1, 
with earliest time points in blue/green and the late in red.  Right  W Ɛ >ĞĨƚ ďƵƚ ĨŽƌ ɴ-
lactoglobulin 2.  Early time points in blue progressing to later time points in red. 
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of weight average contour length over fragmentation time decay curve.  Firstly the 
deposition of fragmentation samples onto mica potentially assumes that the affinity of long 
and short particles to the mica surface would be similar, which cannot be assumed.  
Secondly the tracing of fibrils in an AFM scan by the MatLab application can also introduce 
error.  Fibrils deposited onto a surface can overlap with each other, form larger untraceable 
aggregates and cluster together, the MatLab application uses the approximate fibril width, 
ĂŶŐůĞɽĂŶĚĂŚĞŝŐŚƚĐƵƚŽĨĨ ?ǌ ) ?^ĞĞ ? ? ? ? ? ? ? )ƚŽƚƌĂĐĞƚŚĞƉ ƌƚŝĐůĞƐĂŶĚprovide parameters 
for acceptance or failure of the trace.  The process of tracing for long fibrils is more likely to 
fail due to their greater waviness, potential to overlap and becoming part of larger 
aggregates than small particles.  This means that the tracing potentially underestimates the 
influence of longer particles on the population and therefore give rise to a low weight 
average contour length for the image.  This underestimation would be more pronounced at 
early time points than late due to the greater proportion of long particles at this time and 
might add to the biphasic shape of the decay.  To correct for any bias introduced by 
differing affinities and tracing, the deposition of fibrils onto the mica surface must be 
identical throughout the fragmentation experiment.  When this is the case it can be 
assumed that the total length of particles deposited onto the mica surface will be the same 
independent of fragmentation time.  A plot of total length traced against fragmentation 
time will, for an unbiased sample give a flat horizontal line but where bias is incorporated 
will show a greater length of particles traced at later time points.  To assess this bias and 
determine an appropriate weighting for particles of different sizes a MatLab script (Xue, 
unpublished) was used which looks at the weight average contour length and total traced 
length per image to determine an appropriate correction method.  Comparison of the sum 
total contour length of particles on a surface with the weight average contour length of the 
ƐĂŵƉůĞƐŚŽǁƐƚŚĂƚɲ-synuclein and lysozyme are underestimated at the beginning of the 
ĨƌĂŐŵĞŶƚĂƚŝŽŶ ǁŚĞƌĞ ĂƐ ɴ-lactoglobulin is not.  To assess this bias and determine an 
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appropriate weighting for particles of different sizes a MatLab script (Xue, unpublished) 
was used which looks at the weight average contour length and total traced length per 
ŝŵĂŐĞƚŽĚĞƚĞƌŵŝŶĞĂŶĂƉƉƌŽƉƌŝĂƚĞĐŽƌƌĞĐƚŝŽŶŵĞƚŚŽĚ ?ɲ-Synuclein was corrected using a 
linear correction method whilst lysozyme was subjected to a power law correction method 
ĂŶĚĚƵĞƚŚĞůĂĐŬŽĨƐŬĞǁɴ-lactoglobulin observed did not require any correction.   
 
Figure 4.17 Comparison of the fragmentation over time. 
Top  W Lysozyme, Middle  W ɴ-Lactoglobulin and Bottom  W ɲ-Synuclein.  Circles represent uncorrected 
data.  Crosses represent data with small particles removed.  Inverted triangles represent bias 
corrected data.  Blue shapes represent the first fragmentation and red denote the second 
fragmentation. 
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Comparison of this data to the uncorrected data (Fig. 4.17, Top/Middle/Bottom, inverted 
ƚƌŝĂŶŐůĞƐ )ƐŚŽǁƐƚŚĂƚǁŚŝůƐƚƚŚĞĚĂƚĂƉŽŝŶƚƐĨŽƌĞĂĐŚɲ-synuclein and lysozyme particle are 
at a higher weight average contour length the shape of each data remains the same.  
Whilst this plot shows the difference that bias correction has on the weight average 
contour length during the fragmentation the change of the distribution of particle contour 
lengths over the duration of the fragmentation is better described by the cumulative 
density function (CDF) (Fig. 4.18). 
   
Figure 4.18 Cumulative Density Plots Showing the Change in Contour Length 
Population during Fragmentation. 
Left  W Uncorrected data, Right  W Bias Corrected data.  Top  W Lysozyme, Middle  W ɴ-Lactoglobulin and 
Bottom  W ɲ-Synuclein.  Cumulative density for each time point for both fragmentation experiments 
with the earliest time in blue progressing to the late time points in red.  Inserted into each graph is 
ĂŶĞǆƉĂŶƐŝŽŶŽĨƌĞŐŝŽŶƐ ?ƚŽ ? ? ?ĨŽƌɴ-ůĂĐƚŽŐůŽďƵůŝŶĂŶĚůǇƐŽǌǇŵĞĂŶĚ ?ƚŽ ? ? ?ĨŽƌɲ-synuclein. 
 
ƉĂƌƚ ĨƌŽŵɴ-lactoglobulin whose data did not require correction the bias corrected data 
shows an increase in the proportion of longer particles at the early time points in 
comparison to the uncorrected data.  This data shows a more pronounced change than 
when just looking at the weight average contour length (Fig. 4.17) and allows for the rate of 
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change of the population distribution to be assessed.  Ɛɴ-lactoglobulin did not require 
correction the bias corrected data is unaltered but does show that the early timepoints are 
skewed by the presence of small particles which diminish after a short duration of stirring 
(Fig. 4.18, Middle) something which is also visible from the histogram distribution of 
particle contour lengths at the beginning of fragmentation (Fig. 4.14).  
4.2.2.4   Calculation of the Persistence Length (Lp) of Fragmented 
Amyloid Fibrils 
The MatLab analysed fragmentation images allowed calculation of the Lp for the polymers 
observed in the experiments in batches of six using a a Matlab algorithm (Xue unpublished) 
(Table 4.6).  The samples were concatenated and randomised to avoid the different 
fragmentation times skewing the analysis.  The Lp values obtained were then averaged to 
give the Lp for the entire dataset.  
 
In comparison to the data collected in chapter 3, Table 3.1, the persistence length values 
maintain the same ranking with respect to increasing persistence length and similar 
magnitude.  The Lp ǀĂůƵĞƐ ĨŽƌ ĨŝďƌŝůƐ ŽĨ ɲ-synuclein (1754.72nm and 1906.64nm) and 
lysozyme (1259.951nm and 1883.071nm) are similar in their magnitude and therefore 
exhibit similar rigidities.  The Lp ǀĂůƵĞƐĨŽƌɴ-lactoglobulin (2741.92nm and 3780.535nm) are 
more similar to previously calculated values (VandenAkker et al., 2011) than the values in 
chapter 3.  The data collected from the fragmentation experiments allows for a huge 
number of particles to be assessed in the calculation of persistence length, in fact ~1000 
Table 4.6 Table Showing the Calculated Persistence Length for the 
Fragmented Fibrils* 
 
*Where Lp A?ƉĞƌƐŝƐƚĞŶĐĞůĞŶŐƚŚ ?ʍA?ƐƚĂŶĚĂƌĚĚĞviation, NP = Number Particles analysed and 
NI = the number of images scanned. 
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times more particles than the values previously published (Table 3.2).  The AFM images of 
the initial fragmentation time points are in agreement with this observation as lysozyme 
ĂŶĚɲ-synuclein fibrils are observed as long wavy fŝďƌŝůƐǁŚĞƌĞĂƐɴ-lactoglobulin fibrils are 
shorter and straighter (Fig. 4.7, 4.8 and 4.9). 
4.2.2.5   Determination of the Rate of Fibril Fragmentation 
Rather than use an approach requiring a priori knowledge of the fragmentation process 
Xue et al (Xue and Radford, 2013) used a data driven approach determine which model 
best describes the fragmentation of ɴ2-microglobulin fibrils.  By determining lines of best 
fit for the contour length distributions at each time point the ability of each model to depict 
the fragmentation was assessed using Akaike information criterion (AIC) scoring method.  
This method together with the Hill model (Hill, 1983) describing the fragmentation of stiff 
rods was employed to analyse the change in contour length distribution over time 
(Equation 4.1) 
Equation 4.1 Hill Model of the fragmentation of stiff rods* ߢிሺ݅ǡ ݆ሻ ൌ  ߢଵሾ݆ሺ݅ െ ݆ሻሿ఑మିଵ ቈሺ݅ െ ݆ሻ݈݆݊ ൅ ݆݈݊ሺ݅ െ ݆ሻ݅఑మାଵ ቉ 
*Where ߢி= Fragmentation rate, i=total fibre length, j=the fragmented fibre length (see Fig. 4.2), ߢଵ 
and ߢଶ are floating parameters determined quantitatively using maximum likelihood estimations 
derived from contour length distribution derived from AFM images (Hill, 1983; Xue and Radford, 
2013). 
dŚĞ ĐŽŶƚŽƵƌ ůĞŶŐƚŚ ĚŝƐƚƌŝďƵƚŝŽŶƐ ŐĞŶĞƌĂƚĞĚ ĨŽƌ ƚŚĞ ĨƌĂŐŵĞŶƚĂƚŝŽŶ ŽĨ ɴ-ůĂĐƚŽŐůŽďƵůŝŶ ? ɲ-
synuclein and lysozyme (Xue, unpublished) where used in conjunction with the Hill model 
(Hill, 1983) to calculate the constants ߢଵ and ߢଶ (Equation 4.1) required to generate a rate 
of fragmentation for specific lengths of fibril using a Matlab script (Xue, unpublished). 
The Hill model describing the fragmentation of stiff rods was fit to the length distribution 
data by maximum-likelihood estimation method (W. F. Xue, Homans, & Radford, 2009). 
ĞƐƚ Ĩŝƚ ƉĂƌĂŵĞƚĞƌƐ ʃ ? ĂŶĚ ʃ ? ƚŚĞŶ ĚĞƐĐƌŝďĞ ƚŚĞ ĐŚĂŶŐĞ ŝŶƉĂƌƚŝĐůĞ ůĞŶŐƚŚ ĚŝƐƚƌŝďƵƚŝŽŶ
during the fragmentation of the amyloid fibrils observed during the experiments. These 
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best fit parameters described in equation 4.1 were used to determine the rate of 
fragmentation of particle with length i. A plot of the rate of amyloid fragmentation rate 
against the length of the particle gives rise to a graph showing longer particles fragment 
faster than short (Fig. 4.19). 
Over the course of the fragmentation experiment the rate of fibril fragmentation changes 
with longer particles exhibiting a consistent rate until a particle size is formed which is 
more resistant to breakage dominates the population.  At this point a significant drop in 
fragmentation rate is observed (Fig. 4.19), this data is in agreement with the results 
ŽďƐĞƌǀĞĚǁŝƚŚɴ ?-microglobulin (Xue and Radford, 2013). 
 
Figure 4.19 Graph Showing the Relationship of the Fragmentation Rate Constant with 
Fibril Length 
A semi-ůŽŐ ƉůŽƚ ƐŚŽǁŝŶŐ ƚŚĞ ĐŚĂŶŐĞ ŝŶ ĨƌĂŐŵĞŶƚĂƚŝŽŶ ƌĂƚĞ ĐŽŶƐƚĂŶƚ ŽĨ ɲ-synuclein (blue) ? ɴ-
lactoglobulin (red) and lysozyme (green) with fibril length. 
 
Table 4.7 Table showing the Fragmentation rate of the 3 studied proteins at 3µm 
  ɲ-Synuclein ɴ-Lactoglobulin Lysozyme 
Fragmentation 
Rate at 3µm 
0.00002325s-1 0.0000639s-1 0.000016525s-1 
 
Comparison of the fragmentation rate constant for ƚŚĞ ůŽŶŐĞƌ ƉĂƌƚŝĐůĞƐ ƐŚŽǁƐ ƚŚĂƚ ɴ-
ůĂĐƚŽŐůŽďƵůŝŶŝƐŵŽƌĞƐĞŶƐŝƚŝǀĞƚŽďƌĞĂŬĂŐĞƚŚĂŶůǇƐŽǌǇŵĞĂŶĚɲ-synuclein which exhibit a 
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similar rate.  When the fragmentation rates of the longer particles, 3µm, (Table 4.7) are 
compared to the persistence length of the polymer a correlation starts to appear where 
more flexible polymers fragment slower than more rigid polymers (Fig. 4.20). 
 
 
Figure 4.20 Graph Showing the Relationship Between Persistence Length and 
Fragmentation Rate Constant of 3µm Fibrils. 
A log-log plot showing the Fragmentation rate constant of fibrils 3µm in length compared to the 
ƉĞƌƐŝƐƚĞŶĐĞůĞŶŐƚŚŽĨƚŚĞĨŝďƌŝůƐ ?>ǇƐŽǌǇŵĞ ?ŐƌĞĞŶ ) ?ɲ-SynƵĐůĞŝŶ ?ďůƵĞ )ĂŶĚɴ-Lactoglobulin (red). 
4.3   Discussion 
Due to the role amyloid plays in disease, and the physical properties that make them useful 
nanomaterials, it is important to gain an understanding of the role and influence of fibril 
fragmentation on the kinetics of fibril formation, the stability of amyloid fibrils and their 
cytotoxic potential.  AFM imaging is the perfect tool for quantifying changes in fibril 
dimensions for individual particles as well as enabling the deconvolution of fibril properties 
such as persistence length, Lp. 
Although AFM instrumentation is sensitive enough to observe the changes in length and 
height required to delineate the size distribution of particles contained within a sample, the 
development of deposition conditions that allow for optimum particle analysis at the 
beginning and the end of a fragmentation experiment are key to a successful fragmentation 
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analysis.  Examples of where deposition conditions prevent this analysis are insulin B chain 
and Sup35.  The formation of large aggregates from the Sup35NM species formed under 
current conditions makes proper fragmentation analysis impossible.  Insulin B chain 
appears at the onset of mechanical perturbation to be a good candidate for fragmentation 
analysis, but the loss of affinity for the surface during fragmentation means that calculating 
particle distributions for the time points is possible but of limited value.  The loss of affinity 
for the surface and generation of the background observed as insulin B chain fibrils 
fragment suggests that the fragmentation may occur via a different mechanism to that 
ŽďƐĞƌǀĞĚǁŝƚŚůǇƐŽǌǇŵĞ ?ɴ-ůĂĐƚŽŐůŽďƵůŝŶĂŶĚɲ-synuclein fibrils.  
 
dŚĞ ĚĂƚĂ ĞǆƚƌĂĐƚĞĚ ĨƌŽŵ ƚŚĞ ĨƌĂŐŵĞŶƚĂƚŝŽŶ ŽĨ ĂŵǇůŽŝĚ ĨŝďƌŝůƐ ĚĞƌŝǀĞĚ ĨƌŽŵ ůǇƐŽǌǇŵĞ ? ɴ-
ůĂĐƚŽŐůŽďƵůŝŶ ĂŶĚ ɲ-synuclein shows that although these proteins as monomers have 
similar molecular masses, their aggregation into fibrils with the same cross beta sheet 
architecture gives rise to fibrils of different types of different diameters, 3.5nm, 3.9nm and 
~7nm respectively.  It is also evident by comparison with their height with persistence 
length that fibril flexibility is not related to the diameter of the fibril (Table 4.8) and 
therefore monomer size. 
Table 4.8 Table Comparing Height Data and Persistence Length* 
 
*A table showing the height, persistence length, Lp, the number of particles, NP, and number 
of images captured, NI, to calculate this data. 
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dŚĞ ŚĞŝŐŚƚ ŽĨ ƉĂƌƚŝĐůĞƐ ƚŚƌŽƵŐŚŽƵƚ ƚŚĞ ĨƌĂŐŵĞŶƚĂƚŝŽŶ ƌĞŵĂŝŶƐ ƐƚĂƚŝĐ ĨŽƌ ɲ-synuclein and 
ůǇƐŽǌǇŵĞ ďƵƚ ɴ-lactoglobulin shows an increase in fibril height towards the end of the 
experiment.  This increase in height would potentially alter the particles resistance to 
mechanical stress.  The weight average contour length of the images showing deviations in 
the mean height are in the region of the fragmentation where the rate of fragmentation 
was slowing so whilst it potentially affects fragmentation here it is does not interfere with 
the rate observed for longer fibrils. 
In terms of their physical appearance, oncĞĚĞƉŽƐŝƚĞĚŽŶƚŽŵŝĐĂ ?ƚŚĞĨŝďƌŝůƐŽĨɲ-synuclein 
ĂŶĚůǇƐŽǌǇŵĞĂƉƉĞĂƌĨĂƌŵŽƌĞĨůĞǆŝďůĞƚŚĂŶɴ-lactoglobulin due to their propensity to bend 
and form highly coiled structures (Fig. 4.7, 4.9 and 4.20) and is also in agreement with their 
calculated persistence lengths (Lp) 1259.951nm and 1883.071nm for lysozyme, 1754.721nm 
ĂŶĚ  ? ? ? ? ? ? ? ?Ŷŵ ĨŽƌ ɲ-ƐǇŶƵĐůĞŝŶ ĐŽŵƉĂƌĞĚ ƚŽ  ? ? ? ? ? ? ? ?Ŷŵ ĂŶĚ  ? ? ? ? ? ? ? ?Ŷŵ ĨŽƌ ɴ-
lactoglobulin (Table 7).  These values of Lp ƐƵŐŐĞƐƚ ƚŚĂƚ ɴ-lactoglobulin forms stiffer 
polymers than lysŽǌǇŵĞĂŶĚɲ-synuclein. 
The change in the contour length distribution of the fibrillar samples over fragmentation 
time (Fig. 4.21) shows the progression of contour length distribution from longer particles 
to shorter ones over time but visually gives no idea if the rates of change are similar.   
The conversion of these data into fragmentation rate constants allows for the comparison 
of the different proteins fibrils fragmentation propensity as well as the dependency on fibril 
length.  The rate of fibril fragŵĞŶƚĂƚŝŽŶ ? ůŝŬĞ ɴ ?-microglobulin, is dependent on length 
whereby shorter particles are more resistant to breakage than longer particles.  This is in 
agreement with the model proposed by Xue et al (Xue and Radford, 2013) whereby fibril 
breakage occurs centrally, distal from the ends of the fibres.  The smaller the particles the 
closer the middle of the particles is to the end of the fibrils making them more difficult to 
fracture.   
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There appears to be no change in the approximate size where this change in fragmentation 
rate occurs but the initial rates of fibril fragmentation differ between proteins.  The 
difference in resistance to mechanical stress appears to be linked to the fibrils persistence 
ůĞŶŐƚŚǁŝƚŚƚŚĞƌĂƚĞŽĨĨƌĂŐŵĞŶƚĂƚŝŽŶĨŽƌƚŚĞŵŽƌĞƌŝŐŝĚɴ-lactoglobulin being higher than 
that of the more flĞǆŝďůĞɲ-synuclein and lysozyme (Fig. 4.20). 
 
Figure 4.21 Comparison of Initial AFM images and Fragmentation Decay 
Experiments 
Left  W &DŝŵĂŐĞƐŽĨůǇƐŽǌǇŵĞ ?ɴ-ůĂĐƚŽŐůŽďƵůŝŶĂŶĚɲ-synuclein at the start of fragmentation.  
20µm x 20µm at 2048 x 2048 pixel resolution with 1µm scale bar and 1µm insert magnified x 
5 with a 200nm scale bar.  dŚĞŚĞŝŐŚƚƐĐĂůĞƐĨŽƌɴ-lactoglobulin and lysozyme are set between 
- ?ĂŶĚ  ?ŶŵĂŶĚ ƚŚĞɲ-synuclein is set between -10 and 10nm.  Right  W Cumulative density 
plots showing the change in contour length distribution from the beginning of the 
fragmentation (blue lines) to the end (red lines). 
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Figure 4.22 Comparison of the Kinetic Data and Persistence Length Data from this 
Thesis with the B2m data of Xue et al (Xue and Radford, 2013). 
Top  W A semi log plot showing the dependence on fragmentation rate constant on the length of 
amyloid fibrils, as 4.19 but including the data for B2m (yellow).  Bottom  W A log-log showing how the 
persistence length of the polymer affects the fragmentation rate constant, as 4.20 but including the 
data for B2m (yellow). 
 
When this data is compared to the previously published data regarding the fragmentation 
of B2m fibrils the correlation between the persistence length, Lp, of the particle and their 
resistance to mechanical stress continues (Fig. 4.22).  The relationship between Lp and 
resistance to mechanical stress in the model systems so far analysed is linear with higher 
values of Lp giving rise to species more sensitive to mechanical stress (Fig. 4.23).  The 
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correlation of Lp with resistence to mechanical stress can also be considered in combination 
with the work of vandenAkker et al (VandenAkker et al., 2011), previously discussed in 
chapter 3, ǁŚŽƐŚŽǁ ?ǁŚĞŶ ŝŶǀĞƐƚŝŐĂƚŝŶŐɴ-lactoglobulin only, that there is a relationship 
between persistence length and the proportion of cross-beta sheet contained within the 
structures.  An increase in cross-beta sheet proportion observed in the sample, by 
vibrational sum frequency generation, was shown to give rise to more rigid particles and 
therefore higher persistence length.  In fact, the source of fibril flexibility has been further 
elucidated to be from the interactions between atoms in the cross-beta and not the 
sidechains of the amyloid fibrils (Knowles et al., 2007a).  Whilst this analysis does work for 
amyloid derived from large protein molecules it does pose the question as to what this 
means for small amyloidogenic peptides whose proportion of cross beta sheet in the 
sample is much higher due to much less sequence redundancy in the amyloid core.  These 
materials should therefore exist as straight fibres with high persistence length and this is 
indeed the case for TTR(105-110) (Knowles et al., 2007b) and ILQINS (Lara et al., 2014).  The 
link between structure and persistence length highlights a potential link between the 
molecular structure of fibrils, their resistance to mechanical stress and therefore 
cytotoxicity. 
To conclude, this work has developed a comparative method for the assessment of amyloid 
fibrils resistance to mechanical stress.  The results of this analysis has shown the 
importance of imaging conditions on determining fragmentation rates but more 
importantly shows that polymer diameter, monomer size and rigidity are unrelated.  The 
rate of amyloid fibril fragmentation for the proteins analysed in this thesis follows the same 
ĚĞƉĞŶĚĞŶĐǇŽŶůĞŶŐƚŚĂƐɴ ?-microglobulin.  The agreement of this data with the previously 
published fragmentation mechanism (Xue and Radford, 2013) adds weight to their 
mechanism.  The most important finding is the observation that the rate of fragmentation 
for longer particles is influenced by the Lp of the polymers such that more flexible fibrils are 
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more resistant to mechanical stress than rigid fibrils (Fig. 4.23) and therefore the molecular 
structure of the polymers (VandenAkker et al., 2011).  Whilst there appears to be a 
correlation of Lp with different fragmentation rates the deviation in values is relatively 
small (10-4 to 10-5s-1) which can be due to them having the same generic cross-beta sheet 
structure (Knowles et al., 2007a).  It would be interesting to observe if this correlation is 
amyloid specific or observed in other materials whether they be synthetic or biological for 
example (Knowles and Buehler, 2011) or the materials highlighted in Fig. 3.34. 
The linearity of the relationship between persistence length and fragmentation rate of long 
particles for the four proteins so far studied by this method suggests that it is possible to 
predict the fragmentation rate of amyloid fibrils using their calculated persistence length or 
even their proportion of cross-beta sheet. 
 
 
Figure 4.23 Fragmentation Rate of Amyloid Fibrils Dependent on the Persistence 
Length of the Polymer 
Cartoon showing the fragmentation of flexible amyloid fibrils with low Lp values on left and rigid 
amyloid fibrils with higher Lp values on the rate.  The fragmentation rate for the more rigid particles 
is higher for the more rigid particles as signified by the different sizes of the arrows. 
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4.4   Future Work 
Increasing the number of model systems investigated will allow further confidence to be 
built in the correlation between Lp and the fragmentation rate constant for longer particles 
persists with a larger data set.  This could also be supplemented by studying the 
fragmentation of other synthetic and biological materials with different Lp and core 
structures.  
Also of interest would be to examine the the effect of altering fragmentation conditions on 
the kinetics of breakage to see if the order of resistance is maintained. 
The development of this technique and fibril formation conditions for proteins such as 
Sup35 will hopefully lead to the potential of examining the rate of biologically relevant 
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5.1   Introduction 
Chemical biology is at the interface of chemistry, biology and biochemistry and utilises 
synthetic chemistry to understand biological processes, and covers many areas of scientific 
research such as bioconjugation, proteomics, affinity enrichment and genetic engineering.  
In particular chemical biology has found utility in drug discovery research where 
bioconjugation and genetic engineering is used to generate chemically enhanced biologics 
such as antibody drug conjugates (ADC) (Agarwal and Bertozzi, 2014) and when applied to 
proteomics/affinity enrichment allows the optimisation of small molecule therapeutics by 
highlighting drug-target co-localistion, and drug binding sites (Bunnage et al., 2013, 2015). 
The ability to modify biomolecules with different functionality such as fluorescent dyes, 
radioactive isotopes, enrichment tags and pharmaceutically active molecules is important 
to these endeavours.  Bioconjugation allows the modification of biomolecules by reacting 
functional groups in the molecule with appropriate functionality in another molecule, for 
this to be successful the coupling reactions need to be compatible with the aqueous 
environment that biomolecules typically exist in.  Traditional labelling strategies utilize the 
reactivity of amino acids, for example amide coupling between amines and activated 
 
Figure 5.1 Picture Highlighting the Complexity of Bioorthogonal Labelling 
For a bioorthogonal reaction the conversion of A and B into a molecule A-B must occur in the 
presence of numerous reactive functional groups.  Adapted from Sletten and Bertozzi (2009). 
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carboxylic acids and reaction of the highly nucleophilic sulphur in cysteine residues (Chalker 
et al., 2009).  The prevalence of these functional groups in biology makes them useful but is 
also their main limitation due to a lack of specificity and selectivity. 
 
The absence of specificity in these reactions has led to the development of bioorthogonal 
chemistries, reactions that are compatible with aqueous environments and react 
specifically with their coupling partner even in the presence of the other functional groups 
observed in nature (Fig. 5.1) 
These bioorthogonal chemistries are typically based on classic synthetic reactions and 
commonly follow the rules set out by Kolb et al (2001) in their definition of a click reaction.  
The reactions must be: 
x Modular 
x Wide in Scope 
x High Yield 
x Stereo and Regiospecific 
x Easily purified from inoffensive by products 
Bioorthogonal reactions often utilise functional groups which are unknown in nature for 
example azides (Fig. 5.2, C) and alkynes (Fig. 5.2, B and D).  The reaction of an azide and an 
alkyne was first published in 1893 by Arthur Michael (Michael, 1893) before it was shown 
to occur via a [4 + 2] cycloaddition mechanism by Rolf Huisgen in 1963 (Huisgen, 1963).  In 
its original form the reaction does not comply with the parameters required for a click 
reaction due to the high temperature required to effect the transformation and the 
generation of two 1,2,4 triazole regioisomers (1,4 and 1,5).  The copper(I) catalysed 
reaction, now synonymous with the click reaction, was published simultaneously in 2002 by 
Sharpless and Meldal (Rostovtsev et al., 2002; Tornøe et al., 2002) and allowed for the 
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generation of a single 1,2,4 triazole regioisomer, 1,4, (Fig. 5.2, A) at room temperature in an 
aqueous environment.  This reaction is by far the most common bioorthogonal reaction 
ĂŶĚ ŝƐ ĐŽŵŵŽŶůǇ ƚĞƌŵĞĚĂ  ‘ĐůŝĐŬ ? ƌĞĂĐƚŝŽŶďƵƚŚĂƐ ƌĞĐĞŶƚůǇďĞĞŶ relabelled Copper Azide 
Alkyne Cycloaddition, CuAAC, to avoid confusion with other reactions.   
 
Concerns over the toxicity of the catalytic Cu(I) species to biological systems has led to the 
development of a cycloaddition reaction which does not require catalysis.  By incorporating 
the alkyne component into an eight-membered carbocycle (Fig. 5.2, D), which is higher 
energy than a straight chain alkyne, allows the original Huisgen cyclisation to occur at room 
temperature, in water and without catalysis.  This Strain Promoted Azide-Alkyne 
ǇĐůŽĂĚĚŝƚŝŽŶ ?^W )ŚĂƐďĞĞŶŬŶŽǁŶƐŝŶĐĞƚŚĞ ? ? ? ? ?Ɛ(Wittig and Krebs, 1961) but with 
the current interest in bioorthogonal processes has undergone a renaissance.  In this 
biological context it was first used by Agard et al to label azide modified cell surface glycans 
(Agard et al., 2004) but until recently (Gröst and Berg, 2015) it has not fulfilled all the 
requirements of a click reaction as like the original thermally driven reaction it gives rise to 
a mixture of regioisomers (Fig. 5.2, D), although its ease of use has not stopped its 
utilisation (Fig. 5.2). 
 
Figure 5.2 The differences between CuAAC and SPAAC 
The reaction of an azide with an alkyne in the presence of a copper catalyst at room 
temperature, CuAAC, gives rise to only the 1,4-substituted 1,2,3-triazole (left).  The 
incorporation of ring strain into the alkyne molecule creates a higher energy substrate which 
reacts with the azide at room temperature without catalysis but gives a mixture of 
regioisomers. 
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To utilise these bioorthogonal chemistries the appropriate functionality needs to be 
incorporated into the molecule of interest whether that be in vivo or in vitro.  The methods 
for incorporation of these unnatural functionalities into biomolecules can be split into 4 
main groups: Genetic, Chemical, Expressed Protein Ligation and Enzymatic. 
Genetic  W rDNA technology (see Fig. 3.1) is generally used to generate recombinant 
proteins and has enabled, within the confines of natural amino acids, the ability to modify 
proteins with functionality that aide in their isolation and alter their physical properties.   
 
By recoding rare codons, for example AGG (Lee et al., 2015), an amber stop codon, TAG 
(Chin et al., 2003), or even incorporating a quadruplet codon (Anderson et al., 2004; 
Neumann et al., 2010) it is possible, by supplementing the cell with the genetic information 
required for the synthesis of an engineered tRNA/tRNA synthetase pair, to site specifically 
incorporate unnatural functionality into recombinantly produced proteins (Dumas et al., 
2014; Wang et al., 2009a; Xie and Schultz, 2005) (Fig. 5.3). 
 
Figure 5.3 Schematic showing Potential Uses of the Genetic incorporation of 
Unnatural Amino Acids 
The incorporation of an unnatural amino acid into a protein, see centre picture, can be 
utilised to probe the reactivity, interactions and activity of proteins.  Adapted from (Dumas et 
al., 2014). 
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Chemical  W As discussed previously in this chapter (5.1) the unspecific and unselective 
reaction of the functionality in biomolecules can give rise to a mixture of labelling products.  
By genetic incorporation or utilisation of a pre-existing highly reactive and low abundance 
amino acid  ?WĞ ?ĞƌĞƚĂů ? ? ? ? ? ? ), such as cysteine, it is possible to achieve more selectivity in 
labelling procedures.  Cysteine for example reacts quickly with many electrophilic reagents 
which other cellular functionality react slowly with or not at all for example maleimides and 
ɲ-iodoacetyl functional groups.  It is possible to use this reactivity to generate materials 
which incorporate unnatural functionality by utilising compounds that contain traditional 
reactive partner and unnatural functionality, so called adaptor reagents, (Chalker et al., 
2009; Thompson et al., 2014).  When utilising cysteine mutants this process is essentially 
site selective but suffers from the propensity of thiol groups to oxidise to form a disulphide 
bond which is no longer reactive towards electrophiles. 
Expressed Protein Ligation  W The formation of a peptide (amide) bond during translation 
involves the reaction of the primary amine of the amino acid in the A site of the ribosome 
with the thioester linkage betwen the peptide chain and the tRNA in the P site of the 
ribosome.  The thioester acts as an activated ester which allows the amine to attack the 
electrophilic carbon centre of the thioester.  The process of protein splicing also utilises the 
formation of thioester linkages to combine two protein fragments together with excision of 
an intein.  During splicing a cysteine residue at the N terminus of the intein attacks the 
neighbouring amide bond in the protein to give a thioester which then exchanges with a 
thiol in the second extein before the intein is eliminated and acyl groups shifts from sulphur 
to nitrogen, S-N acyl shift, yeilding the spliced protein (Xu and Perler, 1996).  Expressed 
Protein Ligation (EPL) utilises an intein fusion which is not followed by a second cysteine 
containing extein to promote its elimination from the protein.  Disruption of the splicing 
enables the process to be commandeered by exogenous modified thiols and allows for a 
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site specific modification of the protein at either terminus (Jagadish et al., 2013; Muir et al., 
1998). 
Enzymatic  W The modification of proteins in vivo is central to many cellular processes from 
regulation (phosphorylation) to protein decomposition (ubiquitinylation) but the 
appendage of these molecules to the protein is catalysed by the action of enzymes such as 
kinases (phosphorylation) and ubiqutin transferases (ubiqutin).  By hijacking this process 
and utilising modified substrates containing unnatural functional groups it is possible to 
incorporate unnatural functionality, in a site specific manner, enabling further modification.  
Examples of enzymes whose substrates have been modified in this way include Sortase 
(Schmohl and Schwarzer, 2014; Tsukiji and Nagamune, 2009), Farnesyl transferase 
(Rashidian et al., 2010, 2013a), Acetyl transferase (Yang et al., 2013) and glycosidases 
(Rashidian et al., 2013b; Wu et al., 2015). 
Utilisation of these technologies has the potential for unlocking the secrets of biomolecules 
but also for the incorporation of functionality and properties which make them more useful 
to the pharmaceutical and nanotechnology industry. 
5.2   Chapter Aims 
The aim of this chapter is to develop a flexible, ideally unselective, chemical labelling 
strategy capable of attaching varied functional groups onto amyloid fibrils pre- and post- 
fibril assembly and then generate particle size information from DOSY NMR 
experimentation and image the fluorescently labelled particles. 
The modification of fibrils, pre and post assembly, with altered chemical functionality 
allows numerous applications.  This chapter will aim to develop strategies for analysis of 
particle size by different methods such as NMR and fluorescence microscopy.  The 
development of solution based methods for size determination, such as NMR, is important 
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to supplement imaging methods like AFM where surface deposition may introduce error or 
not be possible as observed with the fragmentation of insulin B chain (4.2.1.2). 
The large number of 1H nuclei present in protein molecules makes their associated NMR 
spectra very complicated; this complexity can be reduced by the attachment of NMR active 
nuclei which are less prevalent in nature, such as 19F.  By attaching a 19F nuclei to a protein, 
and utilising pulsed field gradient (DOSY) NMR it is possible to calculate the hydrodynamic 
radius of the material offering a further method of calculating particle size distributions. 
The covalent attachment of fluorescent dyes to fibrils allows for the localisation of fibril 
aggregates when transferred to biological systems as well as offering an alternative method 
of detection. 
5.3   Chemical Labelling Strategy 
To enable the flexible modification of fibrils pre/post assembly and include a linker unit, a 
two step chemical labelling strategy was envisaged which would first utilise reactive 
centres contained within all proteins such as amines (lysine) and thiols (cysteine) before 
allowing selective modification with bioorthogonal chemistry to incorporate the final 
functionality.  The initial labelling strategy for protein monomers is dependent on the 
amino acid residues contained within the protein sequence, for example the presence of 
reduced cysteines.  Fibril assembly after this first modification would generate fibrils 
activated toward secondary modification whereas modification pre-assembly would give 
fully functionalised fibrils after polymerisation. 
The popularity of bioorthogonal reactions has increased the toolbox available for the 
second, bioorthogonal, labelling step (Shih et al., 2014) but by far the most popular choice 
of bioorthogonal transformation is the [3+2] cycoladdition between an azide and an alkyne, 
the click reaction.  The popularity of this reaction has caused a surge in the amount of 
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commercial reagents that are available containing either of the prerequisite functional 
groups and makes the click reaction an obvious choice for the second labelling step. 
As the main aim of this work was the development of a labelling strategy for the 
incorporation of 19F atoms for detection by NMR it was imperative that the 19F be visible to 
experiment.  The slow tumbling of large molecules in the time frame of NMR spectroscopy 
causes line broadening and eventual disappearance of signal, even for molecules far 
smaller than amyloid fibrils.  Although signal decreases with slower tumbling proteins 
certain regions of protein exhibiting more conformational motility than the bulk of the 
protein show enhanced signal (Baldwin et al., 2008; Platt et al., 2009).  To mimic this effect 
the first and second labelling step must incorporate a linker which confers conformational 
motility to the 19F nuclei from the amyloid core of the protein. 
Modified fibrils would then be subjected to AFM analysis, NMR analysis and fluorescent 
microscopy, with attention being paid to successful incorporation of the fluorescent 
monomers into the fibril architecture to confirm labelling integrity. 
5.4   Results 
5.4.1   Conjugation of Lysozyme 
The commercial availability of lysozyme offers the advantage of being able to modify the 
protein easily in large quantities and as such was an ideal model system for chemical 
labelling.  
The amino acid sequence of lysozyme shows the presence of six lysine residues (red) and 
eight cysteine residues (green) (Fig. 5.4).  Initially a promiscuous labelling strategy which 
could label all amyloidogenic proteins was sought.  Due to the relative abundance of lysine 
compared to cysteine in proteins and that the cysteine residues contained within lysozyme 
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are part of disulfide bonds, a lysine modification strategy was selected for the initial 
modification.  
 
5.4.1.1 Amide Formation Ȃ Amine plus NHS ester 
The most common method of amine modification is by conversion to an amide through 
reaction with an activated carboxylic acid.  To incorporate conformational motility and 
introduce a click coupling partner onto the lysozyme molecule, a polyethyleneglycol 
reagent with an azide group at one terminus and an N-hydroxysuccinimide (NHS) activated 
carboxylic acid at the other (Fig.5.5, 1, Compound ii, Pierce PI26131). 
Treatment of lysozyme, dissolved in pH7 phosphate buffered saline, with the acylating 
reagent gives rise to a distribution of acylation products ranging from a single modification 
to multiple additions (Fig. 5.5, B).  Incorporation of too many groups onto the protein 
structure resulted in the formation of less soluble material in subsequent steps.  The use of 
1.1 to 1.3 molar equivalents of the acylating reagent leaves some residual unmodified 
protein but yields mostly monoacylated material with small amounts of bis-modified 
material as determined by ES(MS) (Fig. 5.5, B). 
The incorporation of azide functionality onto lysozyme molecules for click labelling still 
leaves the choice of both CuAAC and SPAAC click derivatives as potential labelling methods.  
The conversion of lysozyme monomer to fibrillar material requires heating in pH2 HCl, 
conditions which are unsuitable to many of the commercial cyclooctyne reagents required 
KVFGRCELAA AMKRHGLDNY RGYSLGNWVC AAKFESNFNT QATNRNTDGS 
TDYGILQINS RWWCNDGRTP GSRNLCNIPC SALLSSDITA SVNCAKKIVS 
DGNGMNAWVA WRNRCKGTDV QAWIRGCRL 
Figure 5.4 The Amino Acid Sequence of Lysozyme with Reactive Side Chains 
Labelled 
The amino acid sequence of lysozyme with the side-chain amines (lysine) marked in red and 
the side-chain thiols (Cysteine) marked in green.  The eight cysteine residues all form part of 
the secondary structure of the protein forming four disulfide bonds: C6  W C127, C30  W C115, 
C76  W C94, C64  W C80 
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for SPAAC labelling leaving CuAAC as the best method for secondary labelling in this 
instance. 
 
5.4.1.2   Fluorescent Labelling of Lysozyme 
 
CuAAC conversion requires the insertion of catalytic Cu(I) species into the acetylene C-H 
bond before reaction with the azide functionality (McKay and Finn, 2014).  Typical reaction 
conditions to effect the transformation utilise a Cu(II) salt which is reduced in situ by 
sodium ascorbate or triscarboxyethylphosphine and the incorporation of a tristriazole 
ligand which stabilises the Cu(I) species (McKay and Finn, 2014; Presolski et al., 2011).  To 
investigate the conditions required for successful CuAAC, a fluorescent alkyne synthesised 
according to (Xu and Ye, 2011) was utilised (Fig. 5.6, A, Compound ii).  Successful 
incorporation of the fluorescein moiety could not be confirmed by a decrease in 
 
Figure 5.5 Reaction Scheme Showing Modification of Lysozyme with NHS PEG 
N3 and MS Analysis of Product 
A - Cartoon scheme showing an example modification of one lysine residue in the lysozyme, 
PDB 4RLM, structure (i) with an NHS activated PEG azide reagent (ii, Pierce PI26131) to give 
the azide modified product (iii).  B  W Deconvolution of ES(MS) spectra of lysozyme modified 
with 1.3eq of acylating reagent in pH7 phosphate buffer.  The deconvoluted spectra shows 
m/z, where z=1 and therefore each value is a molecular weight of a product in solution. 
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electrophoretic mobility on Tris-Tricine SDS PAGE (Fig. 5.6, B) but fluorescent scanning of 
the gel shows the attachment of fluorescent functionality to the protein (Fig. 5.6, C).  
  
Fluorescent scanning also shows the aggregation of lysozyme into dimeric, trimeric species.  
Confirmation that the dye labelling was via a Cu(I) catalysed process and not a non-specific 
interaction was confirmed by combining the lysozyme azide and FITC alkyne in the absence 
of copper (Fig. 5.6, D and E, lane 2).  The modified lysozyme material was purified from 
excess FITC alkyne by ethanol precipitation.  Electrospray mass spectrometry analysis did 
not give the correct mass ion for the product but in fact gave a fragment ion, 14984Da, 
where the fluorescein isothiocyanate residue had been eliminated from the molecule, 
leaving the triazolyl methylamine attached to the protein. 
 
Figure 5.6 Reaction Scheme of Click Reaction with FITC Alkyne and SDS PAGE 
Analysis 
A - Cartoon scheme showing modification of azido lysozyme with the FITC alkyne reagent.  B  W 
SDS PAGE Tris-Tricine gel coomassie stained showing modification of lysozyme and then click 
reaction with FITC alkyne.  C  W Fluorescence analysis of the same gel.  D  W SDS PAGE Tris 
Tricine gel which is coomassie stained. 1 Unpurified click reaction with FITC alkyne, 2  W 
Lysozyme-N3 and FITC alkyne in the absence of Cu(I), 3  W Purification of click reaction with 
FITC alkyne by ethanol precipitation.  E  W As D but with the gel is fluorescently scanned. 
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The inclusion of lysozyme FITC conjugates into fibrillar species was achieved by 
incorporating the fluorescent material into a fibril formation with the unmodified lysozyme 
monomer in a ratio of 1:12, such that the total protein concentration was 699µM.   
 
 
Figure 5.7 AFM Analysis of Fluorescent Fibrils 
A  W 10µm x 10µm AFM image at 1024 x 1024 pixels resolution with 1µm scale bar and an 
insert of 1µm x 1µm magnified x 5 with a 200nm scale bar showing purified unfragmented 
fluorescent fibrils.  The height scale of the image is set between -5 and 5nm.  B - 10µm x 
10µm AFM image at 1024 x 1024 pixels resolution with 1µm scale bar and an insert of 1µm x 
1µm magnified x 5 with a 200nm scale bar showing purified fluorescent fibrils sonicated at 
20% amplitude for 1min with 5 second bursts.  The height scale of the image is set between -5 
and 5nm.  C  W 10µm x 10µm AFM image at 1024 x 1024 pixels resolution with 1µm scale bar 
and an insert of 1µm x 1µm magnified x 5 with a 200nm scale bar showing unpurified 
fluorescent fibrils sonicated at 20% amplitude for 1min with 5 second bursts.  The height scale 
of the image is set between -5 and 5nm.  D  W Semi-denaturing detergent agarose gel 
electrophesis of A, B and C compared to lysozyme FITC conjugate and unpurified material, 
imaged by fluorescent scanning. 
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Utilising conditions shown to polymerise unmodified lysozyme, heating to 60oC for 6 days 
in acidic medium, the mixture was converted to its amyloid form.  Confirmation that the 
conditions had led to the formation of fibrillar material was achieved by AFM analysis of 
the reaction (Fig. 5.7, A).  AFM analysis of the reaction confirms the presence of fibrils from 
this reaction but not of the fluorescence of the fibrils.  To confirm incorporation of the 
fluorescent material into the fibrillar species, semi-denaturing detergent agarose gel 
electrophoresis (SDD-AGE) was undertaken, showing that not all material was incorporated 
into the fibrillar structure, even after purification.  However, the fluorescence of material 
which did not enter the gel fully is evidence of incorporation of fluorescent material into 
large aggregates (Fig. 5.7, D lane unpurified no sonication).  As the fibrillar aggregates (Fig. 
5.7, A) are too large to enter the gel, the materials were subjected to sonication for 1 
minute to give smaller fibril fragments (Fig. 5.7, C).  The sonicated particles were then able 
to enter the gel and gave rise to a smear on the SDD-AGE (Fig. 5.7, D, lane C).  
To clean the material for SDD-AGE analysis, the fibrillar material was purified by 
centrifugation of the sample at 75k rpm for 15 mins, removal of the supernatant and then 
resuspension of the pellet in fresh pH2 HCl.  This method was an effective means of 
purifying the fibrillar material from smaller molecules although modified monomeric 
material could still be observed in these samples (Fig. 5.7, D lane A).  AFM analysis showed 
that purification did not alter the parent fibrils (Fig. 5.7, A) and that the sonication 
conditions also afforded the same materials (Fig. 5.7, B) as those that ǁĞƌĞŶ ?ƚƉƵƌŝĨŝĞĚ ?&ŝŐ ?
5.7, C).  SDD AGE analysis of the purified unfragmented fibrils did not enter the gel (Fig. 5.7, 
D, lane A) and sonication allowed entry to the gel and gave a smear through the gel (Fig. 
5.7, D, lane B) 




The confirmation of the incorporation of the fluorescent material into the fibrillar species 
gave confidence in the process so that it could be transferred to an NMR active labelling 
strategy. 
5.4.1.3   19F Labelling of Lysozyme for NMR Studies 
NMR has become a standard biochemical tool due to the prevalence of NMR active 
elements such as hydrogen, carbon, nitrogen and phosporous in the structure of 
biolmolecules.  The hydrogen nucleus is the only one of these elements whose naturally 
abundant isotope, 1H, is NMR active.  As all protons in a molecule give rise to a signal the 
complexity of a 1D 1H spectrum for a biomolecule is extreme.  This complexity can be 
reduced by combining experiments with less abundant nuclei such as 15N and 13C after the 
material is produced in an isotopically enriched form.  Utilising less abundant nuclei 
increases the cost and complexity of sample preparation but provides valuable structural 
information by simplifying the spectra and showing molecule connectivity.  Fluorine has a 
single isotope (19F) which is NMR active and not commonly found in biological systems 
making it an ideal nuclei for simplifying spectra whilst, depending on method, still giving 
structural information (Marsh and Suzuki, 2014).  The attachment of conformationally 
flexible protein domains (Baldwin et al., 2008) or caps (Platt et al., 2009) to proteins has 
allowed NMR to be used to monitor the diffusion of amyloid fibrils.  The diffusion of 
molecules in solution is inherently linked to their size, where smaller molecules diffuse 
faster than larger ones.  The rate of diffusion is therefore a characteristic of a molecule and 
is termed the Diffusion coefficient, D.  The relationship between size/hydrodynamic radius 
(Rh) and the diffusion coefficient of spherical materials is described by the Stokes-Einstein 
equation (Equation 5.1). 
Diffusion-ordered spectroscopy is a solution NMR technique which utilises a pulsed field 
gradient, Fig. 5.8, to separate components of a mixture according to their diffusion 
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coefficient (Morris, 2007).  As the nuclei of molecules act as tiny magnets when they are 
placed into a magnetic field they will first align with the magnetic field and then move 
towards the magnet.  By subjecting the sample to increasing magnetic field strength 
smaller materials will move towards the magnet faster than larger materials.  This 
difference in diffusion means that the intensity of the peaks associated with the materials 
will decrease at different speeds. 
 
Figure 5.8 Example of a stegp1s1d DOSY NMR pulse sequence 
A magnetised sample is excited by 90o radiofrequency bursts (Top) and also subjected to magnetic 
ĨŝĞůĚďƵƌƐƚƐ ?ŽƚƚŽŵ )ŽĨĚŝĨĨĞƌĞŶƚƉŽǁĞƌƐĨŽƌĚĞĨŝŶĞĚ ƵƌĂƚŝŽŶŽĨƚŝŵĞ ? ?ɷ ) ? dŚĞĚĞůĂǇďĞƚǁĞĞŶƚŚĞ
ŵĂŐŶĞƚŝĐ ĨŝĞůĚ ŐƌĂĚŝĞŶƚ ďƵƌƐƚƐ  ?ȴ ) ĂůůŽǁƐ ĚŝĨĨƵƐŝŽŶ ŽĨŵŽůĞĐƵůĞƐ ?  ^ŵĂůůĞƌŵŽůĞĐƵůĞƐ ĚŝĨĨƵƐĞ ĨĂƐƚĞƌ
than large molecules which means that the signal intensity for large molecules is maintained 
through the gradient whereas the signal for small diminishes. http://www.chemie.uni-
hamburg.de/nmr/insensitive/tutorial/en.lproj/stegp1f.html 
The decrease in observed signal intensity during a pulsed field gradient NMR experiment is 
related to the diffusion coefficient, D, by the Stejskal-Tanner equation (Equation 5.2) 
(Stejskal and Tanner, 1965). 
 
ܦ ൌ ߢܶ ?ߨߟܴ௛  
Equation 5.1 Stokes-Einstein Equation 
tŚĞƌĞŝƐƚŚĞŝĨĨƵƐŝŽŶĐŽĞĨĨŝĐŝĞŶƚ ?ʃA?ŽůƚǌŵĂŶŶĐŽŶƐƚĂŶƚ ?dA?ďƐŽůƵƚĞdĞŵƉĞƌĂƚƵƌĞ ?< ) ?ɻ
= Viscosity and Rh = Hydrodynamic radius. 
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The decay in NMR signal, I, as magnetic field gradient increases can be calculated and 
plotted against the magnetic field gradient strength, g, using a simplified Stejskal-Tanner 
equation (Equation 5.3). 
 
Equation 5.3 allows for the deconvolution of the constant C using internal standards of 
known diffusion coefficient, D.  With an internal standard which decays to give a known 
diffusion coefficient such as dioxane, DDioxane, it is possible to calculate the constant c ( 
C=c*D) and therefore enables characterisation of the diffusion coefficient of the other 
materials in the sample.  Incorporation of a second reference material containing both 
hydrogen and fluorine atoms, for example trifluoroethanol (TFE), allows the use of DDioxane 
to calculate the diffusion coefficient of unknown fluorinated materials. 
The incorporation of a 19F containing group allows the diffusion of fibrils to be monitored 
using far simpler spectra than that obtained using 1H NMR.  To maximise the signal 
observed in the 19F NMR a commercial label that contained six electronically equivalent 
fluorine atoms, 1-ethynyl-3,5-bis(trifluoromethyl)benzene - (CF3)2 alkyne (Fig. 5.9, 1, 
Compound B) was used.  
ܫ ൌ ܫ଴ ൈ ݁൫ି஼௚మ൯ Equation 5.3 Simplified Stejskal-Tanner Equation Where c = a constant for the experimental conditions and C is the value extracted from fitting the Stejskal-Tanner equation to the acquired data. 
 ܥ ൌ ሺߛଶߜଶሺ ? െఋଷሻሻ ൈ ܦ 
ܫ ൌ ܫ଴ ൈ ݁ቆିఊమఋమ௚మ஽൬ ? ఋିଷ൰ቇ 
Equation 5.2 Stejskal-Tanner Equation 
Where I = Intensity, Io A?dŽƚĂů/ŶƚĞŶƐŝƚǇ ?ɶA?ŐǇƌŽŵĂŐŶĞƚŝĐƌĂƚŝŽŽĨƚŚĞŶƵĐůĞŝƐƚƵĚŝĞĚ ?ɷA?ƚŚĞ
ƉƵůƐĞĚƵƌĂƚŝŽŶ ?ȴA?ƚŚĞŝŶƚĞƌǀĂůďĞƚǁĞĞŶƉƵůƐĞƐ ?ŐA?DĂgnetic field gradient strength and D = 
the Diffusion Coefficient. 
 




By using the reaction conditions previously identified for successful modification of 
lysozyme azide with fluorescein alkyne the (CF3)2 alkyne was substituted into the reaction 
(Fig. 5.9, A).  Confirmation of ligation was achieved by ES(MS) (Fig. 5.9, B) as no change in 
band position was observed by SDS PAGE analysis.  The modified protein was converted 
into a fibrillar state using conditions previously confirmed using the fluorescent analogues 
(5.4.1.2).  A ratio of modified to unmodified monomer of 1:5 was employed in the fibril 
forming experiment.  An overall protein concentration of 699µM was heated to 60oC in pH2 
HCl for 6 days.  The successful formation of amyloid fibrils was determined by AFM analysis 
and showed formation of similar fibrils to the unmodified fibrils (Fig. 5.9).  
To maximise the potential for successful DOSY analysis of amyloid fibrils, the size of the 
parent fibril was reduced by subjecting the fibril solution to fragmentation by stirring for 45 
hours at 1000rpm using an IKA Squid and confirmed by AFM analysis (Fig. 5.10). The same 
fragmentation was undertaken for unlabelled fibrils for comparison (Fig. 5.10). 
 
Figure 5.9 Click Modification of Lysozyme Azide with 1-ethynyl-3,5-
bis(trifluoromethyl)benzene 
A  W Cartoon scheme showing the modification of lysozyme azide (i) with 1-ethynyl-3,5-
bis(trifluoromethyl)benzene (ii) to give an 19F NMR active lysozyme (iii).  B  W Electrospray 
analysis of the conversion showing some unmodified lysozyme remaining but with the 
replacement of the azide lysozyme with the bis(trifluoromethyl) compound. 




The fragmented fibrils were then treated with D2O (for locking of the NMR signal), dioxane 
(1H internal standard) and TFE (19F internal standard) before NMR analysis.  1H NMR spectra 
of the fibrillar and monomeric samples show a change in the peak distribution across the 
spectra and therefore the structure of the protein contained in the sample (Fig. 5.11).  
Comparison of the unmodified lysozyme fibrils with modified lysozyme fibrils shows no 
change although this is not surprising as the modified material only makes up 20% of the 
total sample. 
 
Figure 5.10 AFM Analysis of 
19
F Labelled Fibrils and Unlabelled Fibrils 
20µm x 20µm scans at 2048 x 2048 pixel resolution with 1µm scale bar and a 2µm2 insert 
magnified x5 with 200nm scale bar.  The height scales for the images are set between -5 and 
5nm.  Top  W Unlabelled fibrils: Left  W Parent fibrils, Right  W Fragmented fibrils.  Bottom  W 19F 
labelled fibrils: Left  W Parent fibrils, Right  W Fragmented fibrils. 
 






It is important that the concentration of the internal reference standard is sufficient for the 
DOSY analysis.  At a concentration similar to the protein concentration the dioxane 
(3.75ppm) (Fig. 5.11) signal is visible and the decay measurable but the TFE signal 
(3.88ppm) is completely obscured.  Due to the sample signal intensity observed in the 19F 




F NMR Analysis of Modified Monomeric and Fibrillar Lysozyme 
The higher spectra shows the monomeric 19F labelled lysozyme where as the lower spectra is 




H NMR Comparison of Modified Fibrillar and Monomeric Lysozyme 
The Lower spectra shows the proton spectra for modified monomeric lysozyme which has 
been non-specifically modified with NHS-PEG N3 (516µM) and the upper spectra shows the 
modified monomer incorporated into a fibril formation with unmodified fibrils (699µM).  The 
DProtein region marked in both spectra are the regions which were analysed during the 
magnetic field gradient. 
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TFE with a different internal standard with 1H signals in a region not normally occupied by 
protein protons, 4,4,4-trifluorobut-2-enol (TFBenol), avoided the problem of 1H peak 
visibility (Fig. 5.13, higher).  
 
The 19F spectra for these materials show peaks in the appropriate region for an aromatic 






F Spectra of Labelled Lysozyme Fibrils with TFBenol 
Reference Sample 
19F labelled fibrils (699µM) containing TFBenol, TFE and dioxane references were analysed by 







































In Magnetic Field 
Gradient 
A  W A plot of I/Io 
against Magnetic Field 
Gradient Strength 
showing the decay of 
protein signal and 
internal standards: 
dioxane, TFBenol and 
TFE. 
B  W A plot of 
ln(I/Io ) ?ɲ2ɴĂŐĂŝŶƐƚ'2 
showing the decay of 
protein signal and 
internal standards: 
dioxane, TFBenol and 
TFE 
1  W Decay of 19F signal 
of 1 in 5 labelled 
Lysozyme fibrils 
containing TFBenol and 
TFE. 
2  W Decay of 19F signal 
of 1 in 5 labelled 
Lysozyme fibrils 
containing TFE. 
3  W Decay of 19F signal 
of monomeric  






































In Magnetic Field 
Gradient 
A  W A plot of I/Io against 
Magnetic Field Gradient 
Strength showing the 
decay of protein signal 
and internal standards: 
dioxane, TFBenol and 
TFE. 
B  W A plot of ln(I/Io ) ?ɲ2ɴ
against G2 showing the 
decay of protein signal 
and internal standards: 
dioxane, TFBenol and TFE 
1  W Decay of 1H signal of 1 
in 5 labelled Lysozyme 
fibrils containing TFBenol 
and dioxane. 
2  W Decay of the 1H signal 
of modified containing  
Lysozyme monomer 
containing  dioxane. 
3  W Decay of 1H signal of 
unmodified Lysozyme 
fibrils containing dioxane. 
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Table 5.1  Table Comparing Extracted Values of C with Derived Diffusion Coefficient 
Values DParticle* 
 
*Table showing the C values extracted from the fitting of the Tanners Stejkland equation to the 
experimental data.  By comparison with the known diffusion coefficient of dioxane, DDioxane = 1.16e
-9, 
the Diffusion coefficient of the unknown samples were calculated.  Where the 1H signal of the TFE 
signal is obscured the diffusion coefficient calculated by comparison to TFBenol was used to 
estimate DTFE, see red text, and used to calculate the diffusion coefficient of the modified protein 
samples.   
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The TFE fluorine signal (-76.618ppm) and TFBenol reference in both 1H and 19F and (1H 
6.575-6.513ppm 5.958-5.875ppm and 19F -63.549ppm) material in the sample is obvious 
(Fig. 5.12 and 5.13, lower) as is the decrease in signal intensity and change in peak shape 
observed on conversion from monomeric protein to fibrillar aggregate (Fig. 5.12).   
The lower intensity observed in the fibrillar sample is explained by a decrease in 
conformational motility as the polymeric species is formed.  The TFBenol reference gives 
rise to 1H peaks that are discrete from protein peaks but the 19F reference peak is very close 
to the sample signal due to the CF3 group being attached to an SP2 carbon centre like in the 
label. 
Due to the lack of baseline resolution between the internal references and the protein 
signals the value of C for dioxane was a source of error.  An absence of baseline resolution 
also obscured the 1H TFE signal, to calculate diffusion coefficients in samples containing TFE 
the DTFE value calculated by comparison with the DTFBenol value in the 
19F fibril sample was 
used to estimate values in other experiments (table 1, red text).  To avoid this problem an 
alternative method of calculating the diffusion coefficient by plotting ቀ ூூ೚ቁ Ȁߙଶߚ against 
G2 ?ǁŚĞƌĞɲA?ɷ ?ɶĂŶĚɴA?ȴ- ɷ ? ? ) ?Őŝǀes a straight line with a gradient of -Dparticle.  The signal 
observed for the reference samples is lost by 50% gradient strength therefore the line 
fitted to the decay is skewed by the later data.  The line of best fit is therefore only 
calculated for the portion of data which gives rise to a decrease in signal (sample column of 
Table 5.1). 
The absolute method of analysis of 19F and 1H data appears to give rise to values correlating 
to larger species than the comparative method in all cases see table 5.1.  Whilst there 
appears to be a difference in size between monomer and fibrils in the 1H data this is less 
apparent in 19F spectra as adjudged by Dprotein values, 
1H  W 3.58x10-10 and 19F  W 2.9x10-11.  
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The difference between the fibrillar and the monomer samples diffusion coefficient is small 
and not in line with the significant change in size associated with fibril assembly. 
As discussed in chapter 3 the formation of fibrillar materials from lysozyme at pH2 and 60oC 
is a hydrolytic process in which the peptide backbone of the protein is broken to give 
smaller peptide fragments.  The hydrolysis of the labelled monomer during fibril formation 
means that the label is potentially lost from the protein during aggregation and this 
liberated material is free diffuse throughout the solution unrestricted by the amyloid core. 
Due to the intensity of the observable 19F signal the acquisition time associated with each 
gradient point are extremely long meaning that a full 19F experiment takes about twenty 
four hours and is too long to be a practical in these circumstances. 
The hydrolytic mechanism of fibril formation as well as the long acquisition times 
associated with lysozyme requires the use of another model system with alternative 
characteristics. 
5.4.2   Conjugation of Sup35NM 
Proteins which convert to fibrils at pH7 suffer from the complication that their production 
and purification is often in competition with their aggregation.  As discussed in chapter 3 
the purification of Sup35 and the truncated form Sup35NM is achieved under denaturing 
conditions.  Due to the protection from aggregation that guanidine provides post 
purification and the higher expression yield, Sup35NM was an ideal substrate for chemical 
labelling experiments.  Another aspect which makes Sup35 an ideal substrate for this 
experiment is the structure of the fibrillar materials.  It has previously been shown that the 
N domain is responsible for fibril formation and that the flexible M and structured C 
domains are pointed away from the core into solvent (Baxa et al., 2011) and therefore 
potentially containing conformational motility not observed in the fibril core. 
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5.4.2.1   Site specific labelling Ȃ Sup35NM model system 
To take advantage of the conformational motility proposed to exist in the M domain of 
Sup35NM site specific modification of the C terminus of the protein was performed by 
placing a cysteine residue at the end of the polypeptide.   
To increase conformational motility, an extra linker between the M domain and the 
cysteine was incorporated based on the amino acid sequence, GSGGSGGSG, shown to 




Appendage of the desired linker and cysteine to the Sup35NM sequence to give Sup35NM 
LCys, was achieved by PCR amplification of the Sup35NM sequence with primers encoding 
the tag.  The DNA containing this sequence was then digested and ligated into an empty 
 
Figure 5.17 Purification Profile of Sup35NM LCys 
Left  W Äkta elution profile for Sup35NM LCys.  The denaturing purification of all Sup35 related 
materials gives similar profiles with the left handside of the peak containing the purest 
protein.  Right  W SDS PAGE analysis of the fractions eluted from the column with the 
monomeric protein and dimeric protein highlighted.  The DTT sample is that of material 
eluted from the NiNTA column and then treated with DTT showing that the higher molecular 






Figure 5.16 Amino Acid Sequence of Modified Sup35NM Protein, Sup35NM 
LCys 
The Sup35NM amino acid sequence is supplemented by the addition of a linker previously 
shown to exhibit conformation flexibility, GSGGSGGSG, highlighted in red and the addition of 
a single cysteine residue, text in purple, to the C terminus. 
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pET15b vector before transformation into Top10 E.coli strain for plasmid replication.  The 
vector was then transformed into BL21 [DE3] pLysS E.coli for protein expression induced by 
the addition of 1mM IPTG for four hours. 
The expression and purification of Sup35NM LCys under denaturing conditions gave rise to 
the formation of a product with approximately the correct size, 31257Da as seen on SDS 
PAGE, with a by product roughly twice the size that would not be removed by further size 
exclusion chromatography (Fig. 5.17).  This dimeric product is formed through disulphide 
formation and could be reduced to monomer by treatment with DTT. 
5.4.2.2   Sup35NM LCys Azide Incorporation 
 
Commonly used reducing agents such as dithiothreitol (DTT) and 
triscarboxyethylphosphine (TCEP) are highly nucleophilic and require removal before 
subsequent treatment with an electrophile.  To avoid gel filtration and dilution post 
reduction a resin immobilised phosphine reagent, TCEP, was used to reduce the impurity 
prior to conjugation reaction. 
 
Figure 5.18 Reaction Scheme Showing the Reaction of the Cysteine residue 
with the Iodoacetamide Reagent 
Reaction of the C terminal cysteine residue in Sup35NM LCys protein (Blue square) (A) with an 
Iodoacetamide derivative containing an azide (B) which incorporates the azide onto the 
protein (C). 
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There are two common conjugation chemistries utilised for thiol modification: thiol 
ƌĞĂĐƚŝŽŶǁŝƚŚɲ-iodo acetate derivatives or addition to double bonds in conjugation with a 
ĐĂƌďŽŶǇů ? ƐƵĐŚ ĂƐ ŵĂůĞŝŵŝĚĞƐ ?  ɲ-Iodo acetate reagents where chosen as the coupling 
partner due to their common usage under denaturing conditions for the capping of 
cysteines in proteomic experiments whilst maleimides propensity to ring open in the 
presence of some nucleophiles suggested some stability issues. 
dŚĞ ĂǌŝĚŽ ĨƵŶĐƚŝŽŶĂůŝƐĞĚ ɲ-iodoacetamide (Fig. 5.18, Compound B) used to modify the 
cysteine residue contained a small PEG unit to further increase conformational motility (Fig. 
5.18) and was synthesised from the appropriate azido amine and N-hydroxysuccinimide 
ĂĐƚŝǀĂƚĞĚɲ-iodo acetic acid. 
Residual alkylating agent was removed by Äkta purification using a HiLoadTM 16/600 
SuperdexTM 200pg column in 6M guanidine based buffer which also removed some residual 




Figure 5.19 Purification of Alkylated Sup35NM LCys with Iodoacetyl N3 
Right - HiLoadTM 16/600 SuperdexTM 200pg column Äkta purification profile of the alkylation 
reaction of Sup35NM LCys with Iodoacetyl azide reagent.  Left - SDS PAGE analysis of the 
fractions taken from the Äkta purification showing removal of lower molecular weight 
impurities and the absence of dimer from the mixture.  Fractions 11-15 were combined for 
further reaction. 
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5.4.2.3   Sup35NM LCys N3 Modification Through Click Chemistry 
Modification of the Sup35NM LCys N3 was possible through CuAAC reaction similar to the 
modification of lysozyme but due to the milder aggregation conditions of Sup35NM the 





Figure 5.21 Comparison of Sup35NM LCys N3 Reactivity Towards CuAAC and 
SPAAC Reactions.  
Left  W Coomassie stain of gel showing the modification of Sup35NM LCys N3 with FITC Alkyne 
or BCN FITC for different amounts of time and reagent.  Right  W Fluorescent scan of the same 
SDS PAGE showing reaction of Sup35NM LCys N3 with fluorescent reagents.  Lane 1 = Ladder, 
2 = Sup35NM LCys N3, 3 = 10eq of BCN FITC for 1 hour, 4 = 10eq of FITC alkyne for 1 hour, 5 = 
10eq of BCN FITC for 2 hours, 6 = 10eq of FITC alkyne for 2 hours, 7 = 10eq of BCN FITC for 4 
hours, 8 = 10eq of FITC alkyne for 4 hours, 9 = 5eq of BCN FITC for 4 hour and 10 = 5eq of FITC 
alkyne for 4 hours 
 
Figure 5.20 Scheme Showing the Potential Fluorescent Modification of 
Sup35NM LCys N3 through SPAAC and CuAAC Chemistry 
Reaction scheme showing the reaction of azide modified Sup35NM LCys (A) with a FITC 
modified with a strained alkyne (SPAAC) (B) or a terminal alkyne (CuAAC) (C) to yield  
fluorescent protein products. 
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As with lysozyme, fluorescent click reagents were used to monitor the success of protein 
modification and subsequent fibril formation (Fig. 5.20).  Reaction of BCN FITC (SPAAC), 
generated by reaction of BCN amine with FITC, (Fig. 5.20, Compound B) and FITC alkyne 
(CuAAC) (Fig. 5.20, Compound D) with Sup35NM LCys N3 under the same conditions used 
for lysozyme were monitored over time by SDS PAGE.  Coomassie staining of the gel shows 
no change in electrophoretic mobility for all reactions but the fluorescence scan shows that 
even after 1 hour the SPAAC conditions are far superior to the CuAAC conditions (Fig. 5.21).  
The ratio of observed signal in the SPAAC reactions to the CuAAC reactions shows that the 
SPAAC reactions were % more effective than the CuAAC reactions. 
5.4.2.4   Sup35NM LCys N3 BCN FITC Assembly into Amyloid Fibrils 
The conversion of the Sup35NM LCys N3 BCN FITC conjugate to the amyloid state was 
initiated by buffer exchange into 20mM sodium phosphate buffer, 50mM sodium chloride 
at pH7 to remove the guanidine and any excess small molecule label from the SPAAC 
reaction.  The assembly conditions were identical to those used for unmodified Sup35NM,  
10µM protein concentration at 30oC and the assembly kinetics were monitored by ThT 
fluorescence (Fig. 5.22). 
The lag phase for unseeded polymerisation was about 10 hours similar to that observed 
with unmodified Sup35NM (See 3.2.1.2.2) and 19F modified Sup35NM (Fig. 5.27).  The 
increase in fluorescence intensity observed over the duration of the fibril formation was 
four times higher than baseline compared with unmodified Sup35NM and 19F modified 
Sup35NM where the increase observed was 8 fold.  The difference in signal is due to the 
emission of bound ThT occurring at 482nm which is in the absorbance range of the FITC dye 
conjugated to the protein causing the emission of light to be red shifted, lowering the 
observed signal. 






Figure 5.23 AFM Analysis of Sup35NM LCys N3 BCN FITC Aggregates 
AFM images all of 2 x 2µm areas at 204.8 x 204.8 pixel resolution with a 500nm scale bar.  The 
height scale for the images is set between -60 and 60nm and the peak force error is set 
between -200mV and 200mV.  A  W Height channel information of unsonicated aggregates.  B  W 
Peak force channel of unsonicated aggregates.  C  W Height channel of aggregates which had 
been sonicated for 4 mins with 5 second bursts in an ice bath.  D  W Peak force information of 
the same sample as C. 
 
Figure 5.22 Kinetics of Sup35NM LCys N3 BCN FITC Aggregation 
10µM Sup35NM LCys N3 BCN FITC was treated with ThT and the increase in fluorescence 
monitored.  3 replicates were run of each experiment and then blank corrected.  Red samples 
were unseeded polymerisation and blue samples were seeded polymerisation with sonicated 
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AFM analysis of the polymers formed in the assembly reaction shows a large mass of fibrils 
(Fig. 5.23, A and B) similar to that observed when unmodified Sup35NM and Sup35NMC 
aggregate (see 3.2.1.2.2).  The fragmentation pattern observed (Fig. 5.23, C and D) also 
follows that observed with the unmodified Sup35NM fibrils (see 4.2.1.1, Fig. 4.1) 
The residual monomer concentration in the assembly reaction was measured by 
centrifugation at 75krpm for 15 mins and loading of the supernatant onto and SDS PAGE 
ŐĞů ?dŽĐŽŶĨŝƌŵƚŚĂƚŵŽŶŽŵĞƌŝĐƉƌŽƚĞŝŶǁĂƐŶ ?ƚpelleted under these conditions two serial 
dilutions were run, one of which had been centrifuged (Fig. 5.24, lanes 2-6) and the other 
not (Fig. 5.24, lanes 7-9).  Coomassie stain (Fig. 5.24, left) showed no residual monomer in 
the centrifuged fibril sample (Fig. 5.24, lane 10) but fluorescent scan shows no monomeric 
Sup35NM LCys N3 BCN FITC remained in solution but the formation of lower molecular 
weight fluorescent material not present in the starting material.  This suggests that after 
fibril assembly the unprotected region of the monomer is susceptible to hydrolysis, 
liberating smaller fluorescent materials. 
 
 
Figure 5.24 Sup35NM LCys N3 Assembly Residual Monomer Assay 
Fibril solution (10µM) were centrifuged at 75krpm and then load onto an SDS PAGE, lane 10.  
A centrifuged monomer serial dilution was also loaded: 7µM (lane 2), 3.5µM (lane 3), 1.75µM 
(lane 4), 0.875µM (lane 5) and 0.44µM (lane 6).  An uncentrifuged serial dilution was loaded: 
7µM (lane 7), 3.5µM (lane 8) and 1.875µM (lane 9). 
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Although some hydrolysis of the protein post fibril formation was observed the bulk of 
fluorescence was still attached to the fibrillar material, the combined concentration of the 
lower bands is equal to approximately 5µM protein concentration meaning 5µM remains 
attached to the protein.  Confirmation of the retention of fluorescence post assembly was 
achieved by confocal imaging of fluorescent fibrils deposited onto a mica surface attached 
directly to a microscope slide and shows the large fluorescent clumps with a similar size to 
the aggregates observed on the mica surface by the optical microscope (Fig. 5.25).  
Comparison of the AFM images (Fig. 5.23) of the large aggregates observed in the AFM 




Figure 5.25 Confocal Microscopy of Sup35NM LCys N3 BCN FITC Fibrils 
3 confocal images with 10µm scale bars showing the prescence of large fluorescent clumps.  
In the bottom right a representative image of Sup35NM fibril clumps on the mica surface 
using the optical microscope, scale bar 1mm. 
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5.4.2.5   19F Labelling of Sup35NM LCys N3 
The successful fluorescent labelling strategy and fibril incorporation allowed 
implementation of the method for incorporation of 19F substituents.  To incorporate the 
same electronically equivalent trifluoromethyl groups, used in CuAAC labelling, into a 
reagent applicable for SPAAC chemistry 3,5-Bis(trifluoromethyl)phenyl isothiocyanate was 
reacted with BCN amine to furnish an appropriately modified reaction partner, BCN (CF3)2 




Figure 5.27 SDS PAGE Analysis of the Conversion of Sup35NM LCys to Sup35NM 
LCys N3 BCN (CF3)2 
1 - Coomassie stain of SDS PAGE showing the conversion of Sup35NM LCys (B) to Sup35NM 
LCys N3 (C) and then finally modified with fluorinated reagents to give Sup35NM LCys N3 BCN 
(CF3)2 (D) with a ladder as reference material (A).  2  W Deconvoluted ES(MS) spectra (CF3)2 
modified Sup35NM showing the presence of the desired modification but also some residual 
starting material. 
 
Figure 5.26 Reaction Scheme Showing the Modification of Sup35NM LCys N3 
with BCN (CF3)2 
Scheme showing the conversion of Sup35NM LCys N3 (blue box) (A) with a BCN reagent 
containing two electronically equivalent CF3 groups (B) to give a 19F NMR active protein (C). 
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Using the same conditions used for BCN FITC attachment the BCN (CF3)2 was reacted with 
Sup35NM LCys N3 (Fig. 5.26).  Due to the relatively small changes in size associated with the 
modification no change in electrophoretic mobility was associated with modification (Fig. 
5.27, Left) but successful attachment of the label was confirmed using ES(MS) (Fig. 5.27, 2), 
although there is some of the starting material remaining.  Comparison of the ion intensity, 
as the starting material and the product are very similar, suggests that the reaction has 
gone approximately 50% to completion. 
5.4.2.6   Assembly of Sup35NM LCys N3 BCN (CF3)2 into Amyloid 
Fibrils 
Assembly of the 19F labelled Sup35NM was implemented using the same conditions utilised 
for unmodified Sup35NM for FITC labelled Sup35NM with the kinetics monitored by ThT 
fluorescence (Fig. 5.28) and showed a similar profile to previous Sup35NM and the FITC 
derivative.  
 
AFM analysis of the material generated in the assembly reactions shows the formation of 
large masses of fibrils (Fig. 5.28, A and B) comparable with what is observed during the 
 
Figure 5.28 Kinetic Analysis of Sup35NM LCys N3 BCN (CF3)2 Fibril Formation 
10µM Sup35NM LCys N3 BCN (CF3)2 was treated with ThT and the increase in fluorescence 
monitored.  3 replicates were run of each experiment where the yellow samples contained no 





















Chapter 5: Chemical Labelling of Amyloid Fibrils and its Application to Size Determination 
 
190 
polymerisation of unmodified Sup35NM (see 3.2.1.2.2) and Sup35NM LCys N3 BCN FITC 
(Fig. 5.22).  When subjected to sonication for 4 mins on ice in 5 second bursts the large 
aggregate of fibrils were broken in to small nicely dispersed particles (Fig. 5.29, C and D) 
which are different to what is observed from Sup35NM and Sup35NM FITC fragmentation 
and more similar to what is observed with other proteins. 
 
5.4.2.7   NMR Analysis of 19F Labelled Sup35NM 
Analysis of the 19F NMR spectrum of the fragmented fibrillar samples gave no evidence of 
any signal other than the reference materials.  1H NMR analysis though did show the 
presence of a large number of signals which due to the conditions should be associated 
with fibrils, although the potential hydrolysis observed in Fig 5.24 could also explain this.  
 
Figure 5.29 AFM Analysis of Sup35NM LCys N3 BCN (CF3)2 
AFM images all of 5 x 5µm areas at 512 x 512 pixel resolution with a 1µm scale bar.  A  W 
Height channel information of unsonicated aggregates.  The height scale is set between -60 
and 60nm.  B  W Peak force channel of unsonicated aggregates.  The peak force error scale is 
set between -200 and 200mV.  C  W Height channel of aggregates which had been sonicated for 
4 mins with 5 second bursts in an ice bath.  The height scale is set between -10 and 10nm.  D 
 W Peak force information of the same sample as C.  The peak force error scale is set between -
50 and 50mV. 
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Subjecting the 1H NMR signal to a magnetic field gradient strength showed a decay in signal 
(Fig. 5.30, A) and by comparison of the decay of the region between 0.5 and 1.0ppm to the 
dioxane signal decay gives a diffusion coefficient for the particle (Fig. 5.30, B)  of 5.94 x 10-
10m2s-1 (Table 5.2).  Calculation of DProtein by absolute method (Fig. 5.30, C) gave a value of 







H DOSY NMR Analysis of Sup35NM LCys N3 BCN (CF3)2 Fibrils 
A  W Decay of 1H proton NMR spectra of Sup35NM LCys N3 BCN (CF3)2 fibrils (10µM) as 
magnetic field strength increases.  B  W Plot of the decay of of the region between 0.7 and 
1ppm using a plot of I/Io against G.  C  W As B but plotting ln(I/Io ) ?ɲ2ɴǀƐ'2. 
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As for the lysozyme model the comparative method for Sup35 is likely to be 
underestimated due to the lack of baseline resolution for the internal standards.  No 
monomer comparison was available due to the ability of Sup35 to polymerise under 
ambient conditions.   
 
5.5   Discussion and Conclusion 
The modification of amyloidogenic proteins using bioorthogonal reactions enables the 
addition of a large range of functionality to materials and in the cases investigated here 
does not interfere with the assembly of monomeric proteins into their fibrillar state. 
The understanding of which protein region is susceptible to cross-beta sheet formation is 
imperative for a site selective modification strategy where wrong placement could 
potentially inhibit polymerisation.  In the case of Sup35NM the C domain and the C 
terminus of the M domain had previously been shown to be remote from the cross-beta 
sheet and therefore were an ideal target for modification and formed fibrils similarly to the 
unmodified monomer.  However, when information regarding the active fibril forming 
region is unknown the promiscuous approach still offers potential as a method due to the 
randomness of labelling minimising any potential blocking of monomer interactions as 
observed by the successful modification of lysozyme fibrils. 
The success of the workflow post fibril assembly is dependent on the choice of model 
system and the potential use of the fibrillar material.  Fluorescence labelling of fibrils has 
utility in vivo and is a very good method for confirmation of reaction with azide modified 
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protein monomer but it also gives a degree of confidence in fibril modification that could 
not be achieved using other methods.  The generation of fluorescent fibrils was observed 
for both lysozyme and Sup35NM where the attachment of the fluorophore and continued 
attachment post assembly gave rise to fluorescent fibrils (Fig. 5.7 and 5.24).  Due to the 
hydrolytic mechanism associated with conversion of lysozyme monomer to fibrils under 
high temperature and acidic conditions (Lara et al., 2014), the degree of label lost from the 
fibril core during assembly could not be controlled or determined.  Comparison of the 
labelled monomer to the fibrillar form pre and post purification by SDD AGE show the 
liberation of fluorescent material (Fig. 5.7 D).  After extended heating the fibrils derived 
from lysozyme contain the ILQINS amino acid sequence (Fig. 5.31) but conversion to fibrils 
is not delayed until this peptide is eventually formed.  As hydrolysis occurs the lysozyme 
structure is loosened such that amyloidogenic regions are exposed and allowed to interact.  
The progression towards ILQINS fibrils is therefore a gradual process where peptides are 
liberated from the unprotected non cross-beta sheet core, as shown by the different size 
peptides contained in the fibril core (Lara et al., 2014).  The result of this is that some 
modification remains attached to the fibrils even when a hydrolytic mechanism is used but 
the confidence in labelling and the concentration of said label is impossible to measure.  
 
Although the much milder conditions associated with Sup35NM aggregation should limit 
hydrolysis, the SDS PAGE based residual monomer assay (Fig. 5.24) showed evidence of 
post assembly hydrolytic process where large regions of the C domain were lost from the 
KVFGRCELAA AMKRHGLDNY RGYSLGNWVC AAKFESNFNT QATNRNTDGS 
TDYGILQINS RWWCNDGRTP GSRNLCNIPC SALLSSDITA SVNCAKKIVS 
DGNGMNAWVA WRNRCKGTDV QAWIRGCRL 
Figure 5.31 The Amino Acid Sequence of Lysozyme with Reactive Side Chains 
and Amyloid Sequence labelled. 
The amino acid sequence of Lysozyme with the side-chain amines (lysine) marked in red and 
the side-chain thiols (cysteine) marked in green.  The eight cysteine residues all form part of 
the secondary structure of the protein forming four disulfide bonds: C6  W C127, C30  W C115, 
C76  W C94, C64  W C80.  The amino acid sequence shown to form the amyloid core of pH2 heat 
formed lysozyme fibrils (Lara et al., 2014) is highlighted in cyan. 
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fibrils but confocal imaging of the large aggregates deposited on mica show attachment of 
fluorophore to fibrils (Fig. 5.25).  Unfortunately confocal microscopy of fluorescent 
lysozyme fibrils proved difficult even though SDD AGE confirmed fluorescent dye 
attachment to the fibrils. 
Despite the success of the chemical labelling strategies the conversion of this into a robust 
solution based method for the assessment of particle size of amyloid fibrils by 19F NMR has, 
so far, proved elusive.  The choice of protein model system is imperative.  The addition of a 
19F containing molecule to the C terminus of Sup35NM with a further conformationally 
flexible linker was expected to give the requisite flexibility for NMR visibility but no signal 
was observed.  The lack of signal could be due to the C-terminus of the protein M domain 
not being completely exposed to solvent, the linker groups interacting with the protein or 
the hydrophobic label group burying itself into the protein structure and therefore not 
tumbling independently of the protein.  The presence of 1H signal in the Sup35NM samples 
suggests that some regions of the fibrils do exhibit conformational freedom, with DProtein = 
1.053 x 10-10m2s-1 ?  ZĞƉůĂĐĞŵĞŶƚ ŽĨ ƚŚĞ ƚĞƌŵ  ?ʋɻZh in the Stokes-Einstein equation 
(Equation 5.1) with fT, the friction coefficient of translation, utilised by Baldwin et al 
(Baldwin et al., 2008) to calculate lengths from a diffusion coefficient for a fibrillar sample 
by analogy with a rod (Equation 5.4) it is possible to calculate an expected diffusion 
coefficient for a sample imaged by AFM (Fig. 5.32, A, B, C). 
 
Incorporation of the calculated DProtein value into the Stejskal-Tanner equation allows a 
predicted decay curve to be calculated (Fig. 31, D).  Surprisingly, there is close correlation 
between the decay observed experimentally by NMR and the decay predicted by 
்݂ ൌ  ?ߨߟܮቆ  ?݈݊൫ܮ ݎൗ ൯ െ  ?Ǥ ?ቇହ 
Equation 5.4 Calculation of Friction Coefficient For a Rod of Dimension L and r 
tŚĞƌĞɻA䄀 ǀŝƐĐŽƐŝƚǇ ?>A䄀 ĨŝďƌŝůůĞŶŐƚŚĂŶĚƌA䄀 ĨŝďƌŝůƌĂĚŝƵƐ ?ŚĞŝŐŚƚ ) 
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conversion of mean fibril length into diffusion coefficient.  Comparison of this data with a 
prediction of the monomer derived from a predicted Rh (Fig. 31, D) shows that the decay is 
very similar to the fibril prediction and experimental data. 
 
The similarity of the experimental data to both the monomer and the predicted 
translational motion of the fibrils make it difficult to assess if the 1H signal observed in the 
fibril solution is due to monomer or fibril.  The residual monomer assay for the fluorescent 
 
Figure 5.32 Prediction of NMR Signal Decay for Sup35NM Fibrils 
A  W A 5µm x 5µm image at 512pixel x 512 pixel resolution with 1µm scale bar of fragmented 
Sup35NM LCys N3 BCN (CF3)2.  B  W Fibril length distribution calculated by MatLab analysis of 
the full 10µm x 10µm image observed in A.  C  W Fibril Height distribution calculated by MatLab 
analysis of the full 10µm x 10µm image observed in A.  D  W A plot of I/Io against G showing the 
experimental decay of of labelled fibrils (red), the prediction derived from AFM particle size 
analysis (blue), the predicted decay of monomeric Sup35NMLCys (from the Stokes-Einstein 
equation and Rh=4.75N
0.29 where N = number of residues) (green) and the internal reference 
material (cyan). 
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fibrils (Fig. 5.24) shows that the percentage conversion to fibrils is 100% which would 
suggests that the diffusion is related to fibrils but could also be due to the smaller protein 
liberated from the protein.  The absence of 19F signal suggests that the fluorinated signal is 
not tumbling in a time frame conducive to NMR analysis.  The observation of 1H signal is 
potentially explained by regions of protein having enhanced conformational motility to 
even the C terminus of the protein where the 19F group is attached.  Promiscuous labelling 
of the protein may well allow incorporation of 19F groups onto flexible regions of the 
protein. 
Due to the lack of confidence in the consistency of modified lysozyme fibrils the observed 
19F signal was placed in doubt, the value of DProtein extracted from the 
19F spectra is not 
dissimilar to the monomeric species (Table 1).  Using the mean height (Fig. 5.33, C) and 
fibril length (Fig. 5.33, B) of fragmented lysozyme fibrils derived from AFM (Fig. 5.33, A) in 
conjunction with the Baldwin (Baldwin et al., 2008) equation for determination of ்݂ a 
diffusion coefficient of 1.905 x 10-12m2s-1 would be expected, significantly different to what 
is observed.  The signal decay of the prediction shows significant difference between the 
observed and expected decay. 
The incorporation of internal standards into the DOSY experiment allows for simpler 
estimation of the diffusion coefficient of the other components of the sample but the 
choice of reference is important.  Utilisation of TFBenol as a reference sample gives 1H 
signals with complete baseline resolution with most biomolecules and is therefore an ideal 
reference.  TFE and dioxane suffer from the drawback of not having any 1H baseline 
resolution due to overlap with amino acid side chain signals. 
The strategy of utilising 19F spectra for DOSY analysis does much simplify the analysis of the 
samples in terms of phasing, baseline correction and integration so is of benefit to the 
analysis.  The fact that all parts of the protein contain protons means that it is far more 
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likely to observe conformationally flexible regions and suggests that a promiscuous 
labelling strategy may well be better for achieving flexibility of the 19F label. 
 
To conclude the chemical labelling strategy for the modification of amyloid fibrils is 
successful and enables the flexible functionalisation of monomers.  The fluorescent 
analogues of these materials aide visualisation and in the case of Sup35NM have potential 
 
Figure 5.33 Prediction of NMR Decay for Lysozyme Fibrils 
A  W A 5µm x 5µm image at 512pixel x 512 pixel resolution with 1µm scale bar of fragmented 
lysozyme (CF3)2 fibrils.  B  W Fibril length distribution calculated by MatLab analysis of the full 
10µm x 10µm image observed in A.  C  W Fibril Height distribution calculated by MatLab 
analysis of the full 20µm x 20µm image observed in A.  D  W A plot of I/Io against G showing the 
experimental decay of of labelled fibrils, the prediction derived from the AFM and the internal 
reference material. 
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as in vivo probes.  The development of the labelling procedure to allow the determination 
of particle size by NMR requires further work particulary in finding a model fibril system 
which is suitable for analysis. 
5.6   Further work 
The labelling of amyloid fibrils could be aided by the utilisation of amber codon suppression 
technology or by the implementation of expressed protein ligation or enzymatic 
modifications.  Further investigation of promiscuous labeeling strategies on pH7 forming 
fibrils is also required. 
The transformation of in vitro generated fluorescent Sup35NM into yeast cells would allow 
for the identification of the localisation of these particles post transformation. 
To continue the development of 19F DOSY NMR as a tool for in solution size determination 
the promiscuous labelling of Sup35NM would potentially allow incorporation of 19F label 
onto the conformationally flexible domain visable in the 1H spectra.  Alternatively the use 
ŽĨ ɲ-synuclein as a model system would give access to fibrils with lower propensity to 
aggregate whilst also maintaining the advantage of pH7 fibril assembly.  Investigation of 
other linker units which would be more directional and not liable to collapse onto the 
protein structure such as a polyproline rod (Sato et al., 2007) may give more flexibility and 
therefore NMR signal.  In order to aid the accurate determination of diffusion coefficient by 
comparison with internal reference samples characterisation of the Rh of TFBenol would 
allow the use of only one reference sample with baseline resolution in both 1H and 19F 
experiments.  Alternatively use of TFBenol or other 19F references with 1H baseline 
resolution in conjunction with reference materials with defined diffusion coefficients that 
have distinct 1H NMR signals such as tetramethylsilane (TMS) (Cabrita and Berger, 2001) or 
the water soluble alternative 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) (Horst and 
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6.1   Summary 
Whilst the ability of proteins to adopt the correct protein fold is imperative to their 
biological function, the conversion to amyloid fibrils is not only associated with disease 
(Knowles et al., 2014).  Amyloid formation also has positive impacts such as acting as an 
epigenetic switch allowing for conversion from one phenotype to another and allowing 
adaptation to the environment (Table 1.1) (Prusiner, 1982; Prusiner et al., 1983).  Therefore 
to consider amyloid as a purely negative phenomenon to be cured is wrong.  The 
remarkable physical properties such as strength and stiffness/flexibility (Fig. 1.21) 
associated with amyloid structures make them an ideal starting point for the development 
of nanomaterials for many different purposes. 
Currently only some proteins are known to convert into their amyloid form (Table 1.1) but 
the assumption that all proteins under the appropriate conditions will convert to their 
amyloid form makes an understanding of what is required to induce amyloid formation 
important (Dobson, 1999).  Typically conversion to amyloid involves the misfolding of 
monomeric proteins exposing regions of protein that are susceptible to dimerisation which 
leads to the formation of oligomers and then fibrils. 
Whilst a link between aggregation and disease is observed, the identity of the toxic species 
associated with disease progression is currently contested.  It is apparent from current 
knowledge of the kinetics of fibril formation that fragmentation is a key process in the 
formation of amyloid fibrils but the breakage of fibrils has other implications biologically.  It 
has been observed that fibril fragmentation is a key process in the transfer of information 
from one cell to another in prion inheritience (Byrne et al., 2009).  Recent developments 
have also highlighted fragmentation as a potential mechanism for eliciting toxicity in 
amyloid associated disease (Xue et al., 2009b).  
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In this study we have investigated the expression of amyloidogenic proteins and their 
subsequent assembly into amyloid fibrils.  These materials have enabled the assessment of 
the different fibrils resistance to mechanical stress, as a measure of their propensity to 
fragment, using an AFM based imaging protocol (Xue and Radford, 2013).  In parallel we 
have developed chemical labelling strategies to modify amyloid fibrils in a general way but 
with specific focus on developing an NMR based method for the determination of particle 
size in solution. 
6.2  Production and In Vitro Assembly of 
Amyloidogenic Proteins 
For proteins currently known to convert to amyloid fibrils the conditions required for their 
production and purification vary considerably.  The purification of the material is 
dependent on the ƉƌŽƚĞŝŶ ?Ɛ ƉƌŽƉĞŶƐŝƚǇ ƚŽ ƵŶĚĞƌŐŽ ĐŽŶǀĞƌƐŝŽŶ ƚŽ ƚŚĞ ĂŵǇůŽŝĚ ĨŽƌŵ ĨŽƌ
ĞǆĂŵƉůĞ ɴ ĐĂŶ ďĞĞŶ ŐĞŶĞƌĂƚĞĚ ďǇ ďĂĐƚĞƌŝĂů ĞǆƉƌĞƐƐŝŽŶ Žƌ ƐŽůŝĚ ƉŚĂƐĞ ƐǇŶƚŚĞƐŝƐ ďƵƚ ŝƐ
notoriously difficult to reproducibly generate fibrils, even with identical chemical structures 
(Finder and Glockshuber, 2007).  The aggregation state post purification is the determining 
factor for the observed lack of reproducibility.  This has led to the use of many techniques 
ƚŽĚŝƐĂŐŐƌĞŐĂƚĞɴŵŽŶŽŵĞƌƐƉƌŝŽƌƚŽƉŽůǇŵĞƌŝƐĂƚŝŽŶ(Lee et al., 2007; Teplow, 2006) but 
these methods still rely on an appropriate method of synthesis and purification (Chemuru 
et al., 2014; Finder et al., 2010).   
Where the conversion from monomer to fibrillar form requires initiation by forcibly 
unfolding the protein, like heating in acidic medium, the isolation of the protein is 
simplifiĞĚ ?  Ɛ ĚŝƐĐƵƐƐĞĚ ŝŶ ĐŚĂƉƚĞƌ  ? ƚŚĞ ĐŽŶǀĞƌƐŝŽŶ ŽĨ ůǇƐŽǌǇŵĞ ? ɴ-lactoglobulin and 
insulin B chain are initiated by heating in pH2 this combined with their wide commercial 
availability as monomeric protein suggests that their isolation is relatively easy. 
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For ƉƌŽƚĞŝŶƐ ? ůŝŬĞɴ ?ǁŚŝĐŚĐŽŶǀĞƌƚƚŽƚŚĞŝƌĂŵǇůŽŝĚĨŽƌŵĂƚƉ, ?ĂŶĚƉŚǇƐŝŽůŽŐŝĐĂů ?ƌŽŽŵ
temperature, the purification of pure monomeric protein precursor is complicated by 
concomitant aggregation during expression and purification.  The development of 
conditiŽŶƐ ? ŽďƐĞƌǀĞĚ ŝŶ ĐŚĂƉƚĞƌ  ? ? ĨŽƌ ƚŚĞ ƉƵƌŝĨŝĐĂƚŝŽŶ ŽĨ ɲ-synuclein, Sup35NM and 
Sup35NMC exemplifies the different strategies that need to be employed even for proteins 
ǁŝƚŚƐŝŵŝůĂƌĂŐŐƌĞŐĂƚŝŽŶĐŽŶĚŝƚŝŽŶƐ ?ɲ-Synuclein is a well investigated protein (Cappai et al., 
2005b; Smith et al., 2008; Wu et al., 2009) ĚƵĞƚŽŝƚƐĂƐƐŽĐŝĂƚŝŽŶǁŝƚŚWĂƌŬŝŶƐŽŶ ?ƐĚŝƐĞĂƐĞ
but aside from this its high expression yield and ease of purification under native conditions 
ŵĂŬĞ ŝƚ ĂŶ ŝĚĞĂů ƐƵďƐƚƌĂƚĞ ĨŽƌ ƚŚĞ ĂŶĂůǇƐŝƐ ŽĨ ĂŵǇůŽŝĚ ?  /ŶĐŽŶƚƌĂƐƚ ƚŽ ɲ-synuclein 
purification Sup35NM, Sup35NM LCys and Sup35NMC form aggregates during expression 
which can be disaggregated by denaturing conditions.  The intrinsically disordered nature 
of Sup35NM means that on removal of the denaturant its ability to convert to amyloid 
fibrils is not impaired.  Whilst the N and M domains are intrinsically disordered the C 
terminal domain of Sup35ED ŝƐ ƐƚƌƵĐƚƵƌĞĚ ĂŶĚ ĂůƚŚŽƵŐŚ ŝƚ ŝƐŶ ?ƚ ĞǆƉůŝĐŝƚůǇ ŝŶǀŽůǀĞĚ ŝŶ
amyloid formation its unfolded state give rise to amorphous aggregates in a faster time 
frame than amyloid formation, when the denaturant is removed.  
As well as highlighting the differences in purification of amyloidogenic proteins Chapter 3 
also shows the different conditions required to assemble protein monomers into fibrils.  
The reaction schematic (Fig. 1.15) shows that the initial step in fibril formation is an 
unfolding event which yields molecules which are activated towards cross-beta sheet 
formation.  Initially the assumption was that the harsher conditions of heating the protein 
ŝŶƉ, ?ǁĂƐƌĞƋƵŝƌĞĚƚŽƵŶĨŽůĚůǇƐŽǌǇŵĞ ?ɴ-ůĂĐƚŽŐůŽďƵůŝŶĂŶĚŝŶƐƵůŝŶĐŚĂŝŶ ?ǁŚŝĐŚƵŶůŝŬĞɲ-
synuclein and Sup35 whose amyloid forming regions are disordered, are folded.  Chapter 3 
highlights that simple misfolding is not the only process occurring in these acidic 
polymerisation and in fact amide hydrolysis is an important factor which is corroborated by  





Figure 6.1 Comparison of in vitro formed amyloid fibrils AFM images and their 
properties. 
AFM images of Sup35NMC, Sup35NM, ɲ-synuclein, insulin B chain, ɴ-lactoglobulin and 
lysosyme fibrils deposited onto mica and imaged at a resolution of 1pixel = 9.5656nm.  The 
^ƵƉ ? ?ED ? ^ƵƉ ? ?ED ? ɲ-synuclein, insulin B chain height scales are set between -10 and 
 ? ?Ŷŵ ?  ɴ-Lactoglobulin and lysozyme have a height scale of between -5 and 5nm.  Also 
quoted are mean contour length, height and persistence length values. 
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recent literature (Akkermans et al., 2008; Frare et al., 2004, 2006; Lara et al., 2011a, 2013, 
2014; Piejko et al., 2015).   
The heated acidic conditions employed for these proteins make amide hydrolysis 
ƵŶƐƵƌƉƌŝƐŝŶŐ ďƵƚ ŚǇĚƌŽůǇƐŝƐ ŚĂƐ ĂůƐŽ ďĞĞŶ ŽďƐĞƌǀĞĚ ŝŶ ƉƌŽƚĞŝŶƐ ƵŶĚĞƌ ŶĞƵƚƌĂů Ɖ, ɲ-
synuclein for example has exhibited autoproteolytic activity which liberates more 
amyloidogenic peptides under ambient conditions.  This raises the question of the role that 
hydrolysis plays in the formation of amyloid fibrils generally and although no evidence of 
ƚŚŝƐ ƉƌŽĐĞƐƐ ǁĂƐ ŽďƐĞƌǀĞĚ ĨŽƌ ɲ-synuclein in this work the conversion of fluorescently 
labelled Sup35NM monomer to fibrils, in chapter 5, does show evidence of hydrolysis.  
Comparison by SDS PAGE of fluorescent monomer and fibrils showed the presence of a 
large amount of a slightly smaller material which suggests that it has been excised from the 
cross-beta sheet core.  Whilst there is no evidence as to whether the hydrolysis occurred 
pre or post assembly it does highlight that the substrate protein monomer and the 
monomer unit of the cross-beta sheet core do not necessarily share the same amino acid 
sequence.  The hydrolytic events associated with these proteins suggests further 
ŝŶǀĞƐƚŝŐĂƚŝŽŶŽŶƚŚĞ ‘ŵŝƐĨŽůĚŝŶŐ ?associated with the lag phase of fibril assembly. 
The fibrils derived from the in vitro assembly reactions show the varied structures and 
properties associated with fibrils despite the same core structure (Fig. 6.1), despite in some 
cases the similar size of their starting monomer.  Calculation of the persistence length for 
each species shows that there is no relationship between the rigidity of the polymer and its 
width a fact which seems at odds with the work of Knowles et al (Knowles et al., 2007b) 
who suggest that the core structures exhibit similar flexibility but it is the extraneous 
sidechain interactions which decrease the stiffness.  Our findings suggest that Lp is not 
correlated with fibril width or initial monomer size which is in agreement with the work of 
vandenAkker et al (Schleeger et al., 2013; VandenAkker et al., 2011), who show a 
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correlation with the size of the cross-beta sheet forming domain (Fig. 6.1).  The stiffness 
data described in this work is based on many more particles, tens of thousands, than 
previously attempted, Knowles et al 50 particles per protein, see Table 3.2, and allows 
greater confidence in comparison of these amyloid structures with other polymers. 
6.3   Protein Conjugation and Analysis 
The strength and tunable rigidity inherent to amyloid make it interesting as a nanomaterial 
but the ability to chemically modify fibrils offers the advantage of being able to combine 
these properties with non-biological functionality.  There have been some examples of fibril 
modification previously using traditional labelling approaches (Scheibel et al., 2003) and by 
reappropriation of amino acid sidechain functionality into a role it is not commonly used 
for (Li et al., 2014).  The combination of traditional labelling and state of the art 
bioconjugation techniques allows a completely flexible synthesis of fibrils with the potential 
to use one modified monomer to access a range of modified fibril products pre and post 
assembly.  These modified materials would allow access to conducting polymers as well as 
allowing incorporation of radioactive tracers and therapeutic agents for tissue distribution.   
Due to the complexities associated with fibril formation in both acidic and neutral pH 
media labelling strategies are different for both.  Chapter 5 shows the development of 
labelling strategies which overcome the constraints of both conditions.  The hydrolytic 
mechanism of acidic formation requires promiscuous labelling to give the highest 
probability of the label being attached to the fibrils post assembly.  This method also has 
the benefit of being able to modify all amyloidogenic proteins and requires no prior 
knowledge of the fibril forming region to be employed.  For pH 7 formed fibrils we have 
utilised a denatured protein with the addition of a cysteine residue to allow site selective 
modification.  This method whilst more time consuming gives a more homogeneous 
monomer set and allows for utilisation of prior knowledge regarding the organisation of 
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the fibril to be utilised.  Due to the nature, size, of the particles being generated one of the 
few methods suitable for assessment of whether the modification was attached to the fibril 
post assembly was by fluorescent labelling.  For the cases of both lysozyme and Sup35NM 
fluorescent labelling allowed confirmation of modification but also adds to the evidence of 
hydrolytic events occurring during assembly (6.2). 
 
Although the deposition of fibrils onto a surface for particle size analysis is incredibly 
powerful its limitations were evident from the attempted analysis of the fragmentation of 
insulin B chain in chapter 4.  To circumvent these issues a solution based method for 
 
Figure 6.2  ? Reaction Scheme Highlighting the Different Methods of Formation of 
Fluorescent Protein Monomer. 
A schematic representing lysine/cysteine containing proteins being modified by the 
incorporation of an azide moiety through traditional labelling chemistry.  To the right, 
reaction of the thiol functional group with an iodo acetyl reagent followed by SPAAC to give 
the fluorescent product which is then polymerised in pH7 conditions.  Proceeding left, 
reaction of an amine functional group with an N-hydroxysuccinimde reagent followed by 
CuAAC reaction to give the fluorescent product which is polymerised under pH2 conditions. 
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particle size analysis was developed which uses a labelling strategy developed through 
fluorescent labelling to incorporate 19F nuclei onto proteins which when probed gives rise 
to simplified NMR spectra.  1H DOSY NMR of fusion proteins containing flexible domains 
(Baldwin et al., 2008) and genetically encoded conformationally flexible caps (Platt et al., 
2009) has previously been used to estimate particle diffusion and therefore size. The 
complex spectra associated with 1H spectra complicates these methods but the chemical 
labelling strategy to incorporate 19F nuclei developed in chapter 5.  Whilst the labelling 
strategies employed to date have not yielded a working particle size analysis by 19F NMR 
DOSY the data from the 1H DOSY analysis of Sup35NM suggests that this is mainly due to 
choice of model system and labelling strategy employed.  
6.4   Fragmentation 
The further development of the AFM based methodology, first described by Xue et al (Xue 
et al., 2009a), for analysing the resistance to mechanical stress of amyloid fibrils has shown 
that a key component of the analysis is the generation of samples suitable for AFM 
imaging.  Insulin B-chain and Sup35 both highlight potential limitations of the method.  The 
ĂŐŐƌĞŐĂƚŝŽŶ ŽĨ ^ƵƉ ? ? ĨŝďƌŝůƐ ŝŶƚŽ ŵŝĐƌŽƐĐŽƉŝĐ  “ĐůƵŵƉƐ ? ǁŚŝĐŚ ĂƌĞ ĚŝĨĨŝĐƵůƚ ƚŽ ƵŶƚĂŶŐůĞ 
preclude them from analysis whilst the potential alternative fragmentation mechanism of 
insulin B-chain fibrils prevents monitoring the change in amyloid fibril particle size 
distribution over time. 
Despite the limitations observed, the method was successful for the remaining three model 
systems and the data captured followed the previously ĂŶĂůǇƐĞĚɴ ?ŵƐĂŵƉůĞƐŝŶĨŽůůŽǁŝŶŐ 
a two phase fragmentation where the fragmentation of longer fibrils occurs faster than 
shorter fibrils.  Monitoring the change in fragmentation rate as a function of fibril length for 
all fibrils shows that their rates of fragmentation do not change that much until a point at 
around 250-500nm where the fragmentation rate constant lowers dramatically (Fig. 4.22). 
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Previous work has shown that the Lp of amyloid fibrils is linked with the cross-beta sheet 
structure which runs along the fibril backbone (Knowles et al., 2007a; VandenAkker et al., 
2011).  This work highlights the previously undescribed relationship of Lp with the fibrils 
propensity to fragment when subjected to mechanical stress.  Comparison of the 
fragmentation rate constant for particles 3µm in length for all particles with their Lp shows 
the emergence of an apparent linear correlation between the stiffness of the polymer and 
their resistance to mechanical stress.  Whilst this linearity needs to be further tested by the 
expansion of the data set it does raise the possibility of predicting an amyloid fibrils 
resistance to mechanical stress by calculation of its persistence length. 
6.5   Concluding Remarks 
The prevalence of amyloid in disease and its potential applications as a nanomaterial make 
the development of reproducible in vitro polymerisation of amyloid fibrils great importance 
and allows for their physical properties to be fully investigated and understood. 
By using a range of proteins either commercially available or produced through bacterial 
expression we have investigated different strategies for the purification of monomers, the 
conditions required to initiate their conversion to amyloid fibrils, and their mechanical and 
structural properties.  
The development of robust, reproducible methods for fibril assembly has allowed the 
investigation of the resistance to mechanical stress of amyloid fibrils. This work has 
generated quantitative data from 345403 fibrils across three amyloid forming proteins and 
has enabled a hitherto novel comparison of fibrils propensity to fragment and their 
mechanical stabilities.  This comparison highlights a connection between the fragmentation 
rate of long particles with their stiffness. This study also suggest the fragmentation of all 
fibrillar materials may be expected to break in a similar length dependent manner to that 
described by W.F. Xue & Radford (2013) when subjected to mechanical agitation. This work 
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has highlighted that whilst most fibrillar materials tend to break symmetrically, there may 
be exceptions to this, for example insulin B-chain whose fragmentation generates large 
volumes of small material rather than giving a gradual reduction in size that is observed for 
ůǇƐŽǌǇŵĞ ?ɲ-ƐǇŶƵĐůĞŝŶ ?ɴ-ůĂĐƚŽŐůŽďƵůŝŶĂŶĚɴ2microglobulin. In addition, this work has also 
shown the importance of hydrolysis on the conversion of proteins to amyloid fibrils, in 
vitro, even for proteins not exposed to low pH and elevated temperatures and poses 
questions regarding the primary amino acid sequences observed in mature fibril 
monomers. 
The chemical conjugation strategy presented here in chapter 5 has allowed the 
development of a flexible chemical labelling strategy capable of modifying all amyloid fibrils 
with varied functionality, with particular focus on chemical biology strategies for in-solution 
particle size determination (19F DOSY NMR).  Whilst the NMR size determination has so far 
been unsuccessful it has provided valuable insights into the requirements for conversion of 
this process into a successful method, such as choice of linker and label to different 
amyloid models, which will be able to supplement AFM mediated size determination.  The 
labelling strategy used also allowed development of alternative fluorescently labelled fibrils 
whilst offering advantages for future visualisation of in vitro fibrils in vivo has also provided 
evidence that there is potentially a hydrolytic component to the conversion of proteins to 
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%Extracts polymer information from the ans file 
fib=img.features.polymer; 
%generates a value for the no. of polymers in the file 
s=size(fib,1); 
%A loop which extracts the Contour length, Height, Mode Height and 
Mean 
%Height from the ans file. 
for n=1:s; 
    l{n}=fib(n,1).lContour; 
    h{n}=fib(n,1).z; 
    hparmean{n}=mean(fib(n,1).z)'; 
    hparmode{n}=mode(fib(n,1).z)'; 
end 
%Converts Mean Particle Height into Matrix from cell 
MeanPartHeight=cell2mat(hparmean); 
%Calculates the Mean of the mode particle heights 
ParticleMeanHeightMean=mean2(MeanPartHeight) 
%Converts Mode Particle Height into matrix from cell 
ModePartHeight=cell2mat(hparmode); 
%Calculates the Mean of the mode particle heights 
ParticleModeHeightMean=mean2(ModePartHeight) 
%Extracts the max no. of data points in each cell. 
maxSize = max(cellfun(@numel,h)); 





%Concatenates the columns into one column 
Height=vertcat(H(:),1); 
%All NaNs removed 
Height(any(isnan(Height),2),:) = []; 
%The total no. of height data from traced fibrils 
TracedHeight=size(Height); 
%Selects the first value of the matrix, removes the ,1. 
TracedHeightPixels=TracedHeight(1,1) 








%Converts the l cell array into a matrix Len 
Len=cell2mat(l); 
%Flips the horizontal orientation to vertical 
Len=Len'; 
%Converts the no. of pixels to the length in nm (9.7704 dependent on 









%The sum of the squared contour lengths - single as data is double 
SumCL2=sum(single(CL2)); 
%The sum of the contour lengths - single as data is double 
SumCL=sum(single(CL)); 
%Generation of the length of the longest fibril in nm 
LongestFib=max(CL) 
%loop which finds particles which are of length less than or equal 
to the 
%value p from 1 up to the longest fibril length 
for p=1:LongestFib 
    CDF1{p}=find(CL<=p); 
end 
%Extracts the no. of particles in the cells generated from the loop 
CDF2=cellfun('prodofsize', CDF1); 
%Calculation of the Cumulative Distribution function - each value of 
CDF2 
%divided my the total no. of fibrils 
CDFy=CDF2/n; 
%Generation of Cumulative Distribution Function x axis in nm - upto 
the 
%maximum fibril length 
CDFx=1:p; 
%Calculation of Contour Length weighted mean 
ContourLengthWeightMean=SumCL2/SumCL 
ContourLengthWeightMeanSEM=(SumCL2/SumCL)/sqrt(s) 
%Calculation of Mean Contour Length 
ContourLengthMean=mean2(CL) 
%Calculation of standard error of mean for the Contour Lengths 
ContourLengthSEM=std(CL)/sqrt(s) 
%Calculation of the mean Height from all height values 
HeightMean=mean2(Height) 
%Calculation of the Standard Deviation for Heights (all height 
values) 
HeightSD=std(Height) 
